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Abstract
The diagnosis and treatment of pathologies of the gastrointestinal (GI) tract are performed
routinely by gastroenterologists using endoscopes and colonoscopes, however the small in-
testinal tract is beyond the reach of these conventional systems. Attempts have been made
to access the small intestines with wireless capsule endoscopes (WCE). These pill-sized
cameras take pictures of the intestinal wall and then relay them back for evaluation. This
practice enables the detection and diagnosis of pathologies of the GI tract such as Crohn’s
disease, small intestinal tumours such as lymphoma and small intestinal cancer. The prob-
lems with these systems are that they have limited diagnostic capabilities and they do
not offer the ability to perform therapy to the affected areas leaving only the options of
administering large quantities of drugs or surgical intervention.
To address the issue of administering therapy in the small intestinal tract this thesis
presents an active swallowable microrobotic platform which has novel functionality enabling
the microrobot to treat pathologies through a targeted drug delivery system. This thesis
first reviews the state-of-the-art in WCE through the evaluation of current and past litera-
ture. A review of current practises such as flexible sigmoidoscopy, virtual colonoscopy and
wireless capsule endoscopy are presented. The following sections review the state-of-the-art
in methods of resisting peristalsis, drug targeting systems and drug delivery. A review of
actuators is presented, in the context of WCE, with a view to evaluate their acceptability
in adding functionality to current WCEs.
The thesis presents a novel biologically-inspired holding mechanism which overcomes the
issue of resisting natural peristalsis in the GI tract. An analysis of the two components of
peristaltic force, circumferential and longitudinal peristaltic contractions, are presented to
ensure correct functionality of the holding mechanism. A detailed analysis of the motorised
method employed to deploy the expanding mechanism is described and a 5:1 scale prototype
is presented which characterises the gearbox and validates the holding mechanism.
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The functionality of WCE is further extended by the inclusion of a novel targeting
mechanism capable of delivering a metered dose of medication to a target site of interest
in the GI tract. A solution to the problem of positioning a needle within a 360 degree
envelope, operating the needle and safely retracting the needle in the GI tract is discussed.
A comprehensive analysis of the mechanism to manoeuvre the needle is presented and
validation of the mechanism is demonstrated through the evaluation of scale prototypes.
Finally a drug delivery system is presented which can expel a 1 ml dose of medication,
stored onboard the capsule, into the subcutaneous tissue of the GI tract wall. An analysis
of the force required to expel the medication in a set period of time is presented and the
design and analysis of a variable pitch conical compression spring which will be used to
deliver the medication is discussed. A thermo mechanical trigger mechanism is presented
which will be employed to release the compressed conical spring. Experimental results using
1:1 scale prototype parts validate the performance of the mechanisms.
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Chapter 1
Introduction
1.1 Motivation
There is a growing requirement for surgical procedures to be less traumatic to patients and
require shorter procedure times [1]. These issues are currently being tackled by employing
minimally invasive surgery (MIS). MIS encompasses many surgical procedures in which a
surgeon uses long-handled instruments through a body cavity or a small entry incision to
perform a surgical procedure such as abdominal surgery (laparoscopy).
It is proposed that the application of microrobots to assist remotely in performing
surgical procedures in the gastrointestinal (GI) tract, such as treating colorectal cancer
which is the fourth most common cancer in the UK [2], will greatly increase patient recovery
times and improve surgical outcomes. However the clinical need to treat pathologies of
the GI tract is not being met by today’s technology. It is reasoned that reconfiguring,
adapting and exploiting the latest microscale actuation technology, coupled with creative
and innovative design, will allow increased functionality to be built into conventional WCEs
for the purpose of delivering therapy to a site of interest in the GI tract. The increased
functionality will lead to the exploration and treatment of pathologies of the GI tract
which were previously inaccessible using conventional flexible colonoscopes, resulting in
improved procedure times and comfort for patients. Ultimately the increased functionality
will facilitate the treatment of a larger patient group.
5
Introduction 6
1.2 Background
Conventional surgical procedures rely on an incision long enough for a surgeon to be able
to observe and manipulate the target operating site with their instruments and fingers. A
great deal of damage and trauma can be caused to the bone and surrounding tissue in the
process of reaching the surgical site of interest before the curative procedure can commence.
Therefore it is of great benefit to the surgeon and the patient to minimise this trauma as it
will reduce surgical complications and promote faster recovery times.
One approach towards trauma reduction is MIS. This involves a surgeon inserting long
rigid instruments through a small incision to reach a target operating site. The incision is
generally no longer than 10 mm because restricting the incision avoids excessive damage to
the surrounding tissue and organs.
Although MIS can be seen to bring benefits to the surgeon and to the patient, it also
brings with it certain disadvantages and limitations [3]. As the surgeon is now removed from
direct contact with the operating site they will have lost any sense of touch and feel with
which to aid recognition of the tissue and organs. Instead they must rely on the feedback
generated from operating the surgical instruments. Moreover the reduced access impacts the
surgeon’s ability to manipulate the tools as the 10 mm incision limits the number of degrees
of freedom (DOF) the tools can perform through. These problems together can result in
reduced dexterity which will not only increase the surgeon’s strain but also increase the
possibility of error and lead to potentially longer operating times.
The problem of accessibility in MIS can potentially be overcome by the application of
microrobots [4]. Introducing a microrobot into the body via an incision or through a natural
orifice can offer greater DOF to the surgeon who can now perform the surgical procedure
remotely using the microrobot.
An early example of a basic system can be found in colonoscopy. The M2A is a wireless
swallowable capsule endoscope developed by Given Imaging Ltd. [5] in 2000 to overcome
the problem of examining the small intestine. The capsule which is 11.0 mm in diameter
and 25.0 mm long comprises a complementary metal oxide semiconductor (CMOS) camera,
four illuminating light emitting diodes (LEDs), a radio frequency (RF) module and a power
supply. The problem with this system is that it does not offer the ability to perform therapy
to the affected areas leaving only the options of either administering large quantities of drugs
or surgical intervention.
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The microrobot solutions to MIS use a variety of systems to control and operate their
various functions, but there are limitations such as power consumption when operating
drive motors and space constraints for actuators. However developments in micro actuators
[6], micromotors and the use of shape memory alloys (SMA) [7] may provide solutions for
future in-vivo surgical microrobots.
1.3 Unmet Clinical Needs of Endoscopy
There are a number of wireless capsule endoscopes (WCE) on the market which meet the
medical need for evaluating the appearance of the inside of the GI tract and there are also
capsules which can deliver medication to a region of the GI tract. However these systems
are unable to meet some clinical needs, principally the ability to perform targeted therapy
to an affected area of the small intestines.
There is a clinical need to target and treat pathologies of the GI tract such as ulcerative
colitis, polyps and Crohn’s disease [8]. These pathologies are currently being treated by
using conventional endoscopes in the upper and lower regions of the GI tract but the middle
section, the jejunum and ileum, are only reachable through viewing a series of pictures from
a WCE. The WCE does not meet the clinical need to directly treat these pathologies of
the small intestines. For example if a polyp which required treatment, such as its removal,
was detected by a WCE in the GI tract the operator would be required to revert back to
conventional endoscopy to perform the procedure.
1.4 Research Objectives
The aim of this research is to develop a platform to achieve targeted drug delivery in the
next-generation WCE. A WCE with increased functionality such as the ability to propel
medication through a needle rather than allowing it to disperse throughout the GI tract
would meet the clinical need for targeting a specific location in the GI tract. The WCE
would also be more effective due to the advantages of the shorter discharge time and the
more accurate positioning of the medication. The shorter time will allow for the correct
dosage to be delivered to the required location without it being diluted over the delivery
time from the natural passing of the GI tract or from being dispersed by the constant
movement from natural peristalsis.
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A microrobot with an onboard camera and a targeting system which has the capability of
delivering 1 ml of medication directly into a target site would fulfil the unmet need of visibly
targeting a site with therapy. The drug delivery system when operated would allow a lower
dose of medication to be delivered to the target site, this in turn could improve the patient’s
recovery time. There is also a medical need to diagnose small intestinal Crohn’s disease [9].
This can be achieved by taking a sample of the intestinal tissue, however conventional WCE
cannot perform this function. A microrobot with a targeting biopsy function combined with
an onboard camera would be a significant advancement in the diagnosis and treatment of
small intestinal Crohn’s disease.
Current literature suggests that there is a clinical advantage in monitoring pH levels
during the capsule’s passage through the GI tract as this can give an approximation of
the location of the capsule. Also restricting the capsule’s progress through the GI tract
for a sufficient length of time would enable the pH data to be used for other analytical
purposes such as identifying pathological states associated with abnormal pH levels [10]
and diagnosing gastroesophageal reflux disease (GERD) [11].
1.5 Overview
This section presents an overview of the subject matter covered in each of the following six
chapters.
1.5.1 Wireless Capsule Endoscopy: Background and the State-of-the-Art
This chapter reviews the state-of-the-art in WCE through the evaluation of current and past
literature. A review of current practises such as flexible sigmoidoscopy, virtual colonoscopy
and wireless capsule endoscopy are presented along with the clinical benefits of performing
endoluminal capsule monitoring. An appraisal of the target market for the diagnosis and
treatment of colorectal cancer is presented and a review of the available commercial systems
and how the systems operate is discussed. The biology of the GI tract and the movement
patterns required to process foodstuff such as segmentation and peristalsis is reviewed. The
following sections focus on methods of resisting peristalsis, drug targeting systems, drug
delivery systems and methods of performing biopsies in the GI tract. A review of actuators
is presented, in the context of WCE, with a view to evaluate their acceptability in adding
functionality to current WCEs. The chapter concludes with a comparison of the WCE
Introduction 9
systems discussed in the literature review.
1.5.2 Towards a WCE for Targeted Drug Delivery
This chapter sets out the aims and objectives for this research project. A methodology
to identify key constraints and requirements of the microrobot is presented. The design
methodology presents three research questions, which have been chosen for their impact on
the design of the microrobot at the early design concept stage. The first question addresses
the physical geometry of the microrobot asking what would be the optimal device volume
for a disposable platform. The second question looks at what actuator technology is best
suited for the application and the third question relates to the stopping requirement of
the microrobot, in particular the stopping and holding forces required to resist peristaltic
contractions in the GI tract without damaging tissue. A review of the stages of operation
is presented to evaluate what will be required to achieve a successful WCE procedure. The
chapter concludes with a comprehensive technical specification of the microrobotic platform.
1.5.3 Attaining Equilibrium: Design, Analysis and Evaluation
This chapter presents a novel biologically-inspired holding mechanism based on the order
of insects known as the Coleoptera. Using the biologically-inspired concept of a pair of
folded wings protected by an outer case as a basic premise, a compact holding mechanism
is presented which can be incorporated into the next generation of WCE for the purpose
of resisting natural peristalsis in the GI tract. This chapter describes the requirements of
WCE and discusses the detailed analysis of the holding mechanism. The gear train, which
is an important part of the mechanism, is described and an analysis of the micro-metre gear
teeth, in the context of torque delivery, is presented. An analysis of the two components
of peristaltic force, circumferential and longitudinal peristaltic contractions, are presented
to ensure correct functionality of the holding mechanism. A fully functioning prototype of
the holding mechanism is evaluated and the prototyping methods selected to produce the
component parts of the holding mechanism are discussed. A series of experiments, using
5:1 scale prototype parts, is presented which characterises the gearbox and validates the
holding mechanism.
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1.5.4 Targeted Drug Delivery: Design, Analysis and Evaluation
This chapter presents a novel targeting mechanism capable of delivering a metered dose of
medication to a target site of interest in the GI tract. Building on the medical motivation
given in Chapter 1 and the design specification presented in Chapter 3 this chapter focuses
on finding a solution to the problem of positioning a needle in the GI tract, operating
the needle and safely retracting the needle. The requirements for needle penetration are
discussed and a comprehensive analysis of the mechanism chosen to manoeuvre a dispensing
needle is presented. The analysis focuses on the critical features of the proposed mechanism.
To ensure that the needle positioning mechanism performs mechanically an analysis of
the geometry, and also of the materials the mechanism could potentially be manufactured
from, is reviewed. Prototypes of the mechanism are presented and an evaluation of their
performance is discussed. The final section presents the measurement and characterisation
of the needle positioning mechanism through two 5:1 scale prototypes.
1.5.5 Drug Delivery System: Design, Analysis and Evaluation
This chapter presents a drug delivery system. A novel actuator is considered for its suitabil-
ity to expel a 1 ml dose of medication, stored onboard the capsule, into the subcutaneous
tissue of the GI tract wall. An analysis of the force required to expel the medication in a set
period of time is presented and the design and analysis of a variable pitch conical stainless
steel spring which will be used to deliver the medication is discussed. A thermo mechanical
trigger mechanism is presented which will be employed to release the compressed conical
spring. This method of triggering the spring relies on the Joule’s effect to heat an igniter
which in turn ignites a pyrogen that melts a Nylon wire. The Nylon wire is employed to
retain the coiled spring. A method of overcoming the issue of power distribution through
the microrobot is discussed. The solution takes into consideration the requirement for the
holding mechanism to rotate 360 degrees and also allows for the medication chamber to be
manually filled. A series of experiments using 1:1 scale prototype parts are presented which
validate the drug delivery system.
1.5.6 Conclusion
This chapter discusses the contributions which have been presented in each of the preceding
chapters. The research presents a WCE with increased functionality resulting in the de-
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velopment of the world’s first microrobot with the capability of delivering targeted therapy
in the GI tract. A discussion of the adaptability of the novel mechanisms and how they
can be reconfigured to perform a number of procedures, such as gastrointestinal biopsy, is
presented in the future work.
1.6 Publication Output
Parts of this research have been published in journals and conference proceedings. The jour-
nal article ‘Wireless Capsule Endoscope for Targeted Drug Delivery: Mechanics and Design
Considerations’ has been listed on the ‘most downloaded articles in the past month (pub-
lished in the past 3 years)’ list published by IEEE Transactions on Biomedical Engineering.
Its position was 15th in May 2015 and it finished 19th in September 2015.
Journal Publications
• S. P. Woods and T. G. Constandinou, “A Compact Targeted Drug Delivery Mech-
anism for a Next Generation Wireless Capsule Endoscope,” Journal of Micro-Bio
Robotics, vol. 11, no. 1, pp. 19-34, 2016. doi:10.1007/s12213-016-0088-9.
This article contains content which contributed to Chapters 2, 3 and 6.
• S. P. Woods and T. G. Constandinou, “Engineering Micro Mechanical Systems for the
Next Generation Wireless Capsule Endoscopy,” Biomedical Research International,
vol. 2015, Article ID 741867, 14 pages, 2015. doi:10.1155/2015/741867.
This paper contains content which contributed to Chapter 2 and Chapter 4.
• S. P. Woods and T. G. Constandinou, “Wireless Capsule Endoscope for Targeted
Drug Delivery: Mechanics and Design Considerations,” Transactions on Biomedical
Engineering, vol. 60, no. 4, pp. 945-953, 2013.
This article contains content which contributed to Chapter 4 and Chapter 5.
Conference Publications
• S. P. Woods and T. G. Constandinou, “A Novel Holding Mechanism for Next Gener-
ation Active Wireless Capsule Endoscopy,” Proc. IEEE International Conference of
the Engineering in Medicine and Biology Society, pp. 1181-1185, 2015.
This paper contains content which contributed to Chapter 2 and Chapter 4.
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• S. P. Woods and T. G. Constandinou, “Towards a Micropositioning System for Tar-
geted Drug Delivery in Wireless Capsule Endoscopy,” Proc. IEEE International Con-
ference of the Engineering in Medicine and Biology Society, pp. 7372-7375, 2011.
This article contains content which contributed to Chapter 5.
Press Articles
• M. Piesing “Medical robotics: Would you trust a robot with a scalpel?”, The Observer
(London), October 10th, 2014.
• “IDC Models revolutionary Robotic Pill receives ’thumbs up’ from US technology
website”, IDC Design Lines, February 13th, 2013.
• B. Plackett “The Future Of Medicine: Your Surgeon in a Pill”, Tech Page One,
February 12th, 2013.
• “The ’robotic pill’ - SLA prototyping in miniature”, Design Products & Applications,
October 18th, 2012.
• “IDC Models produces Robotic Pill, a revolutionary new treatment for cancer”, IDC
Design Lines, October 18th, 2012.
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Chapter 2
Wireless Capsule Endoscopy:
Background and the
State-of-the-Art
2.1 Overview
MIS offers reduced trauma to patients through the manipulation of tools through small
incisions [1]. However introducing a microrobot into the body through a natural orifice can
offer greater DOF to the surgeon. This chapter investigates the current solutions available
for the exploration of the GI tract. It focuses on methods for diagnosing pathologies of the
small intestine (ileum) and of the large intestine (colon). The emphasis is placed on WCE
methods rather than methods such as push enthrascopy as WCE offers the surgeon greater
DOF due to the ability to operate the microrobot remotely.
2.2 Background
The introduction of the first flexible colonoscope in 1963 was followed by the first commercial
colonoscope manufactured by Olympus Corp. in 1969 [2]. The flexible colonoscope has
enabled colonoscopy to become the standard procedure for examining the appearance of
the internal surface of the full length of the colon. The colonoscopy procedure involves
an examiner, usually a doctor, introducing a 2 m long flexible tube that is approximately
13.2 mm in diameter into the large intestine. The progress can be monitored through an
15
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eye piece on the instrument or via a monitor.
The procedure is performed to investigate abdominal pain, diarrhoea and abnormalities
found on colon X-rays or CT scans. The procedure normally takes between 15 and 60
minutes for the instrument to be fully retracted through the whole length of the large
intestine. Medication is often given to make the patient sleepy and relaxed as colonoscopy
often gives a feeling of pressure, cramping, and bloating but does not cause any significant
pain.
Endoscopists complain of the technical difficulties involved in managing the long, flexible
instruments and of the difficulty in navigating the tight angles of the colon. These issues
are particularly important to newly trained surgeons as inexperience can lead to increased
procedure times and the potential to cause damage to the intestinal wall such as small
tears or even perforation [3]. The main limitation of the colonoscopy procedure is that the
colonoscopes are unable to reach the full length of the GI tract leaving the small intestine
unexamined.
2.2.1 Current Practices
There are alternative procedures to colonoscopy currently being used to investigate the GI
tract however they also have limitations, they are:
• X-ray performed with a barium enema. This procedure can miss lesions, also if lesions
are found colonoscopy may still be required to biopsy or remove the abnormality.
• Flexible sigmoidoscopy. This procedure examines the descending colon (left side of
the colon) and the sigmoid colon (lower part of the large bowel) for signs of disease.
It is a limited procedure which is used at an early stage to diagnose symptoms such
as unexplained anaemia, visible rectal bleeding and positive haemoccult stools.
• Virtual colonoscopy uses a CT scan to construct a virtual image of the colon. It
can find hidden polyps, obstructions, fistulas and abscesses however it has several
limitations [4]:
◦ Polyps less than 5.0 mm in size cannot be found.
◦ It is not as accurate as colonoscopy at finding flat cancers or lesions that are not
protruding.
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◦ It cannot remove polyps. If they are found then a colonoscopy must be performed
to remove them.
◦ The main disadvantage is high doses of radiation exposure.
• Wireless capsule endoscopy uses a swallowed video capsule to take photographs of the
inside of the GI tract [5]. One major advantage of the procedure is that the patient
is not confined to a hospital environment. The limitations with the procedure are:
◦ Rapid transit of the capsule can miss abnormalities due to blurred photographs.
◦ Relies on peristalsis to progress through the GI tract.
◦ Batteries can fail before examining the entire tract due to slow transit.
◦ If abnormalities are found it can be difficult to determine where they are located.
◦ Capsules can be retained causing an obstruction that will require surgical re-
moval.
◦ Reviewing the photographs is very time consuming.
2.2.2 Clinical Benefits
Endoluminal capsule monitoring devices such as the M2A, Given Images [6], Olympus En-
doCapsule [7] or the MiRo, IntroMedic Corporation [8] are particularly clinically beneficial
for diagnoses in the small intestine [9], which is extremely challenging to access without
them. They are able to detect a number of diseases such as:
• Obscure gastrointestinal bleeding (OGIB). OGIB is persistent or reccurring bleeding
which cannot be explained. The origin of the persistent bleeding is unknown even
after initial endoscopic evaluations [10]. The OGIB procedure accounts for 60%-70%
of all WCE examinations worldwide [11].
• Coeliac disease. Coeliac disease occurs in genetically predisposed individuals. It is an
adverse reaction to the gluten protein found in wheat, rye and barley. It can cause
diarrhoea, abdominal pain, bloating, weight loss and a failure to thrive due to the
reduced ability of the small intestines to absorb nutrients [12].
• Angiodysplasias. Small bowel angiodysplasias (SBA) accounts for 15% of GI bleeding
cases. SBA is a collection of friable blood vessels just under the inner intestinal lining.
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The vessels are susceptible to recurrent haemorrhaging as the ageing process reduces
the surrounding muscle layer [13].
• Small intestinal tumours such as lymphoma, carcinoid tumours and adenocarcinoma
(small intestinal cancer).
• Crohn’s disease. Crohn’s disease can affect any part of the GI tract. It is a chronic
inflammatory bowel disease found in genetically susceptible individuals. The disease
can be triggered by immunological, bacterial or environmental factors. The symptoms
include diarrhoea, weight loss, abdominal pain and vomiting however it may also cause
skin rashes, arthritis and chronic anaemia [4].
Being able to detect pathologies of the GI tract using endoluminal capsule monitoring
devices offers the potential to diagnosing a wide selection of patients.
2.2.3 Target Market Segment
The statistics for cancer in the UK show that the three most common cancers found in
men are prostate (25.6%), lung (13.8%) and colorectal (13.6%) and the three most common
cancers for women are breast (30.7%), lung (11.6%) and colorectal (11.2%) [14]. As is
evident from the statistics colorectal cancer is the fourth most common cancer in the UK
and it represents a significant percentage of patients. Published figures for 2010 show that
approximately 40,700 people (22,834 men and 17,861 women) were diagnosed with colorectal
cancer in the UK and that there were 15,708 deaths attributed to colorectal cancer [15].
The global picture shows that an estimated 1.24 million cases of colorectal cancer were
diagnosed in 2008.
The statistics reveal that there is potentially a large market for the diagnosis and treat-
ment of colorectal cancer which is why the market has responded with new generation
products like the Pillcam SB3 developed by Given Images and the EndoCapsule manufac-
tured by Olympus Medical Systems Corporation. GlobalData estimates that the market for
WCE systems, valued at $163.5 million (£100 m) in 2008, is forecast to grow by an average
7% annually during the next seven years to reach $261.3 million (£161.3 m) by 2015 [16].
The estimated sales figures appear to be in line with reported sales of WCE, for example
since 2001 it is reported that Given Images’ PillCam capsules have been used in more than
2 million patients worldwide [17]. As WCE are becoming the gold standard for inspecting
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the GI tract it is not unrealistic to expect the market to grow as predicted or even exceed
expectations.
2.2.4 Commercial WCE Systems
There are a number of commercial WCE systems available on the market for visualisation of
the GI tract such as the M2A, Given Images [6], the Olympus EndoCapsule [7] or the MiRo,
IntroMedic Corporation [8]. However the market leader is the M2A developed by Dr Gabi
Iddan. Dr Iddan and Dr Gavriel Meron founded the Israeli Company Given Imaging in
1998 and produced the first WCE in 2000. The technology was founded on the idea of
miniaturising missile imaging technology so that it could be utilised in a medical device
that could explore the GI tract.
The M2A capsule was renamed PillCamTM SB(R) in September 2004 (Figure 2.1),
having received its CE approval in May 2001, it then gained FDA approval in August 2011.
In 2006 the PillCamTM SB(R) retailed at $450 (£270) each and was supplied in packs of
ten. The accompanying RAPIDr Application Software and Workstation retailed at $17,000
(£10,520) and the Data Recorder (DR2), which is reusable and includes a belt pack, aerial
harness and batteries, retailed at $4,995 (£3,000) [18]. The PillCamTM SB(R) has proven a
useful medical tool as by May 2009 Given Images had sold 1 million devices. The PillCamTM
contains light emitting diodes, a camera, a lens, batteries, an antenna and a radiofrequency
transmitter. The complete system is outlined in Figure 2.2.
Figure 2.1: PillCamTM SB(R) developed for visualising the small bowel and PillCamTM
ESO developed for visualising the oesophagus [17]
The holding unit contains a magnet which renders the WCE inoperative. Removing
the WCE from the holding unit activates the device. This method of activation ensures
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Figure 2.2: Component parts of the WCE and a system overview including sensor array
and location guide [19]
the batteries have not deteriorated during storage and that they have enough capacity to
complete the 7 to 8 hour transit through the intestinal tract. The capsule records images
of the intestinal tract, approximately 2 every second, and transmits them to a receiver
worn on a belt-pack by the patient. A series of sensors is placed in specific locations
across the abdomen. These sensors are connected by wires to a receiver unit where the
transmitted images are recorded. The sensor array and recorder unit can be worn under
normal clothing. The position of the capsule is triangulated using the sensor array as the
capsule passes through the GI tract, this technique achieves a positional accuracy of ±3 cm.
Once the examination procedure has been completed the image recording unit is connected
to a computer workstation where dedicated software (RAPIDr) is used to evaluate the
data. The software allows the user to watch the captured images at varying speeds both
forwards or backwards and also label individual frames for future reference.
Many clinical studies have been carried out using WCE for the purpose of detecting
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diseases of the small bowel. The type of images which are captured by the procedure and
viewed through the dedicated software are displayed in Figure 2.3.
Figure 2.3: Example of images taken by WCE. Pictures of patients with intestinal stricture
due to tuberculosis with enterolith (A), small bowel tumors (B, C, D), hookworm (E) and
active bleeding without an identifiable causative lesion (F) [19]
As can be seen from Figure 2.3 WCE offers the ability to diagnose a diverse range of
pathologies which can be observed in the small intestines. For example Figure 2.3 A) shows
an image of a patient who has an intestinal stricture due to tuberculosis with enterolith, a
mineral concretion, while Figure 2.3 E) shows a hookworm infestation which is commonly
detected by the WCE procedure.
2.2.5 Biology of the GI Tract
The biology of the GI tract presents many challenges to a successful examination by WCE.
From the negotiation of the pylorus into the duodenum, to obtaining a clear visualisation
of the lumen wall, there are a series of obstacles to be overcome. The GI tract can vary
greatly from patient to patient however the average diameter in adults of the large colon is
approximately 60.0 mm and the average diameter of the small intestines is approximately
20.0 mm [20]. In addition, the GI tract is a slippery environment as the viscoelastic walls
are covered by a 1.0 mm to 2.0 mm [21] thick layer of lubricating mucosa which can have a
coefficient of friction as low as 10−3 [22]. To put the slippery environment into perspective
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the coefficient of friction for the lubricating mucosa can be compared to Teflonr which has
a coefficient of friction four times higher [23].
2.2.5.1 Movement Analysis of the GI Tract
Once swallowed the WCE will pass through the alimentary canal, Figure 2.4. The particular
section of interest for diagnosis and treatment is the small intestines as this section is very
difficult to access. The small intestines comprise of the duodenum, the jejunum and the
ileum. These three sections make up the longest part of the alimentary canal at 6.25 m [24].
The duodenum is C shaped and its mouth, the pylorus, extends from the stomach giving
this section a degree of stability. The jejunum and the ileum are free to move, however their
natural state is collapsed.
Figure 2.4: Sections of the alimentary canal
In order to process foodstuff, a liquid mixture called chyme, the small intestines uses a
series of movement patterns. These patterns, segmentation and peristalsis [20], cause the
chyme to progress through the tract. Segmentation is a contraction of the duodenum for the
purpose of mixing food. There are two processes involved, they are eccentric contractions
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and concentric contraction. The first generates very little intraluminal pressure and the
second can generate pressures as high as 20 mmHg [20]. The frequency of the contractions
is dependent on eating patterns, becoming stronger as chyme is being processed. Peristal-
sis is the process of moving chyme through the intestinal tract from the stomach to the
colon by means of a series of muscle contractions acting in a wave pattern. The muscle
contraction acts in two planes, circumferential and longitudinal. Miftahof (2005) [25] has
developed a mathematical model to describe the dynamics of the electromechanical wave
phenomenon of a segment of the gut. They report that the active force of contraction in
the longitudinal direction to have an amplitude of 17.2 g/cm and an amplitude of 26.9 g/cm
in the circumferential direction.
The process of peristalsis allows food to pass through the GI tract. The time it takes for
this process to be completed can vary between patients with normal transit times ranging
from 20 hours to 56 hours [26]. Transit times of the small bowel range from 15 minutes to
5 hours with the mean average time taking 84 minutes [27].
Prior to administering a WCE it is common practice to determine if the patient is
suitable for the capsule endoscopy procedure. This is achieved through the administering
of a patency capsule. Patency capsules check the patient is not suffering from known or
suspected strictures and that the GI tract is open and unobstructed. If the patency capsule
becomes stuck in the GI tract it will dissolve over a period of time however if the capsule is
passed within normal time parameters the patient can be assessed for the WCE procedure.
2.3 WCE Components
The development of GI endoscopes with more DOF offers greater advantages to the en-
doscopists and to the patient [28]. An early pioneer of active endoscopes was Koji Ikuta
(1988) [29] and co-workers who developed a SMA actuated multi-DOF endoscope with
electric resistance feedback. The snake-like robot could be guided around obstacles using
SMAs. Other systems include the in-pipe inspection robot developed by Toshio Fukuda
(1989) [30] and the inchworm-like locomotion system, that exploited inflatable balloons and
rubber bellows as actuators, developed by Joel Burdick (1994) [31, 32]. The problem with
these prior devices is that they all use wires connected to an outside source to power the
cameras and actuators and as a result make the procedure uncomfortable for the patient.
However to help overcome this issue local sedation is often administered.
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Significant advances in the field of medical devices have been made with the introduction
of WCE [5]. Replacing the standard endoscopy procedure with a swallowable capsule will
benefit the patient in terms of increased comfort and safety and a larger number of patients
can be screened more effectively. As comfort is improved and the indignity of the procedure
reduced the target screening group will also be increased. However commercial WCE have
some limitations one being the lack of an active locomotion system which restricts the ability
to navigate through the GI tract and another the inability to perform therapy to an area
of interest for example delivering medication to a specific pathogen such as an ulcer.
Researchers are developing technologies which will overcome these issues such as in the
area of active locomotion. The addition of active locomotion to a WCE will expand the
diagnostic capabilities of the device and enable the surgeon to perform endoscopy in a
totally controlled manner.
2.3.1 WCE Essential System Features
In order to achieve a successful examination of the GI tract or perform a procedure such
as obtaining a biopsy sample from a specific location, a WCE must possess a number of
essential system features. These system features can be categorised into five main areas:
• Vision system
• Telemetry system
• Central processing unit
• Locomotion/holding
• Power unit
The vision system, which can either be a CMOS or CCD image sensor, is illuminated by a
minimum of 4 white SMT LEDs. CMOS image sensors consume less power than CCD image
sensors however they have lower picture quality. The image sensor must possess sufficient
resolution and field of view to determine macroscopic abnormalities of the intestinal mucosa.
Typically these features are 0.1 mm and 140 degrees [33] respectively with a depth of view
of between 1.0 mm to 30.0 mm and a 1:8 magnification.
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The telemetry system will transmit approximately 55,000 compressed video frames over
the 7 to 8 hour examination period [34] and also any readings which have been taken, such as
pH levels, to an external receiver worn on the body. The external receiver comprises a series
of leads placed over the abdomen and connected to a recording unit. The radio frequency
transmitter must be compact and consume minimal power, it must also be optimised for
transmission through the human body. The allowable limits for the intensity of the radiated
field about the abdomen has been determined by the Federal Communications Commission
(FCC) for Wireless Medical Telemetry Service (WMTS) to be in a band of 608 MHz to
614 MHz however higher frequencies can also be used such as 1,395 MHz to 1,400 MHz [35].
The onboard central processing unit is responsible for controlling all of the functions
of the WCE, such as the telemetry system, power management (i.e. DC/DC conversion),
timing and the control of actuators. The controller is implemented in a custom ASIC.
In order for a WCE to perform therapeutic activities it must be capable of resisting
peristalsis or actively moving to a desired location in the GI tract. To accomplish this task
micro actuators integrated into the WCE are utilised or an external approach can be used
where magnetic fields are used to control the position of the capsule.
The power unit, which generally consists of one or two silver oxide button cell batteries,
is the most important feature of the WCE as it facilitates all the required operations. The
limiting factor for power management is the available space onboard the capsule to accom-
modate the batteries. Alternative wireless power transfer methods are available however
they also require onboard space and large external equipment to operate them.
Different system features can be combined to perform a multitude of medical procedures
such as combining two cameras, one at the front and one at the back of the capsule, to allow
for a greater area of inspection of the GI tract. However system features are restricted by
the geometry of the capsule as the addition of a second camera would prohibit the inclusion
of other system features such as a holding mechanism.
2.3.1.1 Simple Mechanisms
Mechanisms, which consist of a system of parts operating together to achieve a particular
function, have historically been used for a range of purposes from timekeeping [36] to the
production of clothing [37]. However in order for mechanisms to operate they are required
to interact with actuators, such as micromotors. Simple mechanisms facilitate the desired
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movement and offer a potential mechanical advantage to the system. There are a number of
methods for translating the actuator motion into useful motion, some of the general methods
are gears, pulleys, cams, screws, levers and ratchets. A description of the advantages and
disadvantages of these general methods used in the next generation of WCE is outlined in
Table 2.1.
These mechanisms are universal therefore only mechanisms used in WCE will be re-
viewed as they share key characteristics. The following sections review a number of WCE
system features such as methods of obtaining a biopsy sample in the small intestines and
methods for resisting peristalsis. The final section presents a review of fabrication methods
suitable for realising prototypes.
2.3.2 Methods of Resisting Peristalsis
For a WCE to deliver therapeutic treatment to the GI tract it must firstly overcome peri-
stalsis. To this end researchers have proposed many methods to halt the progress of a
capsule such as balloon insulﬄation and harnessing magnetic fields. Having the ability to
temporarily resist peristalsis by means of an anchoring mechanism overcomes the prob-
lem of relying on the operator’s judgement in determining the optimum time to deploy a
therapeutic treatment.
2.3.2.1 Holding
There are three methods employed for halting the progress of a WCE by enabling it to
resist the natural movement from peristalsis. One utilises micro-actuator mechanisms em-
bedded within the capsule, such as the paddling based microrobot developed by Park et al.
(2007) [38]. The second approach exploits external magnetic fields to control the position
of the capsule [39] and the third approach applies a stimulus to the GI tract to inhibit
peristalsis [40].
There has been much development in the field of magnetic control of WCE such as the
magnetic shell employed by Carpi et al. [39]. This system looks to modify existing WCE
with the addition of a magnetic shell. The shell can be used to guide the WCE by means
of an external magnetic field, however this system requires large equipment to perform the
procedure and there is also an increase in the diameter of the WCE making it more difficult
to swallow.
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Table 2.1: Review of simple mechanisms which can interact with actuators
Actuation Advantages Disadvantages
method
Gears Can transmit high torque without slipping Low module (<0.5) gears are difficult to manufacture
Gear trains can deliver a mechanical advantage Expensive to manufacture compared to pulleys
through a gear ratio Lubrication may be required
Gear trains output a definite velocity ratio Misalignment of gears will produce vibration, noise
Standard gear modules of 0.5 to 14 can be selected and quickly damage the gear train
to determine the size of the gear Replacing damaged gears can be difficult and costly
Drive direction can be reversed
Pulleys A set of pulleys offers a mechanical advantage Flanges at the sides of the pulley are undesirable due
Compared to gears it is a simple system which to the belt’s tendency to crawl against them
requires no lubrication Large crowns can cause the belt to break where belt
Crowned pulleys can self-centre a belt through curvature changes rapidly between pulley centres
the use of convex curve or V-forms Relies on friction to deliver power with a potential
Face widths can be the same as the belt width for varying velocity ratios as the belt can slip
There is a degree of overload protection due to Belts may be strained if tight pulley radii are used
potential slipping of the belt Unsuitable for high speeds and high torque transmission
Large shaft centre distances can be accommodated More space is required compared to a gear train
Slight misalignment of pulleys can be tolerated Open belt pulley can be unsafe
Belts are easily replaced compared to gears
Cams An open track or a closed track can be used to Initial start up can generate shock at the beginning
drive the follower and end of the stroke
A closed track has positive drive throughout the An open track requires a sprung follower to guarantee
cycle contact through the cycle
Rotational motion can be translated into variable The interaction between the cam and follower can
linear motion generate noise and vibration
The shape of the cam determines the motion of
the follower
Screws Can translate rotational motion into linear motion V-form threads generate high frictional force making
Threads on a leadscrew can engage with threads them unsuitable for power transmission
on a nut resulting in either rotational movement Trapezoidal threads generate radial pressure on the nut
of the leadscrew with a static nut or the nut causing uneven motion of the nut
advancing with a static screw Threads can wear quickly due to the high degree of
The pitch of a thread can vary the linear movement friction
relative to the rotational speed of the screw Square threads are more difficult to manufacture
Rotation of fine pitched screw threads can exert compared to trapezoidal threads
large axial loads A large volume of space is required to accommodate a
Thread forms are easy to generate using driven leadscrew assembly
conventional CNC machines
Levers A rigid beam pivoting at a fixed point may offer a Pinned joints are required which can be complicated to
mechanical advantage by amplifying the input load produce
An oscillating lever can be used to translate into An incorrectly positioned pivot can negate any
a linear movement mechanical advantage
Space constraints may limit the achievable mechanical
advantage
Ratchets Can transmit intermittent motion Can only be used for slowing a drive system down
Pawls prevents reverse motion of the ratchet The pawl produces a jerking action which may result in
Coarse pitched teeth can produce fine feeds with noise and vibration
multiple pawls A second pawl may be required to prevent the drive pawl
from pulling the ratchet wheel backwards
Pawls may require springing to guarantee correct engagement
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2.3.2.2 Immobilisable In-Vivo Sensing Device
The patent proposed by Gilad and Iddan (2004) [41] attempts to temporarily halt the
progress of a capsule by deploying two anchors into the intestinal wall, Figure 2.5.
Figure 2.5: Immobilisable in-vivo sensing device [41]
The capsule contains an immobilisation unit to immobilise, hold or otherwise arrest the
motion of the capsule. The immobilisation unit is contained in a separate chamber in the
body completely sealed from any of the other components. The exit holes for the anchors
are also sealed with film to prevent ingress from the liquid environment.
The immobilisation unit contains two anchors separated by a spring and a fuse joined to
the anchors. The ends of the spring are soldered to the fuse to ensure a good connection and
to prime the mechanism. The anchors have a 0.5 mm - 2.0 mm point capable of piercing the
endoluminal walls. The anchors are activated by breaking the ferrite fuse which is triggered
through the presence of transmitted radio waves or through the application of an electrical
charge. When the fuse breaks, the pointed anchors are pushed by the spring through an
aperture in the capsule case and through the wall of the GI tract.
The anchors are made from a biodegradable material such as caramel, biodegradable
plastic resins or starches, such as gelatine or wax. The anchors are released from the GI tract
by the process of degradation or becoming soluble due to exposure to the moist conditions in
the GI tract. An anti-biotic coating may be applied to the anchors to counter any possible
injuries encountered through their application.
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The distance the anchors extend from the capsule case would appear insufficient to
penetrate through the 2.0 mm to 3.0 mm thick GI tract wall. Also the compliant nature of
the intestinal wall would suggest that it would move out of the way of the anchors rather
than resisting their force and allowing them to penetrate. Further, a perforated intestinal
wall is an unwanted outcome of small intestinal endoscopy [3].
2.3.2.3 Micropatterned Adhesive Anchoring Mechanism
An alternative method for anchoring to the intestinal wall which reduces the risk of injury
to the intestinal tissue is proposed by Glass et al. (2008) [42]. They propose a three-
legged anchoring mechanism which utilises micropatterned adhesives for resisting peristalsis,
Figure 2.6.
Figure 2.6: CAD conceptual three-legged anchoring capsule [42]
Once an area of interest has been identified in the GI tract by the passing of a standard
microcapsule, the proposed three-legged capsule would be used to follow up the procedure
and further investigate any areas of interest or perform localised therapy.
The anchoring mechanism consists of three axially aligned legs equally spaced around
the capsule. Each leg is connected to a cylindrical pulley which is free to rotate. One end
of a cable is secured to the capsule while the other end is secured to the upper end of the
leg. The normal state of the cables is relaxed with the legs in the closed position. The leg
pulleys are connected to the base of the capsule via rubber springs. When the anchoring
mechanism is activated micromotors or SMA wires pull the cables, this results in a torque
being applied to the pulleys which can now rotate the legs opening them outwards. At
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the same time the rotation applies a torque to the rubber spring resulting in an opposing
torque, this counter torque is the means of returning the legs to the closed position when
the cable torque has been removed.
To secure the capsule to the wall the ends of the legs have a pad which is coated with a
micropattern of adhesive. The adhesive is a biocompatible polymer, polydimethylsiloxane
(PDMS). The advantage of using an adhesive to secure the capsule to the wall is that no
additional energy is required to maintain the bond after adhesion has occurred and that it
requires very little power to remove it due to the peeling action of the arm mechanism.
Although the adhesive pads are embedded in the side of the capsule they are potentially
vulnerable to contamination from the environment as the adhesive layer has no protective
covering. As the capsule passes through the stomach and negotiates its way around the
intestines it is very likely that the adhesive pads will become contaminated with particulates.
This contamination will significantly reduce the effectiveness of the pads adhering to the
intestinal wall. The patient would be required to overcome the obstacle of swallowing a
sticky capsule.
2.3.2.4 Integrated Frontal Clamping System
Menciassi et al. (2005) [43] propose a system for clamping to the wall of the GI tract for
the purpose of long-term monitoring. The system is to be integrated into a WCE to achieve
accurate visualisation of a target location and long-term pH monitoring, Figure 2.7.
Figure 2.7: Prototype of frontal clamping capsule [43]
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The clamping system utilises three grasping units which extend forwards from the cap-
sule and can be activated to clamp to the intestinal wall. The orientation of the three
grasping units has been chosen specifically for the advantage of obtaining visual feedback
of the whole clamping procedure. The disadvantage with this orientation as opposed to a
laterally orientated clamp is the reduced effectiveness of the grasping units as the intestinal
wall is normally collapsed onto the capsule case and not in front of it.
The clamping mechanism is a combination of two subsystems, one system to operate the
protrusion and return of the grasping unit and another system to operate the opening of the
grasping unit. The clamper unit slides in a groove which runs parallel to the capsule’s body
and is the vehicle which moves the grasping unit. The clamper unit is driven by thermally
activating a 100µm diameter SMA wire which is housed in a trench that runs alongside the
groove. The wire has been coiled to generate the large forces required to slide the clamper
unit forwards to bring it into contact with the intestinal wall.
The grasping unit comprises two arms made from SMA, this material has been selected
for its superelastic properties. The arms are normally in a closed position which is achieved
by virtue of a flexure joint which biases the arms. The arms are activated by heating a
20.0 mm long by 50µm diameter SMA wire which has been fixed into holes in the arms.
The heating causes the wire to contract which opens the arms. The method of operation
minimises the power consumption of the system.
2.3.2.5 Legged Anchoring Mechanism
Current devices lack the ability to control their speed and direction relying on natural
peristalsis to move them through the GI tract. A solution that overcomes this problem is
the robotic legged locomotion device developed by Valdastri et al. (2009) [44], Figure 2.8.
The 12-legged endoscopic capsular microrobot features two sets of six legs integrated
into the capsule (Figure 2.8). These propel the device through the GI tract and help to
uniformly distend collapsed colon tissue making visualisation easier. The dimensions of the
device, not including the power supply but including the snap-on vision system, is 11.1 mm
in diameter and 33.0 mm long.
The legs are operated via their connection to a nut which moves axially up and down a
leadscrew. The set of legs simultaneously open and close as the nut translates the leadscrew,
with each set of legs being independently controlled by a motor and gearbox. The number of
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Figure 2.8: Prototype of the 12-legged endoscopic capsular robot [44]
legs distributes the contact force over the colon wall reducing slippage, however a different
configuration of the leg ends such as a shaped paddle may distribute the contact force more
evenly minimising the number of legs while still supporting the tissue.
The design of the legs would appear to allow only for forward movement, this is also
evident in the design of the knee joints as they are designed to allow the leg to flex when
moving forward. Although the design permits navigation of sharp corners like the colon’s
splenic flexure it does not look possible to return to an earlier position for re-evaluation.
The device requires 184 mA under full load, this is supplied by a 100 mA·h battery
which is sufficient to provide enough energy to complete an entire 30 minute colon transit.
However, as the batteries selected are 10.0 mm diameter by 30.0 mm long there is insufficient
room in the device to carry the power supply. The solution that has been adopted is to
trail the batteries behind within a capsule, however this bimodular power solution may not
be acceptable to the medical profession or to the patient.
An issue with this method of active locomotion is how effective the device will be at
performing targeted therapy. The capsule is suspended evenly in the centre of the GI tract
to make movement easier as there is equal space around the capsule for the legs to operate
in. However performing therapeutic activities to the side of the wall will be difficult due to
the further reach needed for tools to contact the intestinal surface. The problem may be
further compounded by the viscoelastic property of the intestines preventing good grip or
manipulation of the tissue.
The fundamental limitation of this system in performing therapeutic activities is the
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overall volume of the capsule which prevents it from being swallowed. The overall volume
would be a result of the tools for performing therapeutic activities being combined with the
existing volume for the leg mechanism and the volume of the trailing power supply.
2.3.2.6 Electrical Stimulation
An alternative approach to controlling the progress and direction of a WCE is through
electrical stimulation. Woo et al. (2010) [45] propose a capsule which can contract the
small intestine using electrical stimuli, Figure 2.9.
Figure 2.9: Concept of the proposed electrical stimulus capsule [45]
Stimulating the tissue of the GI tract with an electrical charge can cause a contraction
of the muscle and prevent the capsule from moving. The method employed by Woo et
al. is to contract the tissue in contact with the centre of the capsule by applying a high
frequency electrical stimuli (>5Hz) to the stainless steel (SUS316L) electrodes at each end
of the capsule. The length of the insulating material between the electrodes determines the
contraction force and affects the overall length of the approximate 11.0 mm diameter capsule
which has been optimised at 35.0 mm long. A maximum static frictional force (MSFF) of
56.5 ±9.77 gf can be generated using the parameters of 5 ms pulses of 20V at a frequency
of 10 Hz. The MSFF is sufficient to hold the capsule against peristalsis for a period of 60
minutes.
Research carried out by Mosse et al. (2001) [46] showed that small diameter electri-
cal stimulated devices (15 mm) moved very slowly (approximately 1 mm/sec) compared to
larger diameters. Mosse et al. proposed an ovoid shaped capsule with an inclusive taper of
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40 degrees at the front, a length of 38.0 mm and a diameter of 23.0 mm. The acrylic device
uses two stainless steel electrodes positioned 180 degrees apart and mounted on the front
of the taper. With the optimised settings of 30 ms pulses of 20 mA at a frequency of 15 Hz
the capsule resulted in a speed of 4 mm/sec.
A limitation with the design proposed by Woo et al. (2010) [45] is that the capsule can
only stop, it does not have the ability to travel in either direction. This issue has been
overcome by Mosse et al. (2001) [46] by applying contacts at the front and back of the
capsule. However the large diameter and increased length of Mosse’s capsule will make it
very difficult to swallow and navigate the tight turns of the GI tract. Previous research
carried out by Woo et al. (2009) [47] presents a capsule which also has contacts on the front
and back. Its dimensions are 22.0 mm long with a diameter of 11.0 mm making the capsules
volume comparable with conventional WCE. However once the onboard components such
as the electrical stimulation unit, RF receiver, antenna and batteries have been included it
only leaves a volume of approximately 0.76 cm3 of useful space.
There are a number of issues with electrical stimulation which may prevent it from
becoming a viable option for navigating the GI tract. One such issue is the electrical
sensitivity of the liver which makes it potentially susceptible to damage from the electrical
discharge. In addition the natural movement patterns from peristalsis could be interrupted
[45].
2.3.3 Drug Targeting Systems
At present there are two main types of drug targeting systems available that can be swal-
lowed for targeting the GI tract, they are non-disintegrating drug delivery devices and
coated capsules which can target the small intestines (enteric).
Enteric coated capsules are orally administered capsules that use a barrier to protect
them from gastric juices, this enables the release of the medication in the small intestine.
This type of system is known as a delayed release dosage form [48] and commercially avail-
able products come in the form of tablets or pellets filled into hard gelatine capsules. They
are generally used to protect the medication from attack by enzymes or low pH levels in the
stomach. They can also be used where drugs irritate the gastric mucosa causing nausea.
The enteric coated capsule relies on the thickness of the coating applied to it to control
the release of the drug into the GI tract. If too much or too little coating is applied it
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may not properly disperse in the required position within the GI tract. This puts greater
emphasis on the control of the manufacturing process requiring the employment of skilled
staff to ensure consistency.
Non-disintegrating drug targeting systems are pill sized capsules capable of being swal-
lowed. They are made from FDA approved materials which can pass through the GI tract
without being affected by the changing environment. They offer the ability to perform
regional drug absorption treatment within the GI tract. There are a number of patents
relating to drug delivery [49, 50] however there are only three commercial companies selling
regional drug absorption services, they are Phaeton Research with the Enterion capsule [51],
Innovative Devices LLC with InteliSite [52] and Philips Electronics with IntelliCap [53].
2.3.3.1 Site-Specific Drug Delivery
The Enterion capsule [51] manufactured by Phaeton Research is a site-specific drug delivery
capsule commercially available for delivering drugs to a specific location in the alimentary
canal. It is administered with a standard volume of water (240 ml) [54] and relies on natural
peristalsis to move it through the body, Figure 2.10.
Figure 2.10: Enterion capsule [51]
The device is manufactured from FDA approved plastics and has a capacity of storing
1 ml of medication in a drug reservoir. The method of delivering the medication offers an
advantage over other capsules as the medication may be in a liquid, powder or solid form.
The drug reservoir and the requirement that the device be swallowed have influenced the
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size of the capsule which is 11.0 mm in diameter and 32.0 mm in length. These dimensions
are contradictory to the general geometric boundaries for swallowing stated in the literature
which are a maximum diameter of 12.0 mm and a maximum length of 25.0 mm [55] however
studies carried out by Conner et al. (2009) [56] have shown that capsules of larger dimensions
(Ø11.0 x 32.0 mm long) are capable of being swallowed by subjects aged 18 to 65 years.
The loading of the medication is performed simply by removing a bung at the rear of
the capsule and filling up the drug reservoir. The bung relies on an elastomeric o-ring to
seal the rear port. The o-ring is a cheap and efficient way of sealing the aperture against
leaks and the design utilises the non-linear force profile of a rolling compressed o-ring to
stop it from accidentally being opened.
The medication is administered through the use of a stored energy source, i.e. a com-
pressed spring which when triggered operates a cylindrical piston. The piston expels the
medication through the rear aperture at the same time as ejecting the bung. The speed
of expulsion will be rapid propelling the detached bung outwards. The bung is then free
to continue on until it is excreted naturally. Although the size of the bung is relatively
small compared with the capsule the shape of the bung does not appear to facilitate easy
expulsion from the body.
2.3.3.2 Releasing the medication
The activation spring propels the medication from the drug reservoir. The spring is held
in position by an anchoring mechanism which consists of a thin thread connected to the
piston and to a heating element which is mounted on a circular printed circuit board.
The anchoring mechanism works by heating the thin thread until it becomes weak and
breaks releasing the spring and hence operating the piston. The heating element which is a
resistor is triggered by an externally applied radiation. When the device passes through an
electromagnetic field at the frequency an onboard receiver is tuned to, the induced current
powers the resistor which heats the thin thread.
The configuration of the anchoring mechanism assembly does not appear to be a simple
task to prepare for loading into the capsule as the thin thread is required to be fixed in
position while it is under the compressive force from the spring. Also these components are
positioned deep within the housing of the capsule compounding the assembly problem.
The 1 ml of medication can be expelled at a target region in the GI tract such as the
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jejunum, ileum, ascending colon or descending colon. It cannot target specific pathogens
such as tumours or ulcers because it releases its payload as a bolus form. This has the
effect of spreading the medication over a section of lumen as the capsule is under constant
movement from peristalsis and has no means of stopping and holding its position.
Tracking the capsule’s position through the GI tract is by means of a gamma-emitting
radionuclide and a gamma camera. There is no visual identification of a target site as it
relies on the position from the gamma-emitting radionuclide tracer. The radioactive dose
of 0.49 mill-Sieverts (mSv) is less than one-fifth of the annual radiation dose that each
person would receive in one year (2.6 mSv) [54] however this may become problematic if
the procedure were required to be performed for multiple treatments over a short period of
time.
2.3.3.3 Liquid or Powder Drug Delivery
The InteliSite is a drug delivery system manufactured by Innovative Devices LLC [52] which
overcomes the problem of losing the cap in the GI tract by employing a system which opens
ports on the side of the device releasing the drugs into the GI tract, Figure 2.11.
Figure 2.11: InteliSite drug delivery system [52]
The InteliSite has a 1 ml reservoir capable of being loaded with either a liquid or a
powder drug formulation. The dimensions of the capsule are comparable with the Enterion
capsule at 10.0 mm in diameter and 35.0 mm long.
The drugs are administered when the capsule is exposed to a radio frequency magnetic
field. The magnetic field causes two SMA wires to heat up and straighten out. This action
causes an inner sleeve which has a series of slots in it to rotate aligning it with a series of
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slots in the outer surface. This action allows the drugs to be released into the GI tract.
The device has no means to propel the drug from the capsule into the GI tract instead it
relies on the natural turbulence generated from the capsule passing through the GI tract to
disperse the medication. This method would appear to be an inefficient means of targeting
a specific site as it will be slow and unreliable.
2.3.3.4 Electronically Controlled Drug Delivery
Philips Research has developed IntelliCap [53] an intelligent pill for electronically controlled
drug delivery in the GI tract. This device uses a micro pump to propel the medication into
the GI tract, Figure 2.12.
Figure 2.12: Philips Intellicap [53]
The dimensions of the capsule are similar to the M2A by Given Imaging Ltd. [6] at
Ø11.0 mm by 26.0 mm long. The IntelliCap incorporates a microprocessor, battery, pH
sensor, temperature sensor, RF wireless transceiver, fluid pump and drug reservoir. The
literature does not specify the capacity of the drug reservoir or the type of medication it can
dispense however from the dimensions and the onboard equipment stated it would appear
that there will be very little room for the medication and that it can only deliver liquids.
The microprocessor controls the delivery of the drug through the internal fluid pump
which can disperse the medication in different delivery profiles such as burst, progressive
release or a multi-location dosing. Before the IntelliCap is swallowed it can be programmed
to deliver the drug at a pre-planned target location. As the pill passes naturally through the
GI tract it monitors the pH levels. The pill uses this information to determine its position
as the pH value varies depending on its location in the GI tract.
The IntelliCap can communicate pH levels and temperature readings to an external con-
trol unit which has the ability to record the data and also to transmit additional commands
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back to the pill. The use of external medical imaging equipment such as magnetic resonance
imaging (MRI) or computerised tomography (CT) scans are proposed if greater accuracy is
required in locating the position of the IntelliCap before it delivers its medication.
2.3.3.5 Electronically Controlled Pill
Philips Electronics N.V. owns a number of patents relating to ingestible electronic capsules
[57, 58]. One such patent is the electronically controlled pill designed by Gerardus Langereis
and George Likourezos (2006) [59]. The electronically controlled pill (Figure 2.13) provides
a delivery system using at least one sensor to sense a change in pH levels. This change in
pH level triggers a valve, pump or hatch to release the medication. The pill can be custom
programmed to a patient’s medical profile.
Figure 2.13: Electronically controlled pill [59]
The pill stores data relating to pH levels in a look-up table. The look-up table correlates
the sensed pH levels with the pill’s position within the GI tract. This method of tracking
is similar to the method used in the IntelliCap by Philips Research [53]. An example of the
pH levels in the various areas of the GI tract can be seen in Table 2.2.
Table 2.2: Comparison of pH levels in the GI tract [59]
Position in GI Tract Mouth Oesophagus Stomach Small Intestine Colon
pH Level 7.4-7.7 6.3-6.9 4.0-4.8 7.0-9.0 4.0-6.5
The pill is activated by pushing a button before swallowing or an alternative method is
to use a dissolvable outer layer which when swallowed will dissolve away revealing electrodes
of a switch which will close a circuit.
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2.3.3.6 Interpreting pH Data
The data from the look-up table could potentially be interpreted incorrectly. As can be
seen from Table 2.2, the pill could appear to be in the stomach with a pH level of between
4.0 and 4.8 but actually be in the colon with a pH reading between 4.0 and 6.5. It would
appear that Philips have tried to overcome this problem by introducing a timing element
which is activated when the pill is swallowed. They also propose an alternative method of
physically locating the pill by using magnets to interact with a metallic liner imbedded in
the outer shell. The location is achieved by placing a magnetic detector on the abdomen
of the patient. This method will only give a position relative to x and y in the body, it
does not specify where exactly it is along the GI tract. Therefore targeting a precise point
becomes difficult as, owing to the mobility of the ileum structure, there is no guarantee that
the target coordinates will lead to the same site as a previous passing.
The pill uses the pH readings and the timing circuitry to determine its relative position
within the GI tract however the tract can vary in length depending on the patient’s age,
gender, size and many other factors. The average length of the small intestines is 6.25 m
[60] however this length can differ enormously between patients, therefore the position of
the capsule within the GI tract cannot be specifically known using this system.
To release the medication a signal is sent from a logic circuit to the release controller
which controls the amount the valve opens. The medication is released from the medicament
reservoir by slowly opening the valve or by pumping slowly using a pump valve to dispense
the medication in a controlled manner. The suggested valve system used by the pill would
be a microfluidic system similar to those used by inkjet printers. These microfluidic systems
can precisely control the quantity of medicament being released. Using such a valve system
is questionable in this application as the release rate would appear to be restricted by the
maximum aperture size of the valve and the physical size of the pump. This system would
also be restricted to liquids as the valve can be easily clogged.
The release controller is a micro-electromechanical mechanism capable of generating a
variable voltage level and supplying it to the electronically controlled valve for opening and
closing it. The release controller is a transistor or D/A circuit that provides voltages to the
valve causing it to open and close.
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2.3.4 Drug Delivery Systems
There are a number of methods employed by pharmacologists to administer drugs to the GI
tract, the most common being enteric coated capsules. This method employs a coating on
the capsule which when swallowed starts to be dissolved by the enzymes in the intestines.
Over a period of time the capsule will pass through the intestinal tract and release the
medication however this method is not reliable for targeting specific locations of the tract
therefore researchers have looked for alternatives methods.
2.3.4.1 Determining the GI Tract Length
The telemetric capsule developed by Lambert et al. (1991) [61] overcomes the problem of
location by using a plastic cogwheel to measure the length of the tract. As the 10.0 mm
diameter plastic cogwheel rotates, due to the pressure applied to it from the intestinal wall,
it contacts a flexible thin plate which has a strain gauge bonded to it. Each rotation of the
wheel bends the thin plate three times causing variations in resistance in the strain gauge.
The resistance variations are transmitted to a receiver.
The capsule has an interchangeable tip used for either aspirating or releasing a liquid into
the GI tract. The tip is controlled by a magnetic switch which is activated by a permanent
magnet being brought into close proximity to the capsule (closer than 15 cm). The switch
triggers a micro furnace to heat up a strip of plastic which breaks after two seconds causing
a clip to open, this releases a compressed spring which starts the delivery (Figure 2.14).
The plastic strip is destroyed each time the capsule is deployed and needs replacing.
Figure 2.14: Inflatable reservoir for releasing medication into the GI tract [61]
The drug delivery tip utilises an inflatable elastic reservoir to store 1 ml of medication. A
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port on the side of the capsule allows for easy filling of the reservoir using a syringe, a tight
Silastic joint prevents the medication from escaping. When the mechanism is activated the
piston moves forward opening the way for the medication to flow through, propelled from
the contraction of the expanded reservoir and delivering the medication into the GI tract.
The use of an expandable elastic material for storing and delivering the medication
makes for a simple and user friendly system, however the expanded bubble may be difficult to
swallow because of its shape and the high friction properties of the material. The medication
will be expelled quickly into the GI tract however there will be no directional control over
the discharge as the release orifice is fixed in a side position. This coupled with the lack
of a camera suggests limited effectiveness. Using a wheel to measure distance is common
practice however the single wheel configuration may not allow for continuous contact with
the GI tract wall as the digestive tract will twist and turn potentially disengaging the wheel.
This will result in unreliable positional data.
2.3.4.2 Odometer Measuring Method
Karargyris et al. (2015) [62] propose the OdoCapsule which provides video stability and
positional information while navigating the GI tract, Figure 2.15.
Figure 2.15: OdoCapsule conceptual design [62]
The system, which is based on previous work carried out by Bourbakis et al. (2010) [63,
64], utilises three positional sensor wheels as opposed to the one wheel approach proposed
by Lambert et al. (1991) [61]. The capsule’s three sensor wheels are mounted on 15 mm
long legs which protrude out of the 13 mm diameter by 30 mm long capsule by 35o due
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to torsion springs. The springs extend the wheels from the capsule’s body so that they
make contact with the GI tract wall. Frictional forces between the intestinal wall and the
wheels cause the wheels to rotate. The rotating wheels emit electromagnetic peaks which
are received by precision sensors on the control board of the capsule allowing the progress
of the capsule to be monitored. The legs are retracted and extended by a micromotor which
pulls or releases a cable connected to each of the three legs.
There is a risk that the capsule may enter the pyloric opening in reverse which could
result in one of the legs becoming stuck in the intestinal wall tissue due to the angle of
the open legs. However this scenario has been considered and the solution reported is to
monitor the feedback from the rotating wheels. If a steady state has been recorded for one of
the wheels the micromotor retracts the legs for a short period of time then releases them to
continue. This method of recovering the legs from a stuck position would rely on sufficient
torque from the micromotor to overcome the force imposed by the collapsed tissue.
2.3.5 WCE Localisation
Returning to a site of interest to perform further diagnosis or to administer therapy in the
small intestines presents many challenges. The mechanical method of employing wheels
proposed by Lambert et al. [61] and Karargyris et al. [62] may offer a potential solution
however relocating the site of a previously captured image, in relation to the position and
orientation of the capsule, is still a challenge to achieve. Further the unrestrained, slip-
pery, compliant environment of the small intestine adds greater complexity to the problem.
Therefore alternative methods of tracking a capsule’s position which do not use a mechan-
ical means of interaction with the GI tract wall have been proposed by researchers, for
example using magnets or using radioactive isotopes.
2.3.5.1 Gamma Scintigraphy
The InteliSite capsule [52] can be tracked through the GI tract using gamma scintigraphy
(Figure 2.16) which will detect Indium (111 In) or Technetium (99 mTc) gamma isotopes
which have been incorporated into the capsule. As with the Enterion capsule there is no
visual identification of a target site as it relies on the position from the gamma-emitting
radionuclide tracer.
As can be seen from Figure 2.16 gamma scintigraphy provides very little information
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Figure 2.16: Gamma scintigraphy of a delivery to the small intestines [65]
regarding the location of the capsule. The capsule can clearly be seen leaving the stomach
however once it enters the small intestines its position relative to the stomach is lost. This
method is also incapable of providing detailed macroscopic recognition of the intraluminal
surface of the GI tract making diagnosis of pathologies impossible.
2.3.5.2 Magnet Based Localisation
The capsule proposed by Song et al. (2009) [66] utilises a system based on two magnets for
real time 6 degrees localisation and orientation in the GI tract, Figure 2.17.
Figure 2.17: Capsule with two orthogonally orientated permanent magnets for real time 6D
localisation and orientation in the GI tract [66]
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A tracking system, which is worn outside the body, is proposed for the detection of
magnetic fields generated by two permanent magnets onboard the capsule. The tracking
system uses a sensor array utilising 64 3-axis magnetic sensors positioned equally between
4 planes of a 0.5 m3 frame to track the movements and position of a capsule in real time.
Two orthogonally orientated permanent magnets with diameters of 6.0 mm and lengths
of 4.0 mm are incorporated into a capsule (Fig. 2.17). The magnetic field intensity of the
magnets is relative to their distance, using an algorithm based on the mathematic model of
the magnetic field the capsules 3D location and 3D orientation can be calculated.
The system accuracy is reported to have an average error of 2.1 mm for the capsule’s
localisation and an average orientation error of 2.1 degrees. However these results are based
on two magnets with diameters of 6.0 mm and lengths of 8.0 mm positioned 100.0 mm apart.
The benefit of using a permanent magnet to realise the localisation of a capsule is that
it generates a magnetic signal wirelessly without the need for an onboard power supply.
However there may be issues scaling down the technology to achieve the full 6D orienta-
tion information as reducing the distance between the two magnets increase the average
localisation and orientation errors. Using a conventional capsule geometry as a standard
for comparison the furthest distance the two magnets could be positioned apart would be
13.7 mm. This distance is significantly lower than the 100.0 mm test distance, and it also
excludes the area required for a camera system, therefore the positional errors may exceed
the limits required for reliable localisation.
2.3.6 Methods of Obtaining Biopsy Samples
It is not only difficult to determine the location of a capsule in the small intestines but it is
also challenging to diagnose pathologies of the small intestinal mucosa. To identify abnor-
malities of the small intestine, barium studies or enteroscopy can be performed, however
these procedures are limited in their ability to diagnose pathologies of the small intestines
[67]. An important diagnostic procedure is biopsy. Small intestinal biopsies involve the
removal of cells or a sample of tissue from the tract wall [68]. A conventional biopsy proce-
dure uses an endoscope which is inserted into the mouth and fed into the small intestines
through the stomach. If larger sections of tissue are required to be removed a thin flexible
tube with a small cutting instrument attached to the end is used, this method also gives a
greater reach than conventional endoscopes.
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2.3.6.1 Small Intestinal Biopsy
The biopsy procedure is a necessary means of diagnosing pathologies early such as in the
diagnosis of small intestinal Crohn’s disease [69]. There are few risks involved in small bowel
biopsy with patients who are cooperative, however there can be some complications such
as perforations, haemorrhages or pain due to infection from bacteria. Also the procedure is
uncomfortable for the patient and requires the throat to be anaesthetised. The fundamental
problem with the biopsy procedure is that it is virtually impossible to reach the total length
of the small intestines with conventional enteroscopy.
There are a number of researchers involved in realising methods of improving these
procedures such as the intracorporeal videoprobe developed by Arena et al. (2005) [70]. This
device seeks to reduce the optical lens system of the rigid endoscope by employing a camera
directly at the tip, this reduction in size will allow for greater capacity for incorporating
diagnosis equipment.
2.3.6.2 Tissue Interaction and Intervention
There are a number of patents relating to tissue interaction and intervention [49, 71]. Some
of the more significant patents are discussed by Moglia et al. (2008) [72] and Toennies et
al. (2010) [73] however these papers fail to cover the more important features of some of
the patents such as the patent filed by Christopher Swain (2005) for his ‘Method, system
and device for in-vivo biopsy’ [74].
Swain proposes a system which uses one or more devices for obtaining images and a
sample from endo-luminal areas of the body, Figure 2.18.
Figure 2.18: System and device for in-vivo biopsy [74]
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The devices may be connected via a thread, tube, cable, wire or flexible narrow shaft.
The connection may be from a few millimetres to a few centimetres in length and could
be an electrical or purely a physical connection. It is proposed that the flexible connection
between the two devices could make swallowing the system easier when compared to a single
rigid device of the same mass. Although this would appear true it may prove more difficult
to swallow the tethered devices as the gap between the devices would prevent the patient
from swallowing the system in one go, this may trigger the patients gag reflex prohibiting
them from swallowing any further devices.
The devices are configured such that one link or lobe would contain a camera and an
illumination unit positioned behind a transparent dome. The other link would contain a
power source and a biopsy or sampling mechanism with provision for storing the sample.
The advantage of this arrangement is that an operator may visualise the procedure. The
biopsy mechanism depicted in Figure 2.18 is not explained in the patent, however there
are a number of other mechanisms described such as the articulated arm which may extend
from the device to grasp and collect a tissue sample. Further tissue samples are collected by
the release of a curved flat spring which is used to move the articulated arm when it grasps
a sample. Another embodiment proposes an electrical motor which could drive a cog and
screw to extend or retract the articulated arm. The forward movement of the arm could be
used to close the jaws of the grasping mechanism. A further embodiment is proposed which
overcomes the problem of positioning the biopsy mechanism by linking it to the second
module with a rigid drive shaft. The second module has a motor which can rotate the first
module via the rigid drive shaft. Balloons and fins are proposed to stabilise or hold the
second module in position while samples are being taken.
Swain’s proposed system relies on two opposing modules to provide the means of ob-
taining a sample of the GI tract, although it states that the proposed solutions could be
combined to perform this function it does not suggest any alternative means of achieving a
targeted sample collection.
Platt et al. (2009) [75] suggest that a large amount of force is required to grasp and tear
a tissue sample away from an organ. The described methods of operating the articulated
arm do not appear to be able to generate a mechanical advantage high enough to generate
sufficient forces to remove a tissue sample.
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2.3.6.3 Magnetically Driven Body-Tissue Sample Device
The capsule medical device for obtaining a body-tissue sample proposed by Tanaka Shinsuke
(2009) [76] seeks to overcome the limitations of two modules by combining the required
features into one device, Figure 2.19.
Figure 2.19: Magnetically driven body-tissue sample device [76]
A cutting unit with a ‘V’ shaped blade is protected by a movable cover. In order to take
a tissue sample the capsule is manipulated into the intestinal wall by virtue of a generated
external rotating magnetic field. The magnetic field acts on an internal magnet causing
the capsule to move in the desired direction. Once the capsule is pressed firmly against the
intestinal wall the magnetic sensor senses the external magnetic field and causes the driving
unit to slide the outer cover back revealing the blade. It is proposed that the tissue will fall
into a cavity between the blade and the capsule wall where it can be removed and stored
in a storage unit. The tissue is removed by means of the external rotating magnetic field
acting on the internal magnet and causing the capsule to rotate. The rotation will generate
a circumferential torque which will act on the tissue resulting in a sample being taken.
The device has the capability of taking images of the intestinal wall and relaying them
back to the operator for inspection and position recognition. It is proposed that the image
system could be used to determine when and what samples are to be taken, however the
method proposed for orientating the blade will make selecting the precise spot very difficult.
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The cutting unit cover significantly extends outside of the capsule’s body interrupting
the smooth outer surface of the capsule, this could potentially make it very difficult to
swallow.
2.3.6.4 Hollow Needle Tissue Sampling
Shinsuke (2009) [76] also proposes a modification to the first embodiment (previously de-
scribed), which relates to a method for extracting and retaining the in-vivo tissue sample.
Figure 2.20 shows two phases of the extraction, phase C1 shows the needle in the forward
position and phase C2 shows the needle collecting a tissue sample.
Figure 2.20: Hollow needle tissue sampling configuration [76]
A hollow needle with a pointed tip is extended through a hole in the capsule casing for
the purpose of obtaining a tissue sample. The needle is controlled through an extending
and withdrawing system that is activated by applying a current to an SMA coil. When
heated through the application of a current the SMA coil shrinks exerting a driving force
to the needle and extending it forwards. The extended needle is rotated due to the torque
generated by the magnetic field, this rotation forces tissue into the hollow needle. A suction
pump which is connected to the hollow needle through a flexible tube sucks up the tissue
sample from the hollow needle and stores it in a storage unit. Removing the current from
the SMA coil causes it to return to its original shape as it does this it retracts the hollow
needle back inside the capsule.
The proposed method for extracting a tissue sample could potentially result in a perfo-
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rated intestine. When the capsule is rotated to force the tissue into the hollow needle the
tip of the extended needle could act like a knife, making a circumferential incision in the
intestinal wall.
2.3.6.5 Micro-Biopsy Actuator
Park et al. (2008) [77] have developed an actuator for small intestinal biopsy which can be
integrated into a conventional capsule endoscope, Figure 2.21.
Figure 2.21: Tissue sampling mechanism with a microactuator for microbiopsy in capsular
endoscopes [77]
The microactuator has been manufactured through a LiGA (Lithographie, Galvanofor-
mung, Abformung) process. The process comprises three steps: applying an X-ray mask
(1.0 mm thick PMMA), X-ray irradiation and electroplating. A full description of the fabri-
cation steps are presented in [78]. The dimensions are 10.0 mm in diameter by 1.8 mm thick.
The actuator comprises three main component parts: a microspike for taking the biopsy, a
torsion spring actuator and an SMA heating wire triggering mechanism. The microspike is
propelled forwards and backwards through the operation of a slider-crank mechanism. The
slider crank comprises a connecting rod which is attached to a torsion spring at one end
and the microspike at the other. A polymer string holds the torsion spring in position by
anchoring it to a series of small fixing posts. This fixing method allows the polymer string
to be routed across the PCB mounting board and across an SMA heating wire. When a
current is applied to the SMA wire it heats up and melts the polymer string and hence re-
leases the torsion spring which in turn propels the microspike forwards and then backwards
to the stored position.
The intention is to incorporate the compact actuator into an existing capsule endoscope
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such as the MiRo [8]. However Park states that for a complete operation to be performed
further functionality such as the ability to hold position in the GI tract while taking a sample
would be required from the WCE. To achieve this functionality it has been suggested that
the autonomous moving functionality of the legged locomotion device developed by Stefanini
et al. [79] and a frontal clamping system developed by Menciassi et al. [80] could be adapted.
However combining these systems presents limitations due to the available space and also
the effectiveness of the frontal clamping approach, as the frontal clamping approach may
not necessarily clamp tissue in an orientation which guarantees contact with the GI tract
wall and the microspike.
The biopsy spike, which is based on previous work carried out by Byun et al. (2005) [81],
successfully removed a sample of tissue. However the microactuator can only be operated
once with no control of the sampling direction and the tissue sample has limited protection
while travelling through the remainder of the GI tract. Also the complexity of the polymer
string configuration and the delicate positioning of the SMA wire would prove very difficult
to reset by an unskilled operator.
The geometry specified for the slider crank allows a maximum stroke length of 4.3 mm.
This stroke length may be required to guarantee a sufficient sample volume has been col-
lected however there is a possibility of perforating the GI tract wall as the average wall
thickness is between 2.0 mm and 3.0 mm thick [82].
2.3.6.6 Rotational Micro-Biopsy Device
Kong et al. (2005) [83] have developed a rotational micro-biopsy module which has been
integrated into a WCE specifically to perform a biopsy of the small intestines. It is a
compact design with a diameter of 10.0 mm and a thickness of 2.0 mm. The thickness is
approximately 10% thicker than the design proposed by Park et al. (2008) [77], Figure 2.22.
The module utilises an eccentrically mounted razorblade configuration to remove a sec-
tion of the GI wall. The release of a torsion spring causes the tissue-cutting razorblade to
protrude from the side wall of the capsule. The blade rotates 120 degrees at a force of 10 N
removing a sample of the wall as it rotates. The continued rotation of the blade causes the
sample to be sealed into the WCE. The seal is achieved by the alignment of the blade edge
with the capsule body.
The razorblade trigger mechanism is a paraffin block which restrains the blade against
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Figure 2.22: Prototype micro-biopsy module [83]
the torque from the torsion spring. The blade is released when the WCE receives a trigger
signal causing the paraffin block to melt at 42 ◦C. The low melting temperature ensures the
intestines remain undamaged. The power requirement to operate the trigger was measured
at 300 mA for 1.7 seconds and it is intended that it will be supplied by an onboard battery.
There are a number of foreseeable problems with the biopsy module. The first and most
important is that the blade needs to remove a sample of between 1.0 mm to 2.0 mm in depth
[83] to guarantee a useful tissue sample has been retrieved. Unfortunately this cannot be
guaranteed as the system relies on the WCE adhering to the intestinal wall and there are
no means of achieving this with the WCE. A second problem is in obtaining a sample from
a specific location. As the capsule is free to rotate as it passes through the GI tract the
unpredictable orientation means relying on chance to target the required point.
2.3.6.7 Miniature Manipulator
A miniature manipulator mounted at the front of an endoscopic system is proposed by Peirs
et al. (2000) [84], Figure 2.23.
This self-propelling system could be adapted to overcome the problem of retrieving a
biopsy sample from the intestinal wall. The device uses two clamping modules which utilise
a series of perforations to hold the intestinal wall through an applied vacuum. The modules
are connected by an expansion/contraction bellow which allows the clamping modules to
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Figure 2.23: Self-propelling endoscope [84]
move independently.
A hydraulically controlled actuator was chosen over SMA and electric actuators to con-
trol a Stewart platform due to the high force which can be generated. The Stewart platform
has 3 DOF which would be utilised to position the micro tools. The disadvantage with the
hydraulic system is that it requires a hydraulic circuit to drive it as it cannot be driven
electronically. It is proposed that the hydraulic power required to drive the actuators be
supplied by an umbilical cord. The proposed configuration of the Stewart platform takes
advantage of high stiffness and the possibility of having a tool channel running through
the centre. The miniature hydraulic manipulator has an outer diameter of 12.0 mm and
a length of 30.0 mm. The platform is driven by three hydraulic pistons connected to the
platform by ball joints which give the platform the ability to move. It is proposed that two
Stewart platforms could be combined to give 6 DOF however at the proposed dimensions
it would result in an extremely large device.
The proposed device has two main issues which prevent it from retrieving a tissue sample
from the small intestines. The first and most important issue is that the large volume of
the device prevents it from being swallowed or if accessing the small intestines through the
large intestines it would not be capable of navigating through the ileocolic valve. Secondly
the power to drive the modules is supplied by a trailing wire this prevents the device from
being totally autonomous and is also potentially disconcerting for the patient.
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2.3.7 Evaluation of Micro Actuators
WCE are passive medical devices, however for these devices to be useful surgical tools they
are required to perform tasks such as a biopsy or electro surgery. To achieve the given task
a degree of mechanical movement is required of the tools. For example a needle must move
forwards to pierce tissue or the jaw of a clamp must close to obtain a sample. The kinematics
of the tools performing the curative treatment can be achieved through the application of
actuators. There are a number of actuators available such as SMA actuators, piezoelectric
actuators and micromotors. Choosing the correct actuator for a given task requires the
consideration of a number of factors such as the available space, the type of movement
and the peak power consumption. Many researchers have adopted SMA actuators as they
have a high degree of allowable strain which takes advantage of the limited space for the
deliverable force.
2.3.7.1 Piezoelectric Squiggle Motor
An actuator solution for controlling an injection system or biopsy system could be the use of
a piezoelectric linear motor to drive a mechanism directly. These motors use the piezoelectric
effect to drive the actuation. The piezoelectric effect is the change in a material’s geometry
due to an applied electric charge or a mechanical stress changing a solid’s shape which
will result in a proportional electrical charge [85]. There are problems with piezoelectric
actuators such as they require displacement amplification mechanisms to obtain a useful
stroke length and they also require large voltages (100 V) to activate them [84].
Non-conductive materials such as quartz (SiO2) exhibit the piezoelectric effect and can
be utilised in such applications as displacement transducers. The Squiggle piezoelectric
linear motor manufactured by New Scale Technologies [86] utilises the piezoelectric effect
to vibrate a leadscrew causing it to travel forwards and backwards, Figure 2.24.
Figure 2.24: Piezoelectric squiggle motor manufactured by New Scale Technologies [86]
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The Squiggle motor (SQL-RV-1.8-6-12) is one of the smallest piezoelectric motors in the
world with a package size of 6.0 mm long by 2.8 mm square and a leadscrew of 12.0 mm
long. The motor has a high positioning resolution of 0.5µm and a stall force (4.5 V input)
of 0.5 N which makes it a good candidate for operating mechanical mechanisms.
An alternative to the piezoelectric Squiggle motor is a micromotor. Micromotors could
potentially be used to drive the mechanisms directly. An examination of the latest available
technology in micromotors shows that there are a limited number of micromotors on the
market which could fit within the package size of a conventional WCE and have a useful
torque capability at a low RPM.
2.3.7.2 Micromotor power comparison
One micromotor which appears to have the required specifications is the Ø1.5 mm x 10.5 mm
long geared micromotor manufactured by Namiki (no. 10-010) [87], Figure 2.25.
Figure 2.25: Namiki four stage geared micromotor
The four stage geared micromotor operates at 60 mW and runs at 76 RPM, this produces
a stall torque of 1.6 mNm. The Namiki motor can be compared with the specifications
of three alternative motors: a Ø6.0 mm x 3.75 mm long motor manufactured by Maxon
Motor (EC 6) [88], a Ø1.9 mm x 10.82 mm long micromotor manufactured by Faulhaber
(02/1)[89] and the Squiggle motor. An important criterion is the micromotor’s maximum
power output. A comparison of the four motors using a merit index to compare the power
output against the motor’s volume (Table 2.3) shows that the Squiggle motor is far superior
to the other motors as the higher the merit index the more powerful the motor is for its
size. However the Squiggle motor operates in a linear orientation compared to the rotational
output of the micromotors.
The Namiki micromotor can be evaluated for its ability to perform the task of moving
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Table 2.3: Power to volume merit index
Maxon Namiki Faulhaber Squiggle
Power mW 30 60 130 340
Volume cm3 0.071 0.019 0.029 0.053
Merit Index∗ 0.422 3.157 4.482 6.415
*A higher merit index represents a more powerful motor for its
volume
a 0.13 g mass of stainless steel. The stainless steel would replicate the mass of an injection
system or biopsy system.
The torque required to move the mass of stainless steel can be calculated using the
following equation:
T = Ioα (2.1)
Where α is the angular acceleration and can be calculated at 265.3 rads/s2 from the
motor’s performance data [90, 91] and Io is the moment of inertia which can be expressed
as mk2 where m is the mass concentrated at a radius, the Radius of Gyration (k), which
would be 5.0 mm. This concentrated mass (0.13 g) would be a worst case scenario as it
assumes the total volume to be moved is positioned at the extreme limit of the microrobot.
The results of the initial torque analysis show that a torque of 0.86µNm would be re-
quired to operate the mechanism. Although the Namiki micromotor is capable of delivering
a significantly higher torque than what is theoretically required provision would need to be
made for the inherent friction in the mechanism and for any load which would be generated
by the mechanism itself.
2.3.7.3 Shape memory alloy actuators
An alternative to micromotors as an actuator mechanism are SMA such as superelastic
nitinol which is an alloy of approximately 50% nickel and 50% titanium. The superelastic
properties of nitinol allow large amounts of deformation to take place without permanently
damaging the lattice structure of the material. This allowable strain makes it possible to
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create super springs which would be triggered by heating. The disadvantages of using SMAs
are that they require high power consumption [92] and they can affect their environment as
a result of heating. Also they are unable to fully recover their original configuration after
cooling due to twinning of the atomic crystal [80]. This can be overcome by detwinning the
lattice by using a secondary process which would apply a bias to the spring.
SMA wires can be employed to drive mechanisms. The wire could be orientated in
a pulley configuration minimizing volume and attaining a mechanical advantage from the
pulley. The approximate relationship between the pulley’s radius (r) and the length (L) of
wire required to rotate the pulley through an angle (θ) have been determined by Gorini, et
al. (2006) [92] and is given by:
L =
pirθ
0.04 · 180 (2.2)
The 0.04 represents a 4% contraction of the wire due to the Joules effect. By considering
a pulley with a radius (r) of 0.9 mm and a required rotation (θ) of 90 degrees the theoretical
length (L) of the wire would be 35.3 mm. The actuator mechanism would require a longer
wire to operate efficiently as the theoretical model does not take into account the friction
in the system and the drop in performance of the wire due to multiple operations. Also
the wire would need to overcome the resistance imposed by a second wire which would be
required to return the pulley to its original configuration. A consideration of the difficulty
in manufacturing and assembling such small and complex components would need to be
taken into account when designing such a mechanism.
2.3.7.4 SMA Wire Based Actuator for a Legged Endoscopic Capsule
Gorini et al. (2006) [92] propose the use of SMA wires to operate an actuator for a six
legged endoscopic capsule, Figure 2.26.
The proposed miniaturised leg mechanism is to be integrated into a WCE for the purpose
of locomotion in the GI tact. The mechanism comprises three main components: a PEEK
prismatic support with dimensions of 3.4 mm x 25.0 mm x 3.2 mm, the leg and the SMA
wire system. The operation of the leg is through the activation of two 100µm diameter
SMA wires connected to a brass micro pulley. The right hand wire is wrapped clockwise
around the pulley and the left hand wire is wrapped anticlockwise around the pulley, with
the ends of the wires fixed to the prismatic support.
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Figure 2.26: Prototype of the SMA leg actuator for a legged endoscopic capsule [92]
Applying a current of 360 mA and 10 V for a period of 4 s to the left hand wire causes
the wire to contract by 6% and rotate the pulley approximately 135 degrees. After an un-
reported period of cooling time the right hand wire is activated bringing the leg back inside
the prismatic support. The degree of leg rotation is dictated by the length of contraction
of the 100.0 mm long SMA wire however the geometry of the prismatic support limits the
length of wire which can be used. This issue has been overcome by the addition of glass
shafts mounted in the prismatic support which allow the wire to be wrapped around them
without shortcutting the circuit. The SMA wire is 40.0 mm longer than required to fully
open the leg as compensation for the resistance from the antagonist SMA wire during the
rotation of the pulley is required.
The wire pulley offers a mechanical advantage which would help to combat the large
lever force being generated by the distance between the leg pivot and tip and also to help
overcome the resistance from the antagonist wire. However the combined volume of six
leg modules equates to 1.6 cm3, comparing this volume to a conventional WCE shows that
there would only be 0.4 cm3 of usable space left for components such as a surgical tool,
camera, battery or RF module.
A disadvantage of SMAs is that they have a high power consumption [93] which results
in a localised elevated temperature at the site of the actuator. This may result in damage
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to the surrounding area. Also the performance of the SMA will reduce over a number of
cycles compounding the problem of the wires’ ability to return to their original state.
2.3.7.5 SMA Spring Driven Locomotive Mechanism
A two-way linear actuator mechanism driven by SMA springs is proposed by Kim et al.
(2005) [94] for the purpose of locomotion in capsule-type endoscopes, Figure 2.27.
Figure 2.27: Locomotive mechanism driven by SMA springs for capsule-type endoscopes
[94]
The 33.0 mm long by 13.0 mm diameter capsule is intended to navigate the GI tract by
means of four sliding clamps which have been arranged around the outside surface of the
capsule body. The core of the capsule has a 7.6 mm diameter hollow which is reserved for
components such as an RF module, camera and batteries.
The four sliding clamps carry micro hooks which protrude from the capsule by 400-
600µm. The purpose of the clamps and hooks are to replicate the motion of insects such
as the earth worm by mimicking its setae. The 180µm diameter angled hooks are similar
to those reported previously by Lee et al. (2004) [95]. The capsule moves forwards through
a sequence of independent clamp movements which are driven by four two-way linear actu-
ators. The two-way linear actuators comprise of two SMA springs which are connected to
either side of the clamp and are activated independently through the Joules effect. When
the forward spring is contracted for a period of 2 s it pulls the clamp forwards at which
point the clamp grips the surface of the GI tract. The forward spring is allowed to cool for
a period of 5 s before the rear spring is contracted. The contraction of the rear spring pulls
the capsule forwards with a maximum stroke length of 7.5 mm. This sequence is repeated
with each sliding clamp being activated in turn to propel the capsule through the GI tract
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at a rate of 110 mm/min. The SMA springs reach a maximum operating temperature of
70 ◦C with an applied current of 400 mA and a voltage of less than 2 V.
The SMA springs are fabricated through a shape setting heat treatment process where
the 150µm diameter wire is wrapped around an M1 bolt which acts as a mandrel and heat
treated for approximately 30 minutes at 400-500 ◦C. The result is a shape set spring with
18 turns, a diameter of 1.0 mm and a length of 4.5 mm. The total length of the spring is
set to 19.5 mm which generates a maximum force of 135.9 g when contracted.
The contraction force generated by the SMA spring is sufficient to propel a commercial
WCE which has a weight of approximately 10 g. However the reliability of the spikes to
make adequate contact with the intestinal wall may result in clamping failures that will
cause a decrease in locomotion speed or even a total failure to move. The large diameter
of the capsule and overall length will make it difficult to swallow. This, combined with the
fact that the spikes are always protruding from the side of the capsule, adds even greater
difficulty to the swallowing process. The direction of the spikes may also cause complications
if the capsule orientation is in reverse when it is travelling through the intestines and also
when it is excreted.
2.3.7.6 SMA Sheet Oesophageal Stopping Mechanism
The procedure of inspecting the lining of the oesophagus using a flexible endoscope is routine
however it is also a very uncomfortable procedure for the patient. Tognarelli et al. (2009)
[96] propose SMA flat springs to halt the progress of an oesophageal WCE for the purpose
of inspecting the oesophagus lining, Figure 2.28.
Figure 2.28: SMA flat springs to halt the progress of an oesophageal WCE [96]
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The transit time through the oesophagus is rapid therefore a stopping mechanism must
have a quick response time. The 11.0 mm in diameter by 31.0 mm long capsule developed
by Tognarelli et al. [96] can deploy a stopping mechanism suddenly to halt its progress
through the oesophagus. The stopping mechanism consists of three equally spaced SMA
flaps, a DC brushless motor, a pulley, a gear set and three 0.15 mm diameter Kevlar wires.
Rather than being triggered by the Joules effect the SMA legs have been set in an open
position to take advantage of the superelastic properties of the material. The DC motor is
connected to the gear set and pulley and is used to wind the legs into a cavity in the capsule
body by virtue of the Kevlar wire which connects the tip of the legs to the pulley. When
the wire is released the flaps return to their original open position and halt the progress of
the capsule.
The thin Kevlar wires may prove difficult to assemble to the pulley mechanism and also
prove potentially unreliable in operation due to the tendency of the wires to get tangled up.
In addition the sudden release of the SMA flaps could cause trauma to the oesophageal wall
lining as the shape of the legs focuses the spring load to the leg tip. The authors attempt to
overcome this problem by suggesting a silicone coating could be applied to the legs however
a more substantial dampening effect may be required.
2.3.7.7 Actuator characteristics comparison
The various actuator mechanisms described offer a diverse range of potential solutions to
control mechanical movement. With each actuator system having a number of advantages
and disadvantages. To gain a better overview and to help understand the various options
an evaluation matrix has been created using a set of criteria relating to the actuators’ char-
acteristics (Table 2.4). The matrix will give a quantitative assessment of the performance
of each method.
The evaluation matrix highlights the problems associated with completing a task such
as controlling the position of a biopsy mechanism within the GI tract. For example the
linear movement of the piezoelectric actuators and SMA actuators will make positioning a
clamping jaw angularly very difficult whereas micromotors would have little difficulty with
this task, however the position of the jaw would need to be determined therefore space for
an encoder system would also be required.
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Table 2.4: Actuator characteristics evaluation matrix
Characteristics Micromotor Piezoelectric SMA
Voltage <5 V >100 V >2 V
Displacement unlimited 0.2% >30%
Force high high medium
Speed <1 kHz ∼10 kHz ∼0.1 Hz
Compactness poor good good
Motion type rotation linear linear
2.3.8 Fabrication Methods for Prototype Realisation
In order to realise a WCE which has additional functionality, such as active locomotion or a
mechanism for performing a biopsy, consideration must be given to the manufacture of the
component parts which make up the mechanism, specifically the mechanical components
as these require a number of process routes before they can be realised. The difficulty in
producing parts for conceptual evaluation and for prototype testing is not just the financial
limitations due to the cost of producing low numbers of components but also in selecting
the right process which is capable of producing the small component features which are
inevitably required when dealing with mechanisms which must fit in package sizes <3.0 cm3.
There are a number of manufacturing processes available for the production of small
components parts. However producing features as small as 50µm can prove very challeng-
ing using conventional machining techniques such as computer numerical controlled (CNC)
milling or CNC turning. There are alternative manufacturing processes, for example semi-
conductor device fabrication techniques have been adapted to fabricate microelectromechan-
ical systems (MEMS). Scaling up this type of technology may offer advantages in producing
complex mechanical systems however it is restricted to 2D structures and it is also limited
to a small selection of materials such as silicon which have limited mechanical properties
[97]. Therefore conventional manufacturing processes must be adapted to achieve the re-
quired outcome. The following section will discuss seven manufacturing routes suitable for
fabricating small complex parts and which are also readily accessible.
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2.3.8.1 Conventional Machining
Conventional machining practices refer to CNC turning and CNC milling, these manufac-
turing processes are the most common method for material removal. They use a single or
multiple point cutting tool to remove material from a securely held workpiece to generate
the desired shape.
Horizontal fixed head CNC lathes are used for producing cylindrical shapes, tapers,
threads and flat faces on any type of round, square or hexagonal stock. They have between
2 to 6 axes which allows for greater flexibility when features such as milled pockets or
holes off the centre line are required [98]. CNC milling machines are used for generating
flat surfaces, profiles, holes and tapped holes however contours with external radii can be
produced with suitable cutting tools.
The tools used for material removal must have a hardness greater than the material
which is being cut. The efficiency of the cutting process relies on a number of factors such
as: the hardness of the material being cut, the hardness and toughness of the cutting tool,
the design of the cutting tool, the type of cutting fluid used, the metal removal rate, the
surface finish required, the required tolerances and the speeds and feeds used.
The accuracy of the turning process will depend on the type of machine tool being used
with typical achievable tolerances being ±0.5 mm for rough turning and ±0.1 mm for fine
turning. However, given the correct conditions even finer tolerances of ±0.01 mm can be
achieved. The surface finish (arithmetic average = Ra) achievable for turning is between
Ra = 0.05µm to 25µm with typical values between Ra = 0.05µm to 5µm being achieved.
Conventional CNC milling offers a great deal of flexibility for the production of complex
features. Part geometry can typically be held to ±0.1 mm with surface finishes of between
Ra = 0.2µm to 10µm however machine tool technology is available that can give even
greater control of the surface finish and geometry of a workpiece for example the KERN
Pyramid Nano is a five-axis CNC machining centre it is capable of a positional accuracy of
±0.3µm and it can generate surface finishes as low as Ra = 0.05µm.
Although high degrees of accuracy and good surface finish can be achieved through
either turning or milling both processes rely on the skill of the machine setter to produce
and maintain them.
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2.3.8.2 Injection Moulding
Injection moulding offers the ability to produce small complex polymer components. The
process is most commonly used with thermoplastics however thermosets and elastomers
may also be processed.
The injection moulding process involves polymer granules being fed from a hopper into
a cylinder containing a motor-driven screw plasticizer. The granules are heated then forced
along by a rotating screw until it reaches a plasticized state. The rotating screw acts as a
ram to inject the material under high pressure, up to 200 MPa, through sprues into a mould
tool. Once the part has solidified, through the cooling of the mould tool, it is then ejected
from the tool [99].
The process can produce complex shapes with fine detail and surface finishes in the
range of Ra = 0.2µm to 1.6µm [100] however allowance for material shrinkage must be
taken and large changes in section should be avoided. Features such as small re-entrant
angles, screw threads and inserts can be produced however these increase the complexity of
the tool increasing tooling costs. Tooling costs can be high however prototype mouldings
can be made using single cavity moulds of cheaper materials such as aluminium.
2.3.8.3 Metal Injection Moulding
Metal injection moulding (MIM) offers the flexibility of plastic injection moulding to produce
small highly complex shaped components from metal or ceramic powder which cannot be
manufactured through conventional methods. The process involves mixing fine grained
powders in the range of 0.5µm to 20µm with an organic binder agent such as a wax or
a thermoplastic to create a feedstock. Conventional injection moulding machines can be
used to inject the feedstock, under high pressure, into an oversized die to create a ‘green’
moulded part, which will shrink in the following process stages. The ‘green’ part undergoes
a de-binderising process where it is heated in a low temperature oven to vaporize the binder
agent leaving a porous ‘brown’ component. The final stage involves sintering the ‘brown’
component in a computer controlled vacuum or controlled atmosphere furnace. The powder
particles are fused together at high temperatures shrinking and densifying the component.
Densities as high as 98% of the theoretical material density can be achieved with the
MIM process and further post-sintering processes can be performed such as heat treatment,
plating or machining if additional features are required. The process can be used to produce
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parts as small as 1 mm with tolerance as low as ±0.025 mm and with surface finishes in the
range of Ra = 0.4µm to 1.6µm however wall thicknesses are limited to between 0.2 mm
to 10 mm and overall component size does not generally exceed 100 mm also component
thickness/width ratio is limited to 3:1 [99].
2.3.8.4 Rapid Prototyping
Rapid Prototyping (RP) provides the opportunity to realise ideas in a quick and cost effec-
tive manner. There are three material addition RP based systems available commercially
they are: liquid based, powder based and solid based [101]. The most common RP system is
stereolithography addition (SLA) which is a liquid based system. The system uses a vat of
photosensitive liquid resin which cures under the exposure to ultra violate light to produce
solid three dimensional models.
The process starts with a closed 3D STL model generated in a CAD package. The SLA
system then divides the model into thin cross-sectional layers from 0.025 mm to 0.5 mm thick
[102]. The part is then built up as the focused laser beam prints the thin layer pattern onto
the surface of the photosensitive liquid resin by virtue of mirrors. The laser beam diameter
is in the range of 0.25±0.025 mm for the standard process and 0.075±0.015 mm for high
resolution. Once the pattern hardens the platform can move down below the level of the
liquid by one layer thickness which is typically between 0.05 mm to 0.1 mm thick. A sweeper
then moves across the vat to cover any exposed surface with resin and then the process of
printing the next layer begins. This method is repeated until the model is complete, the
final operation is to cure the part to complete the polymerization.
RP systems can produce complex 3D models in a variety of materials. The finished
models have the inherent properties of the materials from which they have been manufac-
tured. This gives the advantage that the parts can be used directly in the finished product.
For example Accura 60 is a resin which simulates the properties of polycarbonate it has a
tensile strength of between 58 MPa to 68 MPa. Models can also be used to generate moulds
which can then make further copies of the model in the desired material.
Part sizes are restricted to the maximum build envelope of the system for example
the Viper si2 SLA system has a maximum build envelope in standard mode of 250 x 250 x
250 mm XYZ however this is reduced to 125 x 125 x 250 mm XYZ if high resolution parts are
required. Dimensional accuracy of parts over the build envelope range between 0.125 mm to
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0.25 mm XY however over smaller component sizes the accuracy can be as low as <0.05 mm
XY [103]. The surface finish of a component is significantly influenced by the nature of
the layered process and leads to a common problem of stair-stepping. Surface finishes of
between Ra = 5µm to 40µm [101] can be achieved however it is greatly dependent on the
component’s surface angle. Attention to the orientation of the part during modelling can
minimise the stepping effect and reduce any post-finishing processes.
2.3.8.5 Electrical Discharge Machining
Electrical discharge machining (EDM) utilises the intense heat of an electric spark to remove
any electrically conductive material. There are two basic methods of EDM, wire eroding
and die sinking. The first method uses a wire in a similar action to a bandsaw to produce
profiles in a workpiece, the second method uses a form tool which is sunk into the workpiece
leaving an impression of the tool.
The form tool method offers a high degree of flexibility for prototyping complex parts as
the tool is a mirror image of the required profile. A number of different shaped tools can be
used successively to produce the required shape reducing the cost of producing a complex
form tool. The form tool (cathode) is slowly fed into the workpiece leaving a slight gap
between them, the gap is flooded with a dielectric fluid which assists the erosion process
and the removal of metal particles. The metal or graphite form tool will also erode at a
wear ratio of 3:1 for metallic electrodes and between 3:1 to 100:1 for graphite electrodes
[99].
Controlling the spark gap between the work piece and the tool, which can vary between
20µm to 120µm, and also controlling the frequency and energy of the pulsed DC power
supply enables the volume of material which can be removed and the surface finish of the
work piece to be precisely managed. A typical tolerance of ±0.025 mm can be achieved
however ±0.005 mm can be achieved under ideal conditions. Surface finishes are typically
in the range of Ra = 1.6µm to 4.8µm however the actual finish depends on production
parameters as higher current densities will result in a rougher finish. Very high surface
finishes can be achieved such as a mirror finish (Ra = 0.05µm) however these are time
consuming to produce compared to roughing finishes which are fast to produce but can
have a surface finish as high as Ra = 15µm [104].
Wire electrical discharge machining (WEDM) may offer greater degrees of flexibility for
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prototyping as complex profiles can be produced directly through CNC control of the work-
table eliminating the requirement to produce a form tool. The cutting speed is dependent
on the material thickness the wire is passing through rather than the complexity of the
form being produced. Wire electrodes can be manufactured from a number of materials, for
example: tungsten, molybdenum or brass-covered steel. The choice of material will affect
the degree of cutting accuracy achieved due to the tension obtained from the wire. Typical
wire diameters range between 50µm to 300µm thick allowing fine features to be produced
with surface finishes ranging between Ra = 0.75µm to 1.25µm however there is an overcut
of 20µm to 50µm and the spark produces a recast layer and a heat effected zone of between
2µm to 120µm deep which may require secondary finishing [99].
2.3.8.6 Comparison of Fabrication Methods for Component Realisation
The various manufacturing methods described for making low volume high precision com-
ponent parts have been compared and their process parameters tabulated, Table 2.5.
Table 2.5: Comparison of manufacturing methods suitable for prototyping low volume high
precision components
Manufacturing Number of General Typical Material
process machine tolerance surface finish
axes (mm) Ra = µm
CNC turning 3 ±0.1 0.05 - 5 Various
CNC milling 3 ±0.1 0.2 - 10 Various
Injection moulding 1 ±0.2 0.2 - 1.6 Polymers
MIM 1 ±0.0251 0.4 - 1.6 Metals & ceramics
RP - SLA 3 <0.052 5 - 40 Polymers
EDM - Form tool 1 ±0.025 1.6 - 4.8 Metals
EDM - Wire 2 ±0.013 0.75 - 1.25 Sheet metals
1 Based on dimensions 65 mm
2 Based on dimensions 66.3 mm in the XY direction
Table 2.5 shows a comparison of manufacturing methods suitable for prototyping small
scale component parts which require a high degree of accuracy and surface finish. The
manufacturing processes described are readily available and offer the potential to make
prototypes with small scale features however these processes are limited. For example
generating parts through RP offers a quick and cheap solution to prototype realisation
however the surface finish generated by the process may require further hand work to fully
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achieve the required outcome, this can prove very difficult if the parts are too small to
handle.
Producing prototypes which meet intended requirements will generally involve a compro-
mise either between part accuracy, surface finish, size or cost. The selected manufacturing
method will satisfy the majority of requirements however the designer will ultimately decide
which parameters are the most important and therefore which can be compromised.
2.4 WCE Systems
Table 2.6 is a comparison of the non-disintegrating capsules discussed in the literature
review. The positions marked with a ‘-’ signify that the feature is unavailable or that
details relating to the module’s function have not been published in the literature. As can
be seen from Table 2.6 the WCEs have many different modules however all possible modules
are not contained in any one capsule. A good example of this is the Intellicap [53] which
appears to have the greatest selection of modules although it doesn’t possess the ability
to maintain a static position or have active locomotion capabilities. It is a commercial
capsule that uses time and pH sensing to track its movements through the GI tract and it
is capable of bidirectional communication whereas the majority of the other capsules either
have not got this function or they are only capable of unidirectional communication. The
device is powered by a battery as opposed to magnetism or being tethered and is capable
of delivering a liquid medication.
2.4.1 Volume Limitations
The standard volume for WCE is 2.0 cm3 this has been established by the M2A capsule
developed by Given Imaging Ltd. [6] in 2000. This volume has been proven to be easily
swallowed by the majority of patients who undergo the WCE procedure. The predominant
feature of the M2A capsule is its ability to take images of the GI tract. Other capsules,
such as the Intellicap, have looked to improve the functionality of this capsule by developing
means of performing therapeutic and diagnostic activities.
The additional features incorporated into the Intellicap allow for a therapy to be deliv-
ered to a location in the GI tract with only a small increase in the volume of the capsule
to 2.1 cm3 however this additional functionality is at the expense of the vision capability.
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Table 2.6 presents the varying capsule volumes. It can be seen that the majority of the
capsules have a volume greater than the standard volume and that a number of capsules
such as the electrical stimulus capsule developed by Mosses [46], which has a volume of
5.7 cm3, also exceed the limitations for swallowing, set at approximately 3.0 cm3 [56]. The
six legged endoscopic capsule developed by Gorini et al. (2006) [92] presents a volume that
is lower than the standard volume however the volume only represent the geometry for the
actuators as they do not report the total capsule volume.
2.4.2 Development Status
The development status of the capsules can be grouped into four main categories, com-
mercial, concept, patent and prototype. The type of category a capsule is in has great
significance as it highlights the development status of the technology. For example the En-
terion, InteliSite and IntelliCap capsules are all commercial capsules capable of delivering
medication to the GI tract. The technology involved in these capsules has been proven to
work through clinical trials. These capsules can be compared to the capsule proposed by
Langereis et al. [59] which also delivers medication to the GI tract, however the capsule is
currently only in patent form and as such has not been realised.
The level of technology and the viability of a capsule is further exemplified by the capsule
proposed by Shinsuke [76]. This capsule possesses a large number of modules, it is capable
of obtaining a biopsy sample and taking images of the GI tract. However the capsule has
not been realised as it is also in patent form therefore the viability of the technology and
the practical issue of compressing the technology into a standard volume is in question as
they do not report any clinical results or specify the total volume of the capsule.
2.5 Summary
There are clear benefits to the patient and the clinical practice from using WCE for the
purpose of exploration and diagnosis of the GI tract. The capabilities of this technology,
which include diagnosing pathologies of the small intestines like Crohn’s disease and ulcer-
ative colitis, enable a painless procedure for the patient and result in reduced costs for the
clinical practice administering the procedure as a trained surgeon or a clinical setting is not
required for the procedure to be performed. However there are significant limitations with
WCE as the systems are unable to meet all the clinical needs, such as performing targeted
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therapy to an affected area of the small intestines, taking multiple biopsy samples from
specific locations or actively navigating to a site of interest. These limitations are princi-
pally due to the restrictions of the available space onboard the WCE which prevents all the
features being incorporated into one device. However with advancements in technology and
design the potential of WCE can be further expanded.
The challenge is to develop microscale actuator systems which can be incorporated
into conventional WCE geometry and also be produced using convention manufacturing
techniques. The following chapter will discuss the requirements for a WCE system to
perform targeted therapy in the GI tract and outline the research objectives.
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Chapter 3
Towards a WCE for Targeted Drug
Delivery
3.1 Overview
This chapter will evaluate the medical and technical challenges in performing both diagnosis
and therapeutic procedures simultaneously with a remotely operated microrobot within the
GI tract.
The aim will be to develop a swallowable microrobotic platform which has novel func-
tionality such as a targeted drug delivery system combined with constant pH monitoring.
The particular challenge with designing a microrobotic system which can perform a surgi-
cal procedure such as targeted drug delivery is in the allowable working envelope for the
microrobot. As the microrobot is to be swallowed it requires a small package size of ap-
proximately 12.0 mm diameter by 25.0 mm long. The small package size of the microrobot
places great constraints on the component parts such as the electronics and actuator mech-
anisms. A particular problem is in generating sufficient strength and operating forces from
the miniaturised components.
The research project will investigate novel methods of stopping and holding the micro-
robot against natural peristalsis in the small intestines. The development of a novel system
which can deliver a metered dose of medication to a specifically targeted site will also be
investigated. These systems will involve the design and analysis of innovative microme-
chanical mechanisms. The mechanisms will be responsible for deploying the stopping arms
and controlling the position and deployment of the medication in a ∼20.0 mm diameter
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section of lumen. Potential technologies to investigate which could drive these mechanisms
are piezoelectric actuators, DC electric micromotors and SMA.
3.1.1 Key Research Aims and Objectives
This research project aims to develop a next generation microrobotic platform for targeted
drug delivery in the GI tract. Given the constraints of capsule endoscopy and the design
objectives identified above it is clear that it will be a very challenging task to achieve this
aim. There are a number of specific research objectives that will need to be addressed, they
are:
• To investigate and analyse a new method of attaining equilibrium in the GI tract. This
will involve developing a novel microscale mechanism capable of resisting peristalsis
and gravity to hold the microrobot in a static state for a specified period. There are
a number of factors which will influence the mechanism such as the limited available
space and the availability of microactuators with sufficient torque to perform the given
task. Also there are safety issues to overcome such as the possibility of the mechanism
damaging tissue or even perforating the GI tract wall.
• To research and develop a new method for targeting a specific location in the GI
tract. This will involve developing a number of solutions which combined will allow
the microrobot the ability to return to a site of interest (SOI) and position a needle
within a specified arc to target a pathogen. The specific challenge will be to develop
a mechanism which is capable of positioning a needle within a 360 degree envelope
and hit a SOI with controlled accuracy.
• To explore and evaluate a new method of delivering a metered dose of medication
to a specific location in the GI tract. Once the microrobot has reached the SOI the
challenge will be to dispense the onboard medication through a needle into the GI
tract wall. To achieve this objective a compact remotely operated triggering solution
will be required to release a stored energy device. The specific challenge will be to
develop a mechanism which will operate with minimal power consumption yet occupy
minimal space.
The outcome of the three objectives will be combined and integrated into a WCE to
give additional functionality that will allow a metered dose of medication to be delivered to
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a specific location in the GI tract. The following section presents a methodology to identify
key constraints and requirements of the microrobot.
3.1.2 Design Methodology
Three research questions have been posed for the starting point of the critical evaluation
and analysis of a microrobotic platform which is capable of performing microscale diagnosis
and targeted therapy. Each question focuses on a particular issue which has been chosen for
its impact on the design of the microrobot at the early design concept stage. The questions
will be summarised, followed by a discussion of the research and analysis carried out.
3.1.3 Analysis of Optimal Microrobot Volume
The first question addresses the physical geometry of the microrobot asking what would
be the optimal device volume for a disposable platform taking into account the limitations
of current energy storage devices and actuator torque requirements. To address this ques-
tion an investigation into the available technology was undertaken and an analysis of the
physiological constraints of the GI tract.
Using the PillCamTM by Given Imaging Ltd. [1] as a reference point the geometry of the
capsule can be investigated. Figure 3.1 is a schematic representation of the available space
when loaded with 1 ml of medication and a camera unit. The 1 ml volume of medication
has been chosen as the optimum dose as it is representative of the dose published in the
prior art [2] and also the quantity being used in current trials stated in the literature [3].
Figure 3.1: Schematic representation of existing capsule geometry based on the PillCamTM
by Given Imaging Ltd.
The available space that remains after the medication and camera space have been
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allocated is limited, however this space will be required to house a targeting mechanism, a
delivery mechanism, a holding/stopping mechanism, a pH sensor, a temperature sensor, a
power supply and an RF transmitter.
Figure 3.1 highlights the potential challenges of miniaturising mechanical actuators and
electronic components to fit into the 2.0 cm3 package and fulfil the intended objectives.
It is clearly impractical to use the dimension based on the PillCamTM, therefore a more
realistic approach will be to use the dimensions outlined by the Enterion capsule (Chapter
2, Figure 2.10) [4] which is 7.0 mm longer and has a square form at one end rather than a full
radius. These changes in geometry result in a volume of 2.8 cm3, however the new geometry
remains within the boundaries for swallowing which is set at approximately 3.0 cm3 [5].
The dimensions are an important consideration in the design of the microrobot as not
only will it need to be swallowed but it will also be required to navigate the junctions of the
GI tract. These junctions are: the pylorus, where the stomach meets the small intestines;
the duodenojejunal junction, a peritoneal fold called the ligament of Treitz which holds the
junction in position, and the ileocolic valve which is where the small intestines meet the large
intestines and which is also the most difficult junction to navigate [6]. The consequences of
the microrobot failing to navigate through the GI tract, i.e. becoming an obstruction, will
result in surgical intervention.
3.1.4 Actuators
The second question relates to actuators, traditionally actuators have been adopted for use
on a variety of platforms such as in robotics for the control of movement or in machines
to perform operations [7]. However with the increasing demand for small scale technology
there are greater demands being placed on actuators. For example faster and more pow-
erful actuators with higher torque/mass ratios are required if mechanisms are to be driven
directly. Driving mechanisms directly eliminates the need for bulky mechanical parts such
as linkages and gearboxes and results in a more efficient system. However actuator perfor-
mance is severely restricted by volume constraints.
There are a number of actuators readily available for controlling mechanisms such as
micromotors, piezoelectric actuators and SMA actuators, these have already been discussed
and summarised in Chapter 2, Section 2.3.7.7, however an application where actuators are
combined to produce a mechanism capable of controlling the position of a needle would be
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the Stewart platform.
The Stewart platform offers a degree of rigidity and could be used to control an injection
system as it has the ability to control the position of a needle tip within the GI tract. It
is reasoned that a Stewart platform with 3 DOF, i.e. movement up and down, tilt forward
and backward and pivot side to side could be used to offer limited control of a needle
tip. However the total volume of the mechanism when each of the actuators are combined
would leave insufficient remaining capacity to incorporate all the other required features.
Therefore the focus will be to use micromotors to drive novel mechanisms as they will
give the greatest degrees of flexibility due to the unlimited displacement and low voltage
consumption compared to other actuators (Chapter 2, Table 2.4).
Micromotors manufactured by Namiki and Faulhaber will be explored for their ability to
operate micromechanical mechanisms as they appear to offer a greater selection of motors
for this application.
3.1.5 Investigation into the Microrobotic Platform Attaining Equilibrium
The third question relates to the stopping requirement of the microrobot, in particular the
stopping and holding forces required to resist peristaltic contractions in the GI tract without
damaging tissue.
The question of force being applied to the GI tract wall highlighted the possibility of
the GI tract suffering from post-operative ileus. As a result of the GI tract being handled
the wall can cease to function. This point required further investigation and clarification
as it could have an impact on the design of the stopping mechanism.
After consulting a medical doctor [8] it was confirmed that post-operative ileus is usually
associated with metabolic abnormalities or with the GI tract being handled such as in
laparotomies or abdominal surgery and is not associated with endoscopy or with the use
of WCE. This means that the design and configuration of the legs will not be restricted to
simple shapes and low applied forces. It has been determined by Egorov et al. (2002) [9]
that the values of maximal stress and destructive strain for the transverse small bowel are
0.9 MPa and 140% respectively. These tensile figures can be used to guide the design of the
legs and feet.
There has been much work carried out in leg design in the literature [10, 11] though
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these designs relate to robots which are trying to walk in the GI tract rather than just
stopping and holding position. Consequently there will be different requirements imposed
on the design of the legs such as the configuration of the legs and the shape of the feet. The
shape of the feet will play an important part in the analysis of the interaction with the GI
tract wall as they will be required to overcome the 1-2 mm thick layer of lubricant mucosa
[12] that coats the wall and which can have a coefficient of friction as low as 10−3 [13].
The microrobot’s legs and feet will be required to overcome the peristaltic force imposed
by the GI tract and the gravitational force acting on the mass of the microrobot to maintain
a state of static equilibrium. Figure 3.2 shows the peristaltic forces (Pe) acting on the
microrobot with the lumen shown fully dilated to highlight the extent of the interaction
required from the microrobot to achieve equilibrium.
Figure 3.2: Peristaltic forces (Pe) acting on the microrobot with the lumen shown fully
dilated to highlight the extent of the interaction required to achieve equilibrium
The legs and feet of the microrobot will be required to accommodate the movement
patterns of the GI tract which are segmentation and contraction [14]. These patterns will
affect the loading acting on the legs. The feet will be required to accommodate the smooth
surface of the lower part of the ileum and the thicker more closely set plicae circulares wall
of the jejunum [15]. Inspiration for the design of the legs and feet will be drawn from nature
such as from the cockroach which shows a great aptitude for negotiating difficult terrains
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[16] or from the gecko whose foot hairs (setae) enable it to adhere to surfaces due to the
accumulative action of the setae intermolecular bonding with the surface [17].
3.2 Performance Considerations
There are a number of considerations which will need to be addressed in order for the micro-
robot to achieve a successful WCE procedure, some of the more important considerations
are as follows:
3.2.1 Stages of Operation
The microrobot will be required to perform targeted drug delivery and therapeutic activities.
To analyse the sequence of actions the microrobot will be performing, a flow chart of the
process has been devised, Figure 3.3.
Figure 3.3: Flow chart showing the stages of operation
Showing the step-by-step stages of operation of the WCE will be an aid to the designing
process as it will help focus on the significant aspects of a particular step. For example the
flow chart shows that the microrobot will only require power once it arrives in the GI tract.
With this information we can design the system so that it automatically turns the power on
when the microrobot reaches the GI tract. There are many ways in which we can achieve
this such as timing or by using the sharp increase in pH value when the capsule enters the
small intestines as the trigger to operate the power.
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3.2.2 Electronics
The complex electronics required for the control of the microrobot will not be developed
as part of this research however provision for electronic components will be made. The
microrobot will require onboard space for a number of components such as a transceiver,
batteries, LEDs, connectors and the imager which needs to be mounted at the front of the
capsule.
An onboard embedded controller will be required to control the system functions. The
flow chart (Figure 3.3) outlines a sequence of basic events which the controller will need to
implement. The first task before swallowing the capsule will be to activate the microrobot.
It is envisioned that the microrobot will be stored in an inactive state to save the battery
life. The microrobot will be activated by bringing it into close proximity to a magnet
triggering a reed switch. Once the microrobot has reached the small intestines it will be
required to turn the transmission from the image sensor on. This will be achieved through
timing and pH sensing. When the operator has identified the target location a signal will
be transmitted to the microrobot to deploy the holding mechanism. On receiving a signal
that the holding mechanism has been fully deployed the operator will transmit a further
signal to the microrobot to set the position of the needle. A final signal will deploy the
needle and deliver the medication. Once the medication has been delivered the controller
will automatically retract the needle and holding mechanism. The operator is able to decide
when to switch off transmission from the image sensor.
3.2.3 Power Distribution
The holding mechanism, positioning mechanism and medication delivery mechanism will
bring increased functionality to the microrobot however this increased functionality presents
the challenge of supplying power to the actuators which will be driving the mechanisms.
A circuit schematic of the power distribution for the microrobot is presented in Figure 3.4.
The schematic diagram is based on the anticipated layout of the microrobot.
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Figure 3.4: Circuit schematic of the power supply requirement for the microrobot
Figure 3.4 highlights the requirement for multiple connections to pass through the for-
ward, middle and rear sections of the microrobot. A more precise evaluation shows that
the microrobot can be split into five distinct sections which all have a demand for power:
• The visualisation and processing section
• The holding mechanism
• The needle positioning mechanism
• The medication delivery system
• The power supply section
The configuration of the five sections of the microrobot presents problems of power
delivery through the device, specifically delivering power to the holding mechanism and
the visualisation and processing sections. This is due to the requirement that the holding
mechanism can be deployed diametrically opposite the needle. This feature requires the
front section of the microrobot to rotate 360◦ relative to the rear section. It is assumed that
the rear section will remain static due to the mass of the medication and power supply and
also from the pressure generated by the GI tract wall. The needle positioning mechanism
and the medication delivery system have direct access to the power supply, however the
medication chamber and the micromotor driving the needle positioning mechanism inhibit
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the direct passage of power to the front of the microrobot. Figure 3.5 highlights the five
sections with a cut-through view of the microrobot.
Figure 3.5: Cut-through view of the microrobot with the five main sections labelled
To overcome the issue of power distribution through the microrobot and to control
the angular orientation of the needle positioning mechanism a specifically designed rotary
encoder is proposed.
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3.2.3.1 Rotary Encoder
A specifically designed rotary encoder mounted between the medication chamber and the
needle positioning mechanism is the proposed solution for providing power through the
forward section of the microrobot, Figure 3.6. The rotary encoder uses flexible PCB cabling,
which adheres to the outside of the microrobot’s body, to connect the power supply at the
rear of the microrobot to the rotary encoder board. Utilising the outside of the microrobot
bypasses the need to disrupt the medication compartment making sealing the medication
chamber more straightforward.
Figure 3.6: Rotary encoder: concentric tracks and registration contact a) and contact pins
embedded in the needle funnel b)
The rotary encoder board, which is 0.5 mm thick, allows power to be supplied to the
visualisation and processing section and to the holding mechanism while the front of the
microrobot is rotating. The rotary encoder achieves this through four 0.3 mm wide concen-
tric tracks which have been positioned to take into consideration the limitations of flexible
PCB manufacture and also to accommodate the holes which allow the medication to pass
through the board and into the needle funnel, Figure 3.6, a). Contact pins held in the
needle positioning mechanism make contact with the tracks however they remain free to
rotate with the needle funnel. A fifth contact pin is mounted in the needle funnel and used
in conjunction with a registration contact on the rotary encoder board to determine the
angular position of the needle and holding mechanism, Figure 3.6, b).
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The contact pins align with pads on a flexible PCB board which is incorporated into the
needle funnel. The pins stand proud of the needle funnel by 0.05 mm to ensure they make
contact with the tracks on the rotary encoder board. The flexible PCB passes through
the needle funnel and through the retaining plate. The shape of the distal end of the
holding mechanism’s legs have been designed to accommodate the flexible cable (Chapter
4, Figure 4.26), however the cable cannot pass through the bevel gear set which is positioned
behind the holding mechanism’s legs as it will be rotating. Therefore the power supply is
again routed out through the side of the microrobot and then back into the space behind
the bevel gear set where it can supply power to the visualisation and processing section and
to the holding mechanism.
The power supply for the forward section is supplied through the onboard battery which
is stored at the rear section of the microrobot. As specified the rotary encoder’s flexible PCB
board adheres to the outside of the microrobot’s body and connects to the power supply,
however the power supply is required to be removable to allow access to the medication
chamber for loading.
3.2.4 Energy Requirement
The requirement for the microrobot to perform tasks such as delivering a metered dose
of medication will necessitate the use of a stored energy device. This device could be in
the form of a coiled spring however the camera and lighting system will require electrical
energy to power them. For this purpose high performance batteries have been selected as
they exhibit high energy density ratios. Energy density (Wh/L) is a measure of how much
energy a battery can hold, where W is watts, h is hours and L is litres, the higher the
energy density the longer the runtime will be. A second consideration will be the power
density (W/L) of the battery this is a measure of how much power a battery can deliver on
demand. This is significant as the actuators will only be required to work for short periods
of time however they may require high power, for example, to activate a motor controller.
There are a number of battery options available such as silver oxide button cell batteries
however these are not as powerful as lithium-ion polymer batteries (LiPo) which have the
highest energy density ratio available at 300 Wh/L [18]. They are also rechargeable and
have a slow loss of charge when not in use. Provision for button cell batteries will be
incorporated into the microrobot however the limitations of space at the early design stage
will not prohibit the development of the mechanisms as it is envisaged that shaped batteries
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could be developed at a later stage which would take full advantage of the available space.
3.2.4.1 Power Consumption
As the space available for the power supply onboard the WCE is limited, it is essential that
the needle positioning mechanism and the holding mechanism can both operate with low
power consumption. The energy requirements for both mechanisms have been estimated
from the peak current consumption of the Namiki motor controller (SSD04) and the Faul-
haber motor controller (BLD05002S) which are stated as 800 mA at 6 V and 400 mA at
7.5 V respectively. Three revolutions of the Namiki micromotor are required for positioning
and deployment of the needle; this is achieved in 3.8 s while the holding mechanism can
complete a full opening and closing cycle in 1.78 s. Using a Lithium coin battery with a vol-
ume of 188 mm3 and an energy density of 435 Wh/L (CR1025 Energizer), the mechanisms
will consume at most 28.94 J of energy for each complete cycle which is only 9.8% of the
available energy, offering the potential for multiple operations.
3.2.4.2 Power Supply
A compact method of connecting the power supply to the microrobot is required which will
allow access to the medication chamber for filling and also connect with the flexible PCB
board which links to the rotary encoder. Figure 3.7 shows the chosen design in three stages
of assembly.
Figure 3.7 shows the proposed assembly of the power supply unit. The solution is
a modular system which allows the medication chamber to be manually loaded and also
provides a method of connecting to the rotary encoder PCB board running on the outside
of the body. The solution incorporates a flexible PCB board which wraps around a silver
oxide button cell battery (CR1025 Energizer), Figure 3.7, a). The battery and flexible PCB
board are secured into a cap with resin to ensure the unit cannot be damaged. A contact
board is also secured into the side of the cap which facilitates the connection to the rotary
encoder PCB board, Figure 3.7, b). The cap and battery are fitted to the trigger mechanism
via a snap fit on the trigger board, Figure 3.7, c). The assembly can be loaded onto the
microrobot’s body via a central lug protruding from the trigger board. The lug secures the
power supply unit and also connects the power supply to the micromotor and to the EPIC
device. The flexible PCB board running on the outside of the body is connected to the
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Figure 3.7: Power supply assembly: flexible PCB board wrapped around the battery a)
battery and flexible PCB board secured into the cap with contacts aligned b) and trigger
mechanism and power supply assembly ready to be loaded into the microrobot’s body c)
contact board to complete the connection with the front of microrobot.
The proposed solution allows the medication chamber to be manually filled at the point
just prior to administration. This feature gives flexibility in the choice of medication which
can be prescribed to the patient therefore potentially broadening the scope of its use.
3.2.5 Usability
The microrobot will have the facility to carry onboard medication such as antibiotics or
adrenaline. The medication may have a short shelf life or degrade quickly if it is not
stored correctly therefore the microrobot must have the capability for the medication to
be loaded at the beginning of the procedure. An influencing factor for the manual loading
operation will be the decision to make the microrobot a single use device or a reusable
device as there will be a degree of added complexity if the medication loading system is
required to accommodate multiple loadings. For example, the medication chamber may
be contaminated by the drug or the method for sealing may not withstand the sterilizing
procedure. A further requirement, if the device is to be reusable, will be a replaceable power
supply and the ability to reset or replace the drug delivery mechanisms.
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3.2.6 Ingress Protection
The microrobot will be in a liquid environment when passing through the GI tract. This will
have implications on the performance of the micromotor as any liquid ingress will prohibit
the smooth functioning of the micromotor possibly resulting in total failure. The solution
to the problem will be to seal the driveshaft however this may be problematic due to the
small dimensions of driveshafts (Ø0.5 x 1.3 mm). Also the increased friction due to the
seal will increase the torque required to drive the driveshaft reducing the available torque
to drive the mechanism. Another consideration relating to ingress is the sterilization of
the microrobot as general autoclaving uses steam at temperatures of 134 ◦C to 137 ◦C for
three minutes. The steam which will also be pressurised will penetrate the micromotor
potentially damaging component parts. The alternative is to use gas plasma (hydrogen
peroxide) sterilization which uses temperatures <50 ◦C.
3.3 Summary
A design specification for the microrobotic platform has been derived from the gathered
research data and from the prior art presented in the literature review.
3.3.1 Microrobotic Platform Technical Specification
The microrobot will need to be easily swallowed by the patient and expelled through natural
means. During its journey it will be required to transmit images to an operator and perform
therapeutic activities such as constant pH, temperature and pressure monitoring. It would
also be required to hold itself in position while delivering a metered dose of medication
to a targeted site. Some of the more important performance specifications are that the
microrobot will be comparable in size with its competitors, it will be capable of navigating
the ileocolic valve and it will be capable of delivering 1 ml of medication.
For the microrobot to perform targeted therapy and microscale diagnosis a list of re-
quirements can be drawn from the design specification and broken down into specific system
features for the microrobot such as the camera, power supply, systems controller, pH sen-
sor, drug delivery system and a stopping mechanism. The detailed specifications for the
microrobot’s performance is outlined in Table 3.1.
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The following chapters will discuss the design, analysis and validation of a microrobotic
system capable of performing a therapeutic activity in the GI tract, more specifically the
microrobot will have additional functionality which will allow it to target and treat patholo-
gies in the small intestines which is the most difficult and challenging section to access. The
structure of the chapters are as follows: chapter four presents the design, analysis and
evaluation of a holding mechanism capable of maintaining a state of equilibrium; chapter
five presents the design, analysis and evaluation of a targeting system; chapter six presents
the design, analysis and evaluation of a drug delivery system capable of delivering 1 ml of
medication and chapter seven presents the conclusions and further work.
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Table 3.1: Microrobotic platform technical specification
System Requirement Specification
features
Geometry Microrobot volume Maximum 3.0 cm3
Maximum diameter 11.10 mm
Maximum length 36.0 mm
Maximum weight 5.0 g
Vision Image sensor CMOS
Viewing angle 140 deg
Depth of view 1.0 mm to 3.0 mm
Resolution 0.1 mm
Magnification Optical dome 1:8
Illumination 4 white LEDs
Duration 6 to 8 hours
Holding Attaining equilibrium Expansion
Expand to a circumference >53.0 mm
Resist peristaltic contractions of: >26.9 g/cm circumferential
>17.2 g/cm linear
Actuator Micromotor
Deployment time Maximum 2.5 s
Holding time Minimum 10 s
Targeting Tracking: RF
Timed transit
Telemetry Bidirectional
Actuator Micromotor
Return to site of interest ±5.0 mm
Delivery Delivering therapy Liquid medication
Delivery method Needle
Drug reservoir 1 ml
Wall penetration 1.0 mm to 2.0 mm
Needle penetration force 8.9 MPa
Target location ±30 deg
Actuator Spring
Response time Maximum 5 s
Sensing Monitoring: pH level
Temperature
Pressure
Power Onboard power supply Silver oxide button cell battery
Supply voltage 3.0 V
Battery life 6 to 8 hours
Duration of mechanisms Minimum of 2 cycles
Sterilization Sterilization method Gas plasma (hydrogen peroxide)
Withstand temperatures of 50 ◦C
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Chapter 4
Attaining Equilibrium: Design,
Analysis and Evaluation
4.1 Introduction
This chapter presents a novel biologically-inspired holding mechanism based on the order
of insects known as the Coleoptera. Coleopteran’s, which are more generally referred to as
beetles, have two pairs of wings and include insects such as the coccinellidae (ladybird). The
ladybird, which can grow to 10 mm in size, has the ability to fold away its wings behind
a second hardened pair of wings which are used as a casing to protect them. Using the
biologically-inspired concept of a pair of folded wings protected by an outer case as a basic
premise, a compact holding mechanism can be designed which can be incorporated into the
next generation of WCE for the purpose of resisting natural peristalsis in the GI tract. This
chapter describes the requirements of WCE, discusses a proposed design and analysis of a
holding mechanism based on the design specification presented in Chapter 3 and presents
a 5:1 scale prototype holding mechanism which is validated through experimentation.
4.2 Overview
Conventional WCE have sufficiently small geometry to allow them to pass through the
small intestines and navigate the ileocolic valve without becoming an obstruction. However
the clinical need to target a specific location or feature within the GI tract for medication
delivery or examination of the intestinal wall would require the WCE to stop. Figure 4.1
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Figure 4.1: Microrobot concept design capable of resisting peristaltic pressure through an
integrated holding mechanism. Holding mechanism shown fully open
shows a microrobot concept design capable of resisting peristaltic pressure through the
deployment of an integrated holding mechanism.
4.3 Resisting Peristalsis
The overall geometry of the microrobot system must be capable of housing all the compo-
nents necessary for the WCE to resist natural peristalsis. Therefore a simple mechanism
which can expand in some way to prevent the WCE from moving when a section of the in-
testinal wall is being examined, or for the purpose of administering medication, is proposed.
The holding mechanism must fit within the maximum volume of 3.0 cm3, leave sufficient
space for other features and expand to a minimum circumference of 53.40 mm to guarantee
it occupies the 17.0 mm diameter of the small intestinal tract.
Through a process of divergent and convergent thinking [1] a method of expansion was
selected to hold the microrobot against natural peristalsis. The chosen method of expansion
offers greater advantages compared to alternative methods of resisting peristalsis such as
balloon insuﬄation or electrical stimulation as it guarantees the intestinal tract is in contact
with the body of the microrobot. This is an important requirement as it allows access to
the GI tract wall for the purpose of administering treatment. A number of expansion
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solutions have been considered, for example two, three and four leg designs were explored
which utilised direct drive from a micromotor through a leadscrew or from a geared system.
However operating legs via a leadscrew presents challenges of space and insufficient torque
to combat the leverage action from the pivoting legs. A two leg system driven by a gear
train offered the advantage of using the minimum occupied space and also a reduction in
the number of pinned joints which would be required compared to a four leg approach. A
further advantage of the expansion mechanism is its ability to slow down the transit of the
microrobot by partially opening the legs. This feature offers the potential advantage of
greater control of the delivery of the medication as more precise targeting is possible. This
section concentrates on the design and analysis of the selected method of expansion which
utilises a geared system to gain maximum mechanical advantage and also incorporates a
number of levers and pinned joints which will allow the mechanism to unfold from the
WCE’s protective casing in a similar way to the unfolding of a ladybird’s wings. A selection
of holding concepts is presented in Appendix A.
4.3.1 Holding Mechanism
The concept holding mechanism (Figure 4.1) uses a single micromotor to open and close
two legs. The two legs are connected to a central support via two pinned leg ties. The two-
legged design utilises a micromotor which is orientated in a vertical position, Figure 4.2.
The micromotor is connected to a bevel gear set, this allows the micromotor’s rotation
to be translated through 90 degrees. The bevel gear drives a gear train of spur gears,
which is nested in the large bevel gear, and drives the legs in and out, Figure 4.3. This
novel configuration significantly reduces the micromotor’s RPM. The reduction in RPM
will result in a multiplication of the micromotor’s torque, this will give the legs the strength
required to distend the GI tract wall and hold the microrobot in place.
To secure the microrobot in place the holding mechanism will be required to expand to
a size which is sufficiently large that it resists the natural movement from peristalsis. This
is achieved through an increase in circumference of the microrobot. The holding mechanism
begins with a circumference of 34.5 mm however when activated the mechanism increases
in size to produce a circumference of 60.4 mm which is an increase of 75%. This can be
further increased to 71.25 mm by simply modifying the profile of the legs to increase the
surface area in contact with the GI tract wall.
The vertical configuration of the micromotor offers the advantage of being a very com-
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Figure 4.2: Vertically orientated micromotor driving a bevel gear set
pact design (347 mm3) resulting in the most efficient use of space. The two legs, central
support, leg ties and the microrobot case will absorb the load from the GI tract wall evenly.
The compact gearing allows the rate at which the legs are deployed to be controlled by the
ratio of the gear train.
4.3.2 Gear Train
For the holding mechanism to operate at a safe speed the micromotor will require the gear
train to slow it down. The chosen micromotor is manufactured by Faulhaber and already has
an integral gearbox, which reduces the 20,000 RPM by a factor of 13:1 (reduction absolute
324/25). This results in a starting RPM of 1,543 RPM, which is significantly high; therefore,
further reductions will need to be achieved from the gear train. The output speed of a gear
train can be estimated from the following equation:
RPMout =
Nd1 ×Nd2 ×Nd3 ×Nd4 ×RPMin
Nf1 ×Nf2 ×Nf3 ×Nf4 (4.1)
Where RPMin is the input speed, Nd1 is the number of teeth on the driving gear and
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Figure 4.3: Two-legged design showing the central spur gear being driven by the bevel gear.
The legs are fully expanded to accommodate a circumference of 60.4 mm
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Nf1 is the number of teeth on the follower gear. This formula can be applied to the gear
train with a selection of gear teeth to determine the output RPM, Table 4.1.
Table 4.1: Calculated gear train output from an input of 1,543 RPM
Gear stages Micromotor Bevel Second Output
and bevel gear and stage spur
gear spur gear spur gear gear
No. of teeth on driver (d) 13 8 8 8
No. of teeth on follower (f) 48 34 34 22
Output RPM 417.93 98.34 23.14 8.41
As can be seen from Table 4.1 the number of teeth on the follower gears (f) is higher
than the number of teeth on the driving gears (d), this is to ensure a rapid reduction in
RPM. The target is to deploy the holding mechanism as slowly as possible as this will
reduce the potential for trauma to the GI tract wall from the legs and supports. However
there are limitations to the number of teeth which can be used as the chosen gear module,
which is the ratio of the pitch diameter to the number of teeth on the gear, determines the
overall geometry of the gear. The chosen bevel gear module is 0.2 this results in a maximum
number of teeth of 48 and an overall gear diameter of 10.0 mm (Figure 4.2) as the gear has
the overall limiting factor of the diameter of the microrobot. The spur gears use a module
of 0.1 this results in a maximum number of teeth of 34 as the gears are required to be linked
together in a train and nested in the bevel gear (Figure 4.3). They are therefore limited
again to the overall diameter of the microrobot.
The gear train reduces the 1,543 RPM output from the micromotor to 8.4 RPM this
allows the holding mechanism to be fully deployed in approximately 1.8 s. Based on an
average transit time through the small intestines of 23 mm/min [2] the capsule would have
travelled approximately 0.7 mm before the holding mechanism is fully deployed. Altering
the number of teeth on the driver or follower gears will increase or decrease this figure
however as stated this is severely restricted by the geometry of the microrobot. A complex
multiple layered design has been chosen to achieve the speed reduction. This type of gear
configuration will add to the overall length of the microrobot however the layout does leave
an unused volume of 37.7 mm3 which could be utilised to house a power supply.
An important function of the gear train is to transmit power from the micromotor to the
legs, this will enable the legs to distend the luminal wall and hold the microrobot in position.
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The power transmitting capacity of a gear train can be determined by the following formula:
Tout =
Nf1 ×Nf2 ×Nf3 ×Nf4 × Tin
Nd1 ×Nd2 ×Nd3 ×Nd4 (4.2)
Where Tin is the input torque, Nf1 is the number of teeth on the follower gear and Nd1 is
the number of teeth on the driving gear. Applying this formula to the gear train and using
0.15 mNm torque generated by the Faulhaber micromotor as the input torque (Tin) results
in an estimated output torque (Tout) of 27.5 mNm. However the calculated output torque
does not take into consideration how efficient the gear train is in transmitting power. There
are a number of factors which will influence the efficiency of the gear train for example the
ratio of output power to input power is significantly influenced by friction generated by the
system. The friction generates heat energy which causes loss of transmitted power. Friction
is dependent on the load torque and the contact between the teeth therefore the number of
teeth engaged and the number of stages in the gear train will influence the efficiency of the
gear train. Also bearing material and configuration coupled with the type of lubrication
used will have an impact on the efficiency of the gear train. Using the number of gear stages
and an estimation of a 10% loss at each stage the gear train efficiency (η) can be estimated
by the following formula:
η = Stage1(90%)× Stage2(90%)× Stage3(90%)× Stage4(90%)× Stage5(90%) (4.3)
Table 4.1 shows four gear stages however for the purpose of the efficiency analysis
(equation 4.3) a fifth stage is taken into consideration. The fifth stage does not contribute
to the torque or RPM output as it has the same number of teeth on each gear. The purpose
of the gear stage is to drive both the legs simultaneously. Using 90% for each stage results
in an overall system efficiency of approximately 60.0% this equates to an output torque of
16.2 mNm. The design parameters for the complete gear train are specified in Table 4.2.
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Table 4.2: Bevel gear and spur gear design parameters
Number Normal Outside Pitch Tooth Tooth Pressure Face
of teeth module diameter circle depth thickness angle width
(z) (mn) (OD) (PC) (ht) (t) (Φ) (bt)
Bevel gear 1 13 0.2 3.0 mm 2.6 mm 0.48 mm 0.314 mm 20◦ 0.7 mm
Bevel gear 2 48 0.2 10.0 mm 9.6 mm 0.48 mm 0.314 mm 20◦ 0.7 mm
Drive gear 8 0.1 1.0 mm 0.8 mm 0.24 mm 0.157 mm 20◦ 0.45 mm
Follower 34 0.1 3.6 mm 3.4 mm 0.24 mm 0.157 mm 20◦ 0.45 mm
Drive gear 2 22 0.1 2.4 mm 2.2 mm 0.24 mm 0.157 mm 20◦ 0.45 mm
The gears must perform under the maximum torque delivered by the micromotor how-
ever the chosen gear modules result in very small gears therefore it is essential that the gears
can withstand the stress and strain developed during an operating cycle. The next section
evaluates the gears with a view to determining whether they are capable of withstanding
these loads.
4.3.3 Gear Tooth Loading Analysis
The 0.1 module chosen for the gear train results in a micro-metre gear tooth profile, Fig-
ure 4.4. It is therefore important to determine if the teeth can withstand the bending loads
which they will be subjected to when the micromotor is operated at its maximum RPM. The
Faulhaber (02/1) (Table 2.3) micromotor will be used for the purpose of gear train analysis.
It has a two stage 13:1 reduction gearbox which results in an output of 1,543 RPM and a
torque of 0.15 mNm.
An involute gear tooth profile has been selected for the gears. Figure 4.4 shows the forces
acting at the pitch circle of the involute tooth profile and some additional relationships
between features. For the purposes of analysis the tooth can be modelled as a cantilever
beam.
The contact angle between mating teeth is also known as the pressure angle (Φ) and in
this application it is set at an industry standard of 20 degrees for a spur gear.
The stress figures determined by analysis are an important resource as they can be used
to determine the material the gears are to be manufactured from and the manufacturing
process.
The bending stress for a spur gear tooth or a straight toothed bevel gear can be obtained
Attaining Equilibrium: Design, Analysis and Evaluation 109
Figure 4.4: Gear tooth loading modelled as a cantilever beam
by using the Lewis formula which has been modified to take into consideration the contact
impact of the gears through the addition of a velocity factor:
σ =
Ft
Kvbtmny
(4.4)
Where Ft is the load applied to the tooth, Kv is the velocity factor, bt is the face width,
mn is the normal module and y is the Lewis form factor.
The assumptions made with the modified Lewis formula are that the full load is applied
to a single tooth and the radial component force (F ) is ignored, also that the force is
distributed evenly over the full face width of the tooth and that the stress concentration
effect of the tooth fillet is also ignored.
To calculate the load (Ft) acting at the circular pitch [3]:
Ft =
2000Tf1
d1
(4.5)
Where Tf1 is the torque on the drive gear and d1 is the reference diameter of pinion
and can be calculated by the number of teeth on the pinion (z) multiplied by the normal
module (mn).
The velocity factor Kv compensates for the dynamic effect of the gears pitch line velocity
and the manufacturing method used to produce the teeth profile. For a hobbed or shaped
gear the Barth’s formula can be used to calculate the velocity factor [4]:
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Kv =
3.54
3.54 +
√
Vp
(4.6)
Where Vp is the pitch line velocity and is calculated by:
Vp =
pidn
60
(4.7)
Where d is the pitch diameter and n is the rotating speed of the gear in revolutions per
minute.
The Lewis form factor (y) is a function of tooth shape and is independent of tooth size,
it also does not take into consideration the stress raiser effect of the tooth fillet. It can be
calculated as follows [4]:
y = 0.484− 4.24
z + 6
(4.8)
Where z is the number of teeth on the gear.
The normal module (mn) of a gear is the ratio of the pitch diameter to the number of
teeth on the gear. The module has a direct relation to the geometry of the teeth and the
overall diameter (OD), it can be calculated as follows:
OD = (z + 2)×mn (4.9)
An example of the module’s impact on the outside diameter can be shown using a
module of 0.5 and 22 teeth as this would result in an outside gear diameter of 12.0 mm. If
the same number of teeth were to be used with a 0.1 module the outside diameter would
become 2.4 mm. Therefore the smaller the module the smaller the gear geometry which can
be generated.
Applying the modified Lewis formula (equation 4.4) to the bevel gear set, which has
a module of 0.2, results in a tooth bending stress of 3.57 Nmm−2 for the 13 toothed gear
and 2.30 Nmm−2 for the 48 toothed gear. The calculated low figures for stress can be used
to guide the design of the gears as the results suggest the gear set could be manufactured
from a polymer such as PEEK. The benefit of making the 48 toothed gear from a polymer
would be a simplified assembly as friction bushes can be eliminated by designing the gear
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to have bearing surfaces. However applying the formula to the next gear in the train results
in significantly higher levels of bending stress.
Applying the Lewis formula to the 8 toothed drive gear, which has a module of 0.1
and is connected to the 48 toothed bevel gear, yields a stress of 176.21 Nmm−2. At this
level of stress it would result in a polymer tooth yielding therefore a metallic gear would
be required. The Lewis formula does not take into account the stress raising effect of the
fillets or the stress distribution when the radial component load (F ) is applied, therefore an
FEA analysis has been performed to determine a more accurate level of stress distribution
through the tooth, Figure 4.5.
Figure 4.5: Von Mises FEA 2D isoareas analysis of a stainless steel 304, 0.1 module gear
tooth profile with a radial component load of 1.473 N
Figure 4.5 shows a Von Mises FEA 2D isoareas analysis of a stainless steel 304, 0.1
module gear tooth profile with an applied radial component load of 1.473 N. The radial
load F has been calculated from the applied load Ft and the pressure angle Φ. There is a
distinct difference in the result for loading: Figure 4.5 A) shows the compressive stress to be
139.42 Nmm−2 while Figure 4.5 B) shows the tensile stress to be 121.69 Nmm−2. However
repeating the Von Mises FEA analysis with the load (Ft) acting on the circular pitch resulted
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in similar bending stress figures to the radial component load analysis. Although the FEA
figures are lower than the calculated figure (176.21 Nmm−2) the FEA figures confirm that
the 8 toothed gear must be manufactured from a metal rather than a polymer to ensure
the teeth do not yield under load.
The Von Mises FEA analysis assumes a worst case scenario, that is, at any one time
only one pair of teeth are in contact with each other and that they take the total load.
Generally two pairs of teeth are in contact however this may drop to 1.5 depending on
the degree of tooth truncation and inaccuracies in tooth profile due to the manufacturing
process. Increasing the value of the face width or increasing the module would reduce the
stress in the tooth, however increasing the module would result in an increase in the overall
diameter of each gear in the set and hence the overall size of the gear train would increase.
Also increasing the tooth thickness will influence the overall length of the microrobot due
to the stack-up of dimensions. However increasing the size of the components would make
manufacturing generally easier.
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4.4 Analysis of Holding Mechanism
The microrobot’s holding mechanism will be required to overcome the peristaltic force
imposed on it by the GI tract and the gravitational force acting on it due to its mass in
order for the microrobot to achieve a state of static equilibrium. There are two components
of peristalsis which will potentially influence the operation of the holding mechanism, they
are circumferential and longitudinal peristaltic contractions. To ensure correct functionality
of the holding mechanism an analysis of the potential impact of the two components will
be performed.
4.4.1 Circumferential Peristaltic Force Analysis
To attain a state of equilibrium, the external forces acting on the microrobot must be
balanced for any given orientation; however angles less than 90 degrees from the horizontal
can be neglected from the equilibrium analysis, as in the worst case the load would be acting
vertical to the horizontal resulting in a multiplication factor of sin 90 which equals 1, hence
producing no net increase in load. Figure 4.6 shows the external forces acting on the legs
of the microrobot. For the purpose of the force analysis the contact area has been divided
into six contact points as these points will be in continuous contact with the GI tract wall
throughout the deployment of the holding mechanism.
As can be seen from Figure 4.6 the external forces acting on the microrobot’s legs
are the circumferential peristaltic force Pc, the longitudinal peristaltic forces are neglected
at this stage of the analysis as they do not contribute to the holding function. Using
the figures determined by Miftahof (2005) [5] the maximum circumferential amplitude of
muscle contraction is 26.9 g/cm this results in an estimated load of 687.0 mN for the total
circumferential contact area of the extended legs and microrobot’s body with the GI tract
wall.
The micromotor employed to drive the legs must be capable of delivering an equivalent
force to the legs to maintain a state of equilibrium. The force acting at each point of contact
Pc can be estimated by the following formula:
Pc =
Fc +mg
6
(4.10)
Where Fc is the circumferential force from the GI tract wall, m is the mass of the
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Figure 4.6: Microrobot holding mechanism shown fully open and the external circumferen-
tial peristaltic force Pc acting on the microrobot at six positions
microrobot and is estimated to be 3.45 g and g is gravity.
Using formula (4.10) the load acting at each point equates to 120.1 mN. However due
to the unfolding nature of the mechanism the circumferential peristaltic force will work
towards preventing the legs from opening, Figure 4.7.
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Figure 4.7: Holding mechanism shown fully closed. Circumferential peristaltic forces acting
towards the centre of the microrobot prevent the holding mechanism from opening
For the purpose of simplifying the force analysis the circumferential peristaltic forces
have been assigned individual identification numbers Pc1, Pc2..., Figure 4.7.
4.4.1.1 Load Points Pc Contributing to Torque
The process of operating the legs from the stored position to the fully extended position
results in the circumferential peristaltic force from the GI tract wall (Pc) acting towards the
centre of the microrobot, this is illustrated for Pc1 and Pc5 in Figure 4.8. However due to
the position of the legs’ pivot points the circumferential forces will be required to be broken
down into their component forces as only the perpendicular component force acting on the
leg pivot will work towards preventing the legs from opening Pp1 and Pp5.
The circumferential forces Pc1 and Pc5 act on both legs with equal magnitude and
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Figure 4.8: Circumferential forces Pc1 and Pc5 acting towards the centre of the microrobot
resulting in perpendicular component forces Pp1 and Pp5 working to prevent the legs from
opening
direction therefore, due to the legs being identical in geometrical design, only one side will
require analysing. However the result of the analysis will be applicable to both legs.
To ensure the microrobot’s legs can distend the GI tract wall and achieve a state of
equilibrium the micromotor must deliver an equivalent or greater sum of reaction forces
Fpn than the sum of the perpendicular component forces Ppn. This can be expressed as
follows:
6∑
n=1
Fpn ≥
6∑
n=1
Ppn (4.11)
The magnitude of the reaction force Fp1 (Figure 4.9) can be estimated for a leg movement
through zero degrees to 90 degrees using the following formula:
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Figure 4.9: Circumferential force Pc1 results in a perpendicular component force (Pp1) and
a reaction force Fp1 acting on the microrobot’s leg
Fp1 = Pc1
(
c(sinA)√
b2 + c2 − 2bc(cosA)
)
(4.12)
Using formula (4.12) the calculated maximum reaction force acting on the leg is 45.6 mN,
this occurs at an opening angle of 45 degrees. A plot of the full leg opening cycle can be
seen in Figure 4.10.
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Figure 4.10: Graph plotting the reaction force Fp1 of a full zero to 90 degrees opening cycle
of the microrobot’s leg
The circumferential force from the GI tract wall Pc2 and Pc4 will be acting on both
tie bars, Figure 4.11. The tie bars link the legs to the centre support via pinned joints
therefore they will contribute to the perpendicular component forces preventing the legs
from opening. Similarly to the analysis of the legs only one of the perpendicular component
forces Fp2 or Fp4 will require analysing due to the identical geometry, Figure 4.12. However
both resulting forces will contribute to the total load.
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Figure 4.11: Circumferential forces Pc2 and Pc4 acting towards the centre of the microrobot
result in perpendicular component forces Pp2 and Pp4 working to prevent the legs from
opening
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Figure 4.12: Circumferential force acting on the microrobot’s tie bar Pc2 results in a per-
pendicular component force (Pp2) and a reaction force Fp2 acting on the microrobot’s leg
The reaction force Fp2 acting on the microrobot’s leg, as a result of the circumferential
force acting on the tie bar Pc2, can be seen in Figure 4.12 and can be estimated using the
following formula:
Fp2 = Pc2 cos
[
tan−1
(
c3
(
sinC5
b5 − (c3 cosC5)
))]
sin
[
cos−1
((
a3
2 + b2
2 + c4
2
)− ( b22
2a3c4
))
+ C7
]
(4.13)
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The 120.1 mN circumferential force acting on the tie bar (Pc2) equates to a reaction
force Fp2 of 83.9 mN and occurs at full extension. This can be seen in a plot of a full zero
to 90 degrees opening cycle of the microrobot’s tie bar in Figure 4.13.
Figure 4.13: Graph plotting the reaction force Fp2 of a full zero to 90 degrees opening cycle
of the microrobot’s tie bar
The circumferential peristaltic force Pc3 acting on the centre support (Figure 4.14) would
be split between the two pivot points linking the two tie bars, these two forces will result
in the perpendicular component forces Pp3 and Pp6 which will work towards preventing the
legs from opening. As the geometry and loading are symmetrical only one side of the centre
support requires analysis, Figure 4.15.
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Figure 4.14: Circumferential peristaltic force acting on the microrobot’s centre support Pc3
results in perpendicular component forces Pp3 and Pp6 which will be working to prevent the
legs from opening
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Figure 4.15: Circumferential force acting on the microrobot’s centre support Pc3 results in
a perpendicular component force (Pp3) and a reaction force Fp3 acting on the microrobot’s
leg. The centre support links the two tie bars
Figure 4.15 shows the reaction force Fp3 acting on the microrobot’s leg, as a result of
the circumferential peristaltic force acting on the centre support Pc3, and can be estimated
using the following formula:
Fp3 =
[
Pc3/2
sin(180− (C3 +B2 + C1))
]
sin
[
tan−1
(
a2 sinA3
b3 − (b2 cosA3)
)]
(4.14)
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Using formula (4.14) the maximum load acting on the centre support equates to 70.47 mN
and also occurs at full extension. This can be seen in a plot of a full zero to 90 degrees
opening cycle of the microrobot’s centre support in Figure 4.16.
Figure 4.16: Graph plotting the reaction force Fp3 of a full zero to 90 degrees opening cycle
of the microrobot’s centre support
4.4.1.2 Summation of Reaction Forces
The reaction forces Fpn must be equal to or greater than the sum of the perpendicular com-
ponent forces Ppn acting on the microrobot’s leg to ensure a successful holding mechanism
deployment. As the micromotor’s deliverable torque is known it can be compared to the
sum of the reaction forces to determine if it is capable of delivering an equivalent force to
the legs to maintain a state of equilibrium. The summation of the reaction forces Fp can
be determined by the following formula:
Fp =
6∑
n=1
Fpn (4.15)
The estimated reaction forces Fp1, Fp2 and Fp3, as outlined in the analysis, can be com-
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bined with Fp4 the reaction force for the second tie bar, Fp5 the reaction force acting on the
second leg and Fp6 the second reaction force acting on the centre support to find the max-
imum load which will be required to overcome the circumferential peristaltic contractions
through a full zero to 90 degree leg movement. Figure 4.17 shows a plot of the combined
reaction force Fp for a full leg operating cycle.
Figure 4.17: Graph plotting the combined individual estimated reaction forces Fp1, Fp2, Fp3,
Fp4, Fp5 and Fp6 for a full zero to 90 degree leg operating cycle
The result of the combined reaction force plot (Figure 4.17) shows a load of 181.7 mN
at the start of the opening cycle, rising to a maximum load of 378.15 mN at the end of
the cycle. The maximum load occurs when the holding mechanism is fully expanded to
90 degrees, this results in a torque of 2.78 mNm acting on the final gear in the gear train.
However the result of equation (4.3) shows an output torque (Tout) for the gear train to
be 16.2 mNm, this gives a high margin of safety before the micromotor stalls. Further, the
circumferential peristaltic force analysis represents a worst case scenario as the microrobot
would be orientated at various angles when passing through the GI tract, this would reduce
the applied loads on the legs and hence reduce the torque requirement of the micromotor.
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4.4.1.3 Leg Member Stress Analysis
The radial peristaltic force (Pc) acting on the six external points of the holding mechanism
will develop stress in the leg members as a result of the perpendicular component force (Pp)
acting on them. As the available space for the holding mechanism is limited the legs have
been optimised for size and shape therefore an evaluation of the stress induced in the leg
members has been performed to determine if the legs yield under this load, Figure 4.18.
Figure 4.18: Von Mises FEA 2D isoareas analysis of the holding mechanism’s leg modelled
in stainless steel 304 with the maximum perpendicular component force (Pp) applied
The previous section showed that at the full extension of 90 degrees the maximum load
will be distributed through the holding mechanism therefore an evaluation of the stress
induced in the legs has been performed at this position. The Von Mises FEA analysis of the
stainless steel 304 leg shows that the maximum stress induced in the leg is 75.72 Nmm−2
and that it acts at the surface at point A, Figure 4.18. At these levels of stress a polymer,
such as PEEK, is an option for the leg material as its yield point is higher at 97.0 Nmm−2
however a mechanism manufactured from metal would offer greater strength and stability
and also limit any deflection from other external forces such as the longitudinal peristaltic
force.
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4.4.2 Longitudinal Peristaltic Force Analysis
Although the longitudinal peristaltic force does not contribute to the holding function it
may have a direct influence on the operating performance of the holding mechanism. The
longitudinal force acting on the legs could potentially bend them out of position and prevent
them from being retracted back into the microrobot’s body and hence become a permanent
obstruction. Figure 4.19 shows the longitudinal forces acting on the legs of the microrobot.
Figure 4.19: External longitudinal peristaltic force PL acting on the microrobot at six
positions
For the purpose of the force analysis the longitudinal peristaltic force contact area
has been divided into six contact points positioned linearly with the microrobot’s boy,
Figure 4.19.
Using the figures determined by Miftahof (2005) [5] the maximum longitudinal amplitude
of muscle contraction is 17.2 g/cm. Based on a body length of 32.0 mm long this results in
an estimated load of 539.94 mN for the total linear contact area of the microrobot’s body.
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To determine if the longitudinal peristaltic force PL will influence the deflection of the
legs at full extension we must first calculate the force acting at each point of contact. This
can be calculated by the following formula:
PL =
FL +mg
6
(4.16)
Where FL is the longitudinal peristaltic force from the GI tract wall, m is the mass of
the microrobot and is estimated to be 3.45 g and g is gravity.
Using formula (4.16) the load (PL) acting at each point equates to 95.63 mN. This load
will work towards deflecting the legs however the five points will be focused onto the four
main leg supports A, B, C and D, Figure 4.20.
Figure 4.20: Four main leg supports A, B, C and D which will be subjected to the combined
longitudinal peristaltic force acting on the holding mechanism
The holding mechanism’s leg supports will be subjected to a total force of 478.16 mN.
For the purpose of simplifying the bending analysis we will investigate the deflection of
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leg support B as this has the smallest cross sectional area (Figure 4.20). It will have a
proportional longitudinal load of 119.54 mN applied to it.
Using the principle of a cantilevered beam the load (P ) at the free end can be used to
determine the displacement (δ) of the beam by rearranging the following formula [6]:
P =
3EIxδ
L3
(4.17)
Where L is the length of the leg and E is the material’s Young’s modulus. Ix represents
the moment of inertia through section x− x for a solid rectangular beam and is given by:
Ix =
bh3
12
(4.18)
Where b is the width and h is the height of the beam’s cross section.
Using formula (4.17) the calculated maximum deflection of leg support B at full extension
equates to 37.10µm. This is based on the leg being manufactured from stainless steel 304. A
plot of the bending profile for a full deployment of leg support B can be seen in Figure 4.21.
Figure 4.21: Plot of the holding mechanism bending profile for the longitudinal peristaltic
force acting on leg support B modelled in stainless steel 304
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The effect of the longitudinal peristaltic force acting on the holding mechanism appears
to be limited as at maximum extension (6.6 mm) the deflection is only 37.10µm. However
due to the limited space the supports have very small cross sectional areas hence the deflec-
tion represents 9.27% of the leg’s thickness therefore the deflection may result in potentially
high induced stress in the leg.
Using beam bending theory the maximum bending stress induced in the leg can be
calculated by the flexure formula [6]:
σmax =
Mc
Ix
(4.19)
Where σmax is the maximum normal stress in the beam and will occur at a point furthest
away from the neutral axis, M is the maximum bending moment (comprising of the length
L of the beam multiplied by the load P ), c is the perpendicular distance from the neutral
axis to a point farthest away from the neutral axis and Ix is the moment of inertia of the
cross-sectional area through section x− x.
At a maximum deflection of 37.10µm the longitudinal peristaltic force (PL) will induce
a stress of 98.62 Nmm−2 in leg support B. At these levels of stress it would be inadvisable to
use a polymer for the leg material as there would be insufficient capacity to accommodate
unforeseen external forces. However manufacturing the leg support from stainless steel 304,
which has a yield point of 290 Nmm−2, would offer a safety factor of approximately three
times therefore the structural integrity of the holding mechanism can be assured.
The deflection analysis represents a worst case scenario as the design of the housing
for the legs attempts to reduce the impact of bending by supporting the legs between the
gearbox housing and a retaining plate. A further degree of support will be gained from the
connection between the gears and the legs as the drive shaft connecting the gears to the
legs passes through the gearbox housing, the leg and into the retaining plate. This method
of assembly will give support to both sides of the drive shaft and hence help to limit the
deflection of the legs.
4.5 Prototype Manufacture
The following section presents a discussion of the prototyping methods selected to produce
the component parts of the holding mechanism. The advantages and limitations of the cho-
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sen manufacturing processes are evaluated and the resulting component parts are presented.
The section focuses on the legs, tie bars and gear train components however the gearbox
and retaining plate have been manufactured using similar methods.
4.5.1 Gear Train Prototyping
There are a number of process routes which can be used to produce the holding mecha-
nism’s gear train, for example hobbing, rapid prototyping or wire EDM are all methods
which could be employed to produce the spur gear set which drives the legs in and out.
However results from a preliminary trial modeling 1:1 scale model parts using an SLA pro-
cess yielded component parts which could not perform to the required level, therefore a more
conventional manufacturing process was chosen. The need for accurate feature geometry
and the restrictions in material choice combined with the costs associated with manufac-
turing microscale parts resulted in the selection of a CNC milling process to produce the
5:1 scale model prototypes. Figure 4.22 shows a 5:1 scale model of the complete gear train
assembled in the gearbox housing.
Figure 4.22: 5:1 scale prototype of the holding mechanism’s gear train manufactured from
Nylon 6 and gearbox modelled in PMMA
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Figure 4.22 shows a prototype of the gear train using all the gears specified in the concept
design (Figure 4.3 and Table 4.1). However the gears have been orientated in a chain rather
than the 8 toothed gears being stacked on top of the 34 toothed gears. The purpose of the
simplified prototype was to manually test the functionality of the bevel gear set and the
holding mechanism’s legs as the simpler design requires only 2.6 turns to fully operate the
mechanism whereas the compound gearbox would require 46 turns to fully operate the legs.
Prototyping the gears using a CNC milling machine allowed the use of small diameter
end mills (Ø0.5 mm) to generate the tooth profiles and to achieve the tight root radii of
the teeth. However the use of Nylon 6, which was selected for its mechanical properties
from a limited list of materials, resulted in the gears having significant burrs owing to the
manufacturing process, Figure 4.23.
Figure 4.23: CNC milled 8 tooth spur gear manufactured from Nylon 6. The profile of the
teeth are obscured by significant burring
There are a number of manufacturing issues which can leave the gears with excessive
burrs, for example the end mill feed rate may be too fast or the wrong style of cutter
may be selected. Cutter selection is very important as different materials have different
requirements. Cutting plastic requires a sharp edged tool therefore a hollow ground edged
tool is preferable over a radially ground tool as it will be sharper and result in a cleaner
edge.
4.5.1.1 Gear Measurements
Under a microscope at 30X magnification the burrs from the 8 tooth spur gears were removed
with a very sharp blade to allow inspection of the gears in order to confirm dimensional
accuracy. Inspection was performed on a profile projector type PJ-300 manufactured by
Mitutoyo at 10X magnification and a Mitutoyo 0-25 mm digital micrometer. The measured
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results have been collated in Table 4.3.
Table 4.3: Statistical measured data for the 0.5 module, 8 tooth spur gears
Value Average Min. Max. Standard
(mm) (mm) (mm) (mm) deviation
Outside diameter (OD) 5.0 5.032 5.02 5.04 0.008
Face width (bt) 2.25 2.291 2.28 2.30 0.009
Tooth thickness (t) 0.785 0.798 0.79 0.81 0.006
Tooth depth (ht) 1.2 1.16 1.14 1.18 0.011
Comparing the measured dimensions with the design values shows that the average gear
tooth thickness is greater than the nominal value and that the average tooth depth is shal-
lower than nominal. The measured dimensions are well within the expected manufacturing
tolerance limit for the given part however the tendency for the teeth to be slightly bigger
than required may pose problems with the gears meshing and running smoothly in the
assembly.
4.5.1.2 Gear Train Performance
As can be seen from Figure 4.23 there are significant burrs on the top and bottom of the
teeth profiles, these burrs are also evident on the larger gears in the train although not to
such an extent. The burrs can influence the performance of the gear train in a number of
ways, they can directly change the gear profile by being trapped between the rotating teeth
and, in addition, the excess material will reduce the clearance between the gears, these
two faults may result in a greater bending load being imposed on the tooth. The reduced
clearance will also increase the friction within the system which places a greater load on
the micromotor driving the train.
The average thickness of the teeth (0.798 mm) suggests that the gear train would not
run smoothly due to the reduced clearance however on the larger gears the average thickness
of the teeth was undersized (0.71 mm). This compensated for the thicker teeth and resulted
in a smooth running gear train, once the burrs had been removed. The slightly larger sized
teeth on the smaller gears are an advantage in this instance as they can withstand a greater
bending stress during operation.
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4.5.1.3 Bevel Gear Set
The bevel gear set allows rotation from the micromotor to be translated through 90 degrees.
To allow efficient translation the bevel gear adopts an involute gear profile however the
section profile reduces in scale from the larger outside edge to the smaller inner edge. The
diminishing form terminates at the pitch apex which is the point where the centre of the two
gears meet. The complexity of the gear profile would require a generating type of bevel gear
cutting machine [7]. However as the gear tooth loading analysis in Section 4.3.3 reported,
the bevel gear will be subjected to limited stress during an operation therefore an SLA
manufacturing process was selected. This method of manufacture offered approximately
80% cost reduction compared to CNC milling. Figure 4.24 shows the prototype bevel gears
and bevel gear cover designed using AutoCAD Inventor 2014 and modelled in Accura 60.
Figure 4.24: Bevel gear set manufactured by SLA in Accura 60 and bevel gear cover man-
ufactured by CNC milling from PMMA
Modelling the gears using the SLA process offered further advantages, for example it
was possible to produce a square hole in the centre of the 48 toothed bevel gear for the
purpose of mating with and driving the 8 toothed spur gear. Also the dimensional accuracy
of the SLA parts, when produced using the high resolution mode, resulted in a tolerance
band of ±0.008 mm for the teeth. The mounting distance, which is the distance from the
back of the 48 toothed gear to the centre of the 13 toothed gear, was increased by 0.35 mm
from the nominal design specification to allow for running clearance between the gears and
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to accommodate for any tolerance stack-up between the parts. A disadvantage of the SLA
process is that the surface finish of the component is influenced by the layering technique
and can result in a stepped surface. However the orientation in which the gears were made
resulted in smooth surfaces at the sides of the teeth and a more pronounced stepped surface
at the top of the tooth. This resulted in the gear set running smoothly with very little back
lash (0.12 mm).
4.5.2 Holding Mechanism Prototyping
The holding mechanism has been designed to unfold from inside the protective case in a
similar way to the unfolding wings of a ladybird. The mechanism is protected on either
side by the gearbox housing and a retaining plate. The holding mechanism comprises
a micromotor, gearbox, retaining plate, two M3 screws, two legs, a centre support, two
tie bars and four pins. Figure 4.25 shows the individual prototyped parts of the holding
mechanism.
Figure 4.25: Individual parts of the holding mechanism: assembled gearbox, retaining plate,
M3 screws, legs, centre support, tie bars and pins
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The final two gears in the gear train are the 22 toothed gears, these gears are the means
of driving the holding mechanism. A driveshaft protruding from the gear passes through
the gearbox, with sufficient clearance to allow the gear to rotate freely, and is press fitted
into a corresponding hole at the proximal end of the leg. The driveshaft extends into the
retaining plate giving support to both sides of the leg this will help to minimise deflection of
the leg when it is at full extension. The gearbox has a centrally positioned boss shaped such
that it offers support to the legs when they are in the stored position and prevents them
from collapsing inwards. The boss prevents the legs from opening and closing unevenly
as it guides the centre support via a channel which prevents the support from twisting,
Figure 4.26. The centre support has an integral slot which accommodates a peg mounted
on the gearbox. The purpose of the peg is to prevent the mechanism from over running and
falling out of the body, Figure 4.27. A greater stroke length could be achieved from the
holding mechanism by increasing the length of the slot in the centre support as this would
give a greater circumferential reach to the holding mechanism. However the shape of the
distal end of the legs has been designed to accommodate cables which must pass through
the gearbox to provide power to the micromotor, camera and processor (Figure 4.26).
The Nylon 6 pins are press fitted into the legs and centre support, they facilitate the
free movement of the tie bars and centre support however the thickness of the tie bars does
not allow for sufficient support from the shank of the pins. Insufficient support may allow
the bars to buckle and hence they will not be retracted back into the microrobot’s body.
To overcome this issue the pins have large diameter heads which act not only to retain
the tie bars but also to prevent them from twisting and buckling. Press fitting the pins
as opposed to using nuts and bolts for a secure pivoting method significantly reduces the
space requirement.
The retaining plate serves two purposes. Firstly it keeps the legs and tie bars from
running out of position and secondly it connects the holding mechanism to the main body
of the microrobot and allows the holding mechanism to rotate about the body. A second
boss is used to align the retaining plate with the gearbox. The benefit of this method
of assembly is that it does not add any length to the body yet provides stability and a
quick method of alignment. The fixings used to hold the retaining plate in position are
M3 countersunk head screws with hexagon sockets manually modified to the correct length.
The locations of the screws have been chosen such that their heads miss the legs and the
threads miss the gears in the gearbox. Using countersunk head screws takes advantage of
their heads’ slim profile to minimise the impact on the overall length of the microrobot.
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Figure 4.26: Holding mechanism fully collapsed. The shape of the distal end of the legs has
been designed to accommodate cables. Retaining plate has been removed for clarity
Figure 4.27: Holding mechanism fully expanded. The peg in the centre support slot prevents
over expansion of the mechanism. Retaining plate has been removed for clarity
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4.5.2.1 Holding Mechanism Performance
The holding mechanism has been designed for ease of manufacture and also for ease of
assembly. However there were a number of issues with individual component parts and
with the assembly of the parts which required addressing before a working prototype could
be realised. Figure 4.28 shows the fully assembled holding mechanism with the retaining
plate secured in position with two M3 countersunk head screws and titanium pins fitted to
secure the tie bars.
Figure 4.28: Holding mechanism fully extended with retaining plate secured in position and
titanium pins fitted to secure the tie bars
Manually operating the gearbox, through a driveshaft mounted onto the 13 toothed
bevel gear and protruding through the side of the gearbox (Figure 4.26), resulted in three
and a half turns being required to fully expand the holding mechanism and three and
a half turns to collapse it. However the calculated number of turns required to operate
the mechanism was 2.6 turns. The difference in these two figures can be attributed to
the backlash in the gear train which predominantly comprises of the clearance between
the gears, required for free running, and also the clearance between the gears’ driveshaft
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and the housing. A press fit was designed for the gears’ driveshaft with the leg however
manufacturing methods resulted in an oversized hole in the leg preventing the driveshaft
from being securely retained. The issue of slipping was overcome by the application of
an adhesive to the driveshaft however a more secure solution for the future would be to
integrate the final gear in the train with the leg.
The simple means of connecting the tie bars to the centre support and legs was via a
press fitted pin however the manufacturing accuracy of the Nylon 6 pins and the holes in the
legs and centre support resulted in an inadequate connection. A further contributing factor
was due to the thin section the pins would be mating with as the lack of material offered
insufficient support to the press fit and hence it could not retain the pin. To overcome this
issue new pins manufactured from titanium were made to suit the holes however if the pins,
legs and centre support were manufactured in stainless steel the joint would be secure.
4.6 Measurement and Characterisation of the Holding Mech-
anism
This section presents a series of experiments designed to validate the holding mechanism.
The experiments have been designed to characterise the holding mechanism through quan-
titative assessment of a 5:1 scale model prototype test rig manufactured using conventional
manufacturing processes from Nylon 6 (PA6) and aluminium alloy (7075-T651). The bevel
gear set was manufactured using an SLA process in Accura 60. The mechanical properties
of the 5:1 scale prototype are related to the materials’ Young’s modulus and the geometry
of the component parts therefore the performance of the 5:1 scale prototype suggests that
future prototypes at 1:1 scale will perform as designed.
4.6.1 Motor Torque Protocol
The holding mechanism operates through a micromotor driving a gear train which opens
and closes two legs. To determine the overall efficiency of the holding mechanism system
the input must first be characterised. The 5:1 scale of the prototype test jig limits the
allowable torque which can be transmitted through the gear train; the deliverable torque is
further limited by the available manufacturing processes and available materials. Therefore
a specifically configured motor will be used which offers the correct input characteristics
suitable to operate the 5:1 scale test jig safely.
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A 9 V DC motor and 16:1 gearbox have been specifically wound to deliver a speed
of 275 RPM and a torque of 5 mNm at 52 mA. The motor’s performance at the selected
current should deliver the required torque however inaccuracies, such as the variations
in resistivity of the coils and also variations in the magnetic flux density of the magnets
and how well they are aligned, can cause the torque constant to vary by ±7%. Further
manufacturing inaccuracies will also be present in the two stage 16:1 gearbox which is rated
at 80% efficiency. To overcome the limitations of manufacturing and establish an accurate
output from the motor assembly the actual output torque from the motor will be measured.
A motor controller will be used to set the motor’s parameters and control the input current.
A 20 mm long arm fixed to the motor will be used to measure the torque delivered at the
set current.
4.6.1.1 Motor Torque Procedure
The test set-up used to determine the load generated by operating the 9 V DC motor and
gearbox is presented in Figure 4.29.
Figure 4.29: Layout of the test fixture to determine the output torque of the 9 V DC motor
and 16:1 gearbox at 52m A
To determine the deliverable torque of the 9 V DC motor and gearbox (DCX12S EB KL
9 V DC motor and GPX12 AA 16:1 planetary gearhead, Maxon Motor UK Ltd.) an arm
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with a known length is rotated using an input which is set via a motor controller (ESCON
36/2 driver (403112)). The motor controller is programmed to supply a current of 52 mA.
The controller is configured via a USB interface and graphical user interface (ESCON studio
2.2). The motor is driven counter-clockwise rotating a 20 mm long arm into a 2 N loadcell
(Intelligent loadcell ILC 879-009, ±0.1% of full scale) which is mounted on a MultiTest
2.5-i (805-102) test system manufactured by Mecmesin. The stall torque will be measured
and recorded for a duration of 10 s on a computer running EmperorTM (force) software (V
1.18-408 (5/10/13)) and connected to the MultiTest system. The test will be performed 10
times and the average force used to calculate the motor’s deliverable torque at 52 mA.
4.6.1.2 Results and Discussion
The deliverable motor torque test set-up can be seen in Figure 4.30.
Figure 4.30: Deliverable motor torque test set-up comprising: a motor controller driving a
9 V DC motor and 16:1 planetary gearhead attached to a 20 mm long arm. The arm contacts
a MultiTest 2.5-i test system fitted with a 2 N loadcell and connected to a computer running
EmperorTM (force) software
The average measured load generated by the 20 mm long arm at 52 mA was 248 mN.
The measured load equates to a torque of 4.96 mNm which is 99.2% of the required 5 mNm.
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The motor and gearbox have been characterised in terms of the input current and output
torque. These input parameters can now be used to calculate the efficiency of the gearbox.
4.6.2 Gearbox Torque Protocol
A requirement of the gearbox is to transmit power from the 9 V DC motor to the final gear
in the gear train, which has the function of driving the legs of the holding mechanism in
and out. To guarantee a successful procedure the final gear in the gear train must supply
sufficient torque to drive the legs therefore the efficiency of the gearbox must be validated.
Using the established motor input parameters this experiment sets out to establish what
torque is being generated at the final gear in the gear train and what the efficiency of the
gearbox is.
4.6.2.1 Gearbox Torque Procedure
The test set-up used to determine the efficiency of the 5:1 scale prototype gearbox can be
seen in Figure 4.31.
Figure 4.31: Layout of the test fixture to determine the efficiency of the 5:1 scale prototype
gearbox with an input motor torque of 4.96 mNm
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A 5:1 scale prototype gearbox manufactured from Nylon 6 (PA6) and aluminium alloy
(7075-T651) will be tested using a 40 mm long arm attached to the output driveshaft of the
final gear in the gear train using a similar test method to the motor torque test protocol. A
torque of 4.96 mNm will be applied to the motor driving the gearbox which has a gear ratio
of 183:1. The operation of the gearbox will be controlled via a rocker switch connected to
a motor controller (ESCON 36/2 driver (403112)). The load developed by the arm will be
measured by a 25 N loadcell (Intelligent loadcell ILC 879-002, ±0.1% of full scale) which
is mounted on a MultiTest 2.5-i (805-102) test system manufactured by Mecmesin. The
load profile of the 40 mm long arm will be measured and recorded for a duration of 10 s on
a computer running EmperorTM (force) software (V 1.18-408 (5/10/13)) and connected to
the MultiTest system. The test will be performed 10 times and the average peak force used
to calculate the gearbox’s deliverable torque and efficiency.
4.6.2.2 Results and Discussion
The test set-up used to measure the efficiency of the gearbox can be seen in Figure 4.32.
Initial tests showed that the gearbox test fixture (Figure 4.31) was unstable during
testing. Therefore to ensure the 40 mm long arm transferred the maximum force available
from the gear train into the 25 N loadcell the gearbox test fixture was held securely in a
toolmaker’s vice which was secured to the base of the test machine via a clamp (Figure 4.32).
A typical load profile of the load developed at the end of the 40 mm long arm with a
motor input torque of 4.96 mNm is presented in Figure 4.33.
Figure 4.33 shows a peak load of 5.47 N acting at 2.55 s however it required 2.13 s to
achieve this maximum load. The long period of time can be attributed to the backlash in
the gear train which allowed the gear train to slowly bind under the input torque. The
graph shows that once the peak load had been achieved the load slowly dropped off over a
period of 4.5 s until the motor was switched off. This reduction in deliverable force was a
result of creep. The Nylon 6 material the gears were manufactured from allowed the teeth
to deflect under load and also allowed excessive torsion of the gear’s driveshaft.
Using the measured motor input torque of 4.96 mNm the theoretical output torque for
the gearbox at 59% efficiency (equation 4.3) would be 537 mNm. However the average
peak load for 10 operations was measured at 5.36 N this equates to a deliverable torque
of 214 mNm. The measured results equate to a gearbox efficiency of 23.6% which rep-
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Figure 4.32: Gearbox efficiency test set-up comprising: a rocker switch connected to a motor
controller which is controlling the gearbox input motor. A 40 mm long arm connected to
the final gear in the gear train contacts a MultiTest 2.5-i test system fitted with a 25 N
loadcell and connected to a computer running EmperorTM (force) software
resents a loss of approximately 25% efficiency at each of the five gear stages. The gear-
box is designed to deliver 183.4 times the input torque however the actual requirement
to guarantee a successful operation is a minimum of 18.5 times the motor’s input torque
(2.78 mNm/0.15 mNm). Multiplying the input torque (4.96 mNm) by 18.5 results in a min-
imum torque requirement of 91.9 mNm. Comparing the minimum torque requirement to
the measured result (214 mNm) shows that the 5:1 scale prototype would deliver sufficient
torque to drive the legs.
Improvements in the efficiency of the 5:1 scale gearbox can be achieved through a number
of changes. For example, reducing the backlash and changing the material the gears are
manufactured from to a stainless steel would stop the teeth from deflecting and significantly
reduce the driveshaft’s ability to twist. However the greatest improvement would result from
reducing the friction which is generated by the gear train. The 13 toothed bevel gear was
mounted in the gearbox base to allow easy alignment and support of the gear however the
29.0 mm length of the gear’s driveshaft rubbed on the gearbox housing which then required
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Figure 4.33: Load profile of a typical 40 mm long arm deflection with a motor input torque
of 4.96 mNm
a greater degree of torque to overcome the increase in friction. This gear configuration
would not be present in the 1:1 scale microrobot.
4.6.3 Holding Mechanism Protocol
The holding mechanism will be required to overcome the external circumferential peristaltic
forces imposed on it by the GI tract wall in order for the microrobot to achieve a state of
static equilibrium (Figure 4.6). This experiment sets out to measure the load being delivered
to the ends of the legs, tie bars and centre support by the motor and gearbox. The measured
results will be compared with the individual estimated torques which have been calculated
in the circumferential peristaltic force analysis (Section 4.4.1).
4.6.3.1 Holding Mechanism Procedure
An M4 threaded boss mounted in the centre of the 5:1 scale gearbox assembly will be used
to hold a series of cylindrical dynamometers to measure the load being delivered to the
expanding holding mechanism’s legs, tie bars and centre support. The test set-up used to
measure the loads can be seen in Figure 4.34.
The holding mechanism comprises the legs, tie bars and centre support which are man-
ufactured from aluminium alloy (7075-T651). The joints of the mechanism are secured
together using M2 stainless steel slot pan head machine screws to guarantee the parts can-
not separate during an operating cycle. The legs are secured to the final two gears in the
gear train via M2 screws which clamp against the gear’s driveshaft to ensure there is no slip-
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Figure 4.34: Test set-up used to measure the load being delivered to the holding mechanism’s
legs, tie bars and centre support
ping at the connection. Using a motor controller (ESCON 36/2 driver (403112)) connected
to a rocker switch the input torque (4.96 mNm) of the gearbox motor will be controlled. A
series of cylindrical dynamometers (manufactured by RVFM) starting at 2.5 N and ranging
up to 20 N will be positioned at each of the five circumferential peristaltic positions (Pc) to
measure the force being generated by the holding mechanism at that point. The central bar
of the dynamometer will be fixed via an M4 locking nut to the central boss of the gearbox
assembly, while the body of the dynamometer will be fixed via a specially designed coupling
to one of the five gauge fixing points (Figure 4.34). The centre of each fixing point has been
designed to correspond with the circumferential peristaltic contact points. The gauge will
be set to read zero by adjusting the calibration nut at the end of the dynamometer.
The holding mechanism will be operated five times and the dynamometer’s maximum
load recorded. If the holding mechanism reaches full expansion without stalling the motor
then a higher gauge dynamometer will be fitted and the experiment repeated until the input
motor stalls. The average maximum load will be used to calculate the force which can be
delivered to the legs, tie bars and centre support by the motor and gearbox.
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4.6.3.2 Results and Discussion
The experimental set-up used to measure the force being delivered to the leg tip (Pc1) can
be seen in Figure 4.35. The set-up shows the holding mechanism performing an opening
cycle and reaching full extension with a 2.5 N cylindrical dynamometer interfaced with the
leg tip and the central boss.
Each circumferential peristaltic position (Pc) has been tested to its maximum deliverable
capacity and the results recorded. Table 4.4 shows the average measured force from the
cylindrical dynamometers for each position.
Table 4.4: Measured force from each of the circumferential peristaltic positions (Pc) and
calculated perpendicular component forces which have been further evaluated to derive the
deliverable torque acting at each position on the final gears in the gear train. A comparison
of the derived torque can be made with the minimum torque requirement
Circumferential Measured Perpendicular Derived Minimum torque
peristaltic force component force torque requirement
position (N) (N) (mNm) (mNm)
Pc1 2.8 0.80 33.22 9.43
Pc2 2.2 1.53 55.08 19.89
Pc3 2.4 6.05 216.92 33.41
Pc4 2.8 1.95 70.10 19.89
Pc5 3.6 1.04 42.71 9.43
The individual measured forces have been used to calculate the perpendicular component
forces acting on the drive gears. Using these figures the deliverable torque acting at each
position on the final gears in the gear train has been derived. To make a comparison between
the derived torque and the minimum required torque a multiplication factor of 33 has been
applied to the minimum torque requirement, this is to compensate for the ratio between
the two input motors (4.96 mNm/0.15 mNm). Comparing the minimum torque requirement
for each of the circumferential peristaltic positions to the measured results shows that the
5:1 scale prototype would deliver sufficient torque to expand the holding mechanism and
achieve a state of equilibrium.
The measured results (Table 4.4) confirm the approximate reduction of 25% in efficiency
at each gear stage of the gearbox as Pc1 is 22.2% lower than Pc5 and Pc2 is 21.4% lower than
Pc4. A further point to note is the deliverable torque of the centre support (Pc3) which is
higher than that achieved by the other positions. This can be attributed to the 22 teeth
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drive gears providing a torque to both legs at the same time which will provide a more
balanced and efficient system. Although the gearbox is inefficient the high ratio (183:1)
offers an advantage of preventing the holding mechanism from collapsing easily when an
external load is applied, furthermore once the mechanism has opened it no longer requires
power to maintain its position under load.
4.7 Summary
In this chapter the author has presented a novel holding mechanism concept for the purpose
of resisting natural peristalsis in the GI tract. The mechanism has been based on the
biologically-inspired concept of a pair of ladybird wings being folded into a protective case.
A holding mechanism integrated into a WCE would increase the functionality allowing more
active treatment of pathologies of the GI tract to be performed such as the treatment of
Crohn’s disease.
Through analysis, fabrication and evaluation of a 5:1 scale prototype it has been shown
that the 183:1 gearbox, driven by a micromotor with a deliverable torque of 4.96 mNm, can
produce sufficient torque to extend the holding mechanism. The results show that in future
prototypes a 1:1 scale version with a micromotor delivering a torque of 0.15 mNm would be
sufficient to overcome natural peristalsis, however in-vivo tests would need to be performed
to validate the actual figures. A further advantage of the holding system is the ability to
deploy the legs in stages. A staged deployment would act as an anchor and hence offer
the ability to slow the transit of the microrobot. This additional feature would enable the
microrobot to overcome the issue of differences in transit time in different regions of the GI
tract. For example the transit time is more progressive in the proximal section of the small
bowel compared to the lower segment [8].
The method in which the holding mechanism unfolds, coupled with the means of posi-
tioning the mechanism, ensures that the GI tract has been stretched around the body of
the microrobot and is orientated to the site of interest. This novel feature is very important
as it guarantees the microrobot is in contact with the GI tract wall which is required for
therapeutic treatment to be performed.
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Figure 4.35: Experimental set-up of the holding mechanism’s opening cycle with a 2.5 N
cylindrical dynamometer interfaced with the leg tip (Pc1) and the central boss of the gearbox
assembly. Start position with the gauge calibrated to read zero load a), halfway through
the opening cycle with a reading of 0.45 N on the gauge b) and the holding mechanism at
full extension with a reading of 0.9 N on the gauge c)
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Chapter 5
Targeted Drug Delivery: Design,
Analysis and Evaluation
5.1 Introduction
Chapter 4 presented a holding mechanism for the purpose of resisting natural peristalsis in
the GI tract. This chapter builds on the holding mechanism to further increase the func-
tionality of WCE by incorporating a novel targeting mechanism with the aim of delivering
a metered dose of medication to a targeted site of interest in the GI tract. Following the
medical motivation given in Chapter 1 and the design specification presented in Chapter
3 this chapter will focus on finding a solution to the problem of positioning a needle in
the GI tract, operating the needle and safely retracting the needle. A fully functioning
prototype targeting mechanism is presented which is capable of positioning a needle within
a 360 degree envelope. A discussion of the prototyping methods selected to produce 5:1
scale component parts of the mechanism is discussed and through a series of experiments
the novel targeting mechanism is validated.
5.2 Overview
The clinical need to target a specific location or feature within the GI tract for medication
delivery can be achieved using a microrobot consisting of an onboard image sensor, a means
of resisting natural peristalsis and a drug targeting system. Figure 5.1 shows a concept
design of a microrobot with an integrated targeting system.
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Figure 5.1: Microrobot concept design capable of delivering 1 ml of targeted medication.
Needle shown fully extended
There are a number of methods which have been explored that can deliver medication to
a SOI in the GI tract such as utilising a micro pump to propel medication to the site or letting
the medication naturally release through a side port on the microrobot’s body. However
these methods do not target a specific location therefore alternative designs have been
explored which more specifically address the requirement of targeted delivery. For example
a method of using a micromotor to drive a needle in and out was explored, however this
method was limited to only targeting one potential location. Alternatively, a combination
of two micromotors was explored which orientated the needle radially then extended and
retracted the needle, however due to issues of supplying power to the micromotors and the
limited available space a single motor drive was selected. Appendix B presents a detailed
review of the alternative needle positioning mechanisms which were explored.
The proposed system uses a needle to deliver 1 ml of medication to a target site rather
than releasing its payload as a bolus form. This method offers the advantage of being more
effective than current systems due to the shorter discharge time and the more accurate
delivery position. The shorter discharge time will allow for the correct dosage to be delivered
to the required location without it being diluted over the delivery time from the natural
passing of the GI tract or from being dispersed by the constant movement from peristalsis.
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A significant feature of the targeting mechanism is its ability to penetrate the GI tract
wall which guarantees medication has been delivered to the SOI. The needle positioning
mechanism (Figure 5.1) utilises a single micromotor to position and operate the dispensing
needle. However the same micromotor radially positions the holding mechanism due to
a mechanical coupling between the two mechanisms. The dispensing needle is positioned
diametrically opposite the holding mechanism therefore when the holding mechanism is
fully expanded the GI tract wall will be stretched over the position where the needle will
be deployed which guarantees penetration of the GI tract wall.
5.3 Targeted drug delivery
The design of the needle positioning mechanism consists of a 1.5 mm diameter × 10.5 mm
long micromotor manufactured by Namiki, two opposing ratchets, a needle funnel, a needle
cam and a movable needle. Also features integral to the microrobot’s body are required.
The first operation is the angular control of the position of the needle and the second
is the extension and retraction of the needle. The 1 ml of medication will be stored in
a compartment of the body and be delivered through the needle by means of pressure
generated by a piston. The piston will be activated by a spring allowing for a rapid delivery
of the medication. The method of deploying the medication will be discussed further in
Chapter 6.
It is a requirement that the needle can be positioned at selected points within a 360
degree envelope. For the purpose of prototyping, 16 equally-spaced fixed positions have been
chosen. The angular positioning of the needle is achieved by the anticlockwise rotation of
the micromotor while the advancement and retraction of the needle is achieved by the
clockwise rotation of the micromotor.
5.3.1 Needle Positioning
Manoeuvring the needle to a selected position is achieved by applying a negative voltage
to the micromotor. The negative voltage will cause the micromotor to rotate in an anti-
clockwise direction. The needle funnel (Figure 5.2, a) rotates anticlockwise by virtue of a
ratchet which is mounted on the micromotor’s drive shaft. The ratchet engages with a set
of sprung legs which are integral to the needle funnel (Figure 5.2, b). The needle is engaged
with the needle funnel and will be carried round with it.
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Figure 5.2: Needle positioning mechanism: needle funnel a), ratchet driving the needle
funnel and needle b), and enlarged view of the protrusions c)
When the needle funnel is rotating anticlockwise an arm which protrudes from the
side of the needle funnel rides over the top of a plurality of protrusions (Figure 5.2, b)
on the inside face of the body. The function of these protrusions is to prevent the needle
funnel from rotating clockwise when the motor is reversed. It achieves this by engaging
the end of the arm with a parallel surface of the protrusion (Figure 5.2, c) preventing any
further movement clockwise and aligning the needle with one of the 16 fixed ports on the
microrobot’s body.
While the needle funnel is rotating anticlockwise it is also carrying with it the needle and
the needle cam (Figure 5.4, a). This is achieved through the sprung legs on the needle cam
disengaging with the ratchet which would be used to drive it and flexing out of position.
A further improvement to the original concept employs two sprung arms rather than
one, Figure 5.3. The orientation of the arms has been modified so that they are now in
compression when the needle is being operated rather than bending, this results in a stronger
mechanism as the arms will be able to withstand higher compressive forces than bending
forces.
Employing two arms will maintain a balanced system giving a smooth action to the
mechanism and distributing loads more evenly. The longer arms will facilitate a greater
cantilever action reducing the load applied to the beam. In addition the protrusions have
been refined and repositioned to impose a smaller deflection to the arms and they have also
decreased in contact angle to make a smoother transition over the flexing period.
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Figure 5.3: Needle positioning mechanism extended cantilever: needle funnel with two arms
a), two arms engaged with the protrusions b), and enlarged view of the protrusions c)
5.3.2 Needle Deployment
Applying a positive voltage to the micromotor reverses its direction, this disengages the
needle funnel ratchet from its sprung legs and engages the needle cam ratchet with a set of
sprung legs that are integral to the needle cam (Figure 5.4, a).
Figure 5.4: Needle cam operating cycle: stored position a), needle ready to exit b), full
stroke c), and retracted position d)
When engaged the needle cam ratchet drives the needle cam in a clockwise direction
while at the same time the needle funnel legs ride over the ratchet used to drive them. The
needle is engaged with a track in the needle cam by means of a driving peg mounted on the
side of the needle. The track is shaped to convert the rotational motion of the cam into
a variable linear motion. This linear motion allows the advancement and retraction of the
needle. The linear displacement of the needle with respect to the rotation angle can be seen
in Figure 5.5.
The needle cam displacement profile Figure 5.5 shows the needle advancing forwards to
its maximum stroke length of 4.2 mm in the first 90 degrees. This is followed by a delay
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Figure 5.5: Needle cam linear displacement profile
period which is designed to allow the medication to be delivered. The remaining 110 degrees
retracts the needle back 2.45 mm to the stored position (Figure 5.4, d). It can clearly be
seen from the plotted profile that the needle does not return to its original starting position,
this prevents any further operation of the needle.
An improvement to the original design (Figure 5.4) allows the needle to be positioned
and repositioned as many times as is required before the medication is released, Figure 5.6.
This feature gives an added degree of flexibility to the procedure. The cam has a significantly
shorter stroke length (2.0 mm) than the previous design however it has the advantage of
allowing the needle to be repositioned even if the needle has been deployed to deliver the
medication. This is a safer mechanism than previously envisioned as it gives the operator
greater flexibility rather than limiting them to a one shot approach.
Figure 5.6 shows the sequence of operation for the extension and retraction of the needle.
Figure 5.6, a) shows the needle in the stored position, this is the position the needle will
be in when the microrobot is swallowed and travels through the GI tract to the target site.
Figure 5.6, b) shows the needle at full extension giving a reach of approximately 6.92 mm
radius and a stroke length of 2.0 mm. The design of the cam utilises a direct linear movement
so that a positive force can be delivered to the needle which will be required to penetrate
the wall of the GI tract. Figure 5.6, c) shows the needle retracting backwards by virtue of
the track slowly spiralling inwards. Figure 5.6, d) shows the needle returning to the stored
position once the medication has been delivered.
The 360 degree needle cam linear displacement profile Figure 5.7 shows the needle
reaching its maximum stroke length of 2.0 mm in 60 degrees. The proceeding delay period,
required for medication delivery, has increased in duration from 23 degrees to 75 degrees.
The increase in delay allows for a greater margin of error for the timing of the medication
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Figure 5.6: 360 degree needle cam operating cycle: stored position a), full stroke b), needle
returning to the stored position c), and retracted position d)
release. The remaining 225 degrees gradually retracts the needle back to the starting po-
sition, from where the needle can be further deployed. To ensure the needle performs as
expected, a spring is required to guarantee the driving peg, mounted on the side of the
needle, engages with the cam track throughout the operating cycle.
5.3.3 Needle Cam Spring Design Analysis
A compression spring is required to overcome the possibility of the needle cam moving out
of position radially and becoming jammed when the needle positioning mechanism rotates
anticlockwise to position the needle. The spring is mounted on the needle and constantly
opposes the forward force from the needle cam. The constant force ensures that the needle
is always pressed against the needle cam track wall and therefore it will follow the profile
of the track. Figure 5.8 shows the position of the spring in the stored position and at full
extension.
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Figure 5.7: 360 degree needle cam linear displacement profile
Figure 5.8: Needle cam spring in the stored position and at full extension
The 360 degree needle cam design (Figure 5.6) has a stroke length of 2.0 mm and allows
the needle to extend 1.5 mm from the body of the microrobot. This geometry is based
on the current literature which suggests that the average wall thickness for the length of
the GI tract is between 2.0 mm and 3.0 mm thick [1]. Therefore 1.5 mm will be sufficient
to prevent the needle from puncturing the wall of the GI tract when deployed. However
the load generated by the compressed spring directly acts against the micromotor driving
the mechanism therefore an analysis of the forces involved is required to determine if the
micromotor can deliver sufficient force.
The load generated by a deflected compression spring can be calculated from the spring’s
spring rate and the distance the spring has been compressed using the formula:
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F = Lt × S (5.1)
Where Lt is the distance the spring has traveled and S is the spring constant of the
spring and can be calculated by:
S =
Gd4
8nD3
(5.2)
Where G is the module of rigidity, d is the wire diameter, n is the number of active coils
and D is the mean coil diameter.
Analysing the chosen spring parameters shows that a free length of 4.597 mm long x
0.101 mm diameter stainless steel wire spring with a module of rigidity value of 69.0 GNm−2
[2], 12.5 active coils and an outside diameter of 0.889 mm can generate a load of 381 mN
at the full 2.0 mm deflection. The selected micromotor can deliver a torque of 1.6 mNm
therefore at full extension it will have a potential deliverable force of 800 mN which will be
sufficient to compress the spring. The spring’s operating sequence can be seen in Figure 5.9.
Figure 5.9: Needle cam spring stages of operation
As the operational requirement of the spring is less than 10,000 cycles the spring is
categorised as working statically therefore fatigue will not affect its performance. However
compressing the spring by 2.0 mm would be operating outside the recommended safe working
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limits for minimum working length and therefore an analysis of the stress induced in the
spring has been undertaken.
The stress acting on the spring is an important design factor as the spring would be a
critical component in the delivery of the medication and failure to perform would result in
failure to deliver the medication. For this reason the maximum allowable stresses would be
determined as a percentage (59%) of the materials ultimate tensile strength (UTS) [3].
Using the dimensions of the spring, the stress (τ) in the spring can be calculated using:
τ =
8PDKc
pid3
(5.3)
Where P is the load, D is the mean coil diameter, Kc is a curvature correction factor
and d is the wire diameter. The curvature correction factor is used to correct for the uneven
stress distribution across the section of the wire as a result of the curvature of the wire and
can be calculated using the Sopwith formula [3]:
Kc =
D/d+ 0.2
D/d− 1 (5.4)
The stress induced in the compressed spring calculated from equation (6.3) equates to
872.7 MNm−2. This can be compared to the calculated maximum allowable stress which
is 1,298 MNm−2 (59% of UTS 2,200 MNm−2). As can be seen the stress in the spring is
67.2% of the allowable stress therefore as the spring will not be cyclically loaded it will be
an acceptable design solution in this situation.
5.3.4 Requirements for Needle Penetration
The chosen method for administering medication is through the use of a needle injected
into the target location on the GI tract wall. It is therefore essential that the needle can
penetrate the GI tract wall sufficiently to allow the medication to be dispersed throughout
the tissue.
The force required for the needle to penetrate the GI tract wall can be determined from
the following equation [4]:
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Fpen = PpenA (5.5)
Where Fpen is the penetration force, Ppen is the penetration pressure and A is the cross
sectional area of the needle.
The penetration pressure (Ppen) has been empirically determined by Byun et al. (2005)
[5] to be 8.9 MPa from experiments carried out using chicken breast flesh as an equivalent
material to the GI tract wall. The dimensions of the needle tip are 0.45 mm in diameter
with a wall thickness of 35µm and a 30 degree bevel 1.25 mm long. Using these figures
a penetration force (Fpen) of 405.9 mN would be required to successfully penetrate the GI
tract wall with the needle.
Combining the calculated penetration force (405.9 mN) with the force required to operate
the needle cam spring (381 mN) results in a total force of 786.9 mN required to penetrate
the GI tract wall. Comparing the total calculated penetration force to the micromotor’s
deliverable force of 800 mN (ignoring any losses due to friction) shows that the needle tip
design will penetrate the wall successfully.
5.4 Analysis of Needle Positioning Mechanism
The chosen concept for positioning the needle (Figure 5.3) relies on the smooth operation
of the flexing arms and rotating ratchets. To ensure that the needle positioning mecha-
nism performs mechanically requires further analysis of the geometry and of the potential
materials the needle funnel could be manufactured from.
5.4.1 Anticlockwise Motion: Needle Positioning
The process of positioning the needle requires the needle positioning mechanism to be
rotated anticlockwise. This anticlockwise motion will cause the needle funnel arms to be
flexed out of position by the protrusions on the inside face of the body (Figure 5.3, c). Once
the arm has passed the protrusion it will return to its original configuration. At the same
time the legs on the needle cam will ride over the ratchet which is used to drive it.
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5.4.1.1 Needle Funnel Arm: Bending Stress Analysis
Flexing the arm out of position will result in a stress induced in the arm. The amount of
stress in the arm will be a result of the material’s geometry, the Young’s modulus for the
material and the amount of movement the arm will make. Various materials can be evalu-
ated for their ability to withstand this stress and maintain design integrity. To determine
the most suitable for this application Table 5.1 shows a selection of materials and their
properties which can be compared for the purpose of evaluating the needle positioning arm.
The table data has been sourced from various published results [6, 7, 8].
Table 5.1: Material selection matrix
Material Density Yield Shear Young’s Poisson’s Cost
gcm−3 point modulus modulus ratio GBP/kg
Nmm−2 kNmm−2 kNmm−2
Stainless Steel 304 8.08 290 72.4 193 0.3 6.0
Ti Alloy 6AL 4V 4.43 880 42.7 114 0.3 40.0
Nylon 6 1.14 82 1.24 3.3 0.4 2.12
PVC 1.44 58 1.13 3.0 0.4 0.84
Acetal Copolymer 1.41 60 1.01 2.7 0.4 2.80
PEEK 450G 1.32 97 1.31 3.5 0.4 71.2
The material selections have been chosen for their ability to perform in the harsh envi-
ronment of the GI tract and their biocompatibility with the human body. An examination
of the data in Table 5.1 shows that stainless steel 304 will be seven times heavier than an
equivalent part made in Nylon 6 and three times more expensive, however its yield point is
three and a half times higher than Nylon 6 making it more resistant to induced stress.
To evaluate the resulting stress and strain involved in flexing the needle funnel arm,
certain assumptions will be made. Firstly the needle funnel arm will act like a cantilevered
beam and secondly the system will be in a state of static equilibrium at the point of
maximum deflection. Only the state of maximum deflection will be considered as this is the
position which will induce the maximum stress and strain in the beam. Also it is assumed
that the beam will be longer than its width or depth, the deformations are smaller than
its length, the normal remains normal, straight and un-stretched and the material is both
homogenous and isotropic and behaves in a linear-elastic manner when a load is applied.
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Using the principle of a cantilevered beam the displacement (δ) of the beam can be
calculated by using [9]:
δ =
PL3
3EIx
(5.6)
Where P is the load, L is the length of the arm and E is the material’s Young’s modulus.
Ix represents the moment of inertia through section x− x for a solid rectangular beam and
is given by:
Ix =
bh3
12
(5.7)
Where b is the width and h is the height of the beam’s cross section.
As the geometry of the protrusions are known, the distance the arm will be flexed
through can be calculated (δ = 0.17 mm), therefore the cantilevered beam equation can
be rearranged to find the load (P ) that would be required to make the arm deflect by the
calculated amount.
Applying the same geometry but varying the material’s properties the force (P ) required
to make the maximum deflection (δ) can be calculated for each material. The results of this
comparison are tabulated in Table 5.2. A height (h) of 0.3 mm and a width (b) of 0.2 mm
have been used for the purpose of the calculations.
Table 5.2: Resulting load (P ) for the selected material properties
Variables Units Stainless Ti Alloy Nylon 6 PVC Acetal PEEK
Steel 304 6AL 4V Copolymer 450G
δ mm 0.17 0.17 0.17 0.17 0.17 0.17
L mm 4.0 4.0 4.0 4.0 4.0 4.0
Ix mm
4 0.00045 0.00045 0.00045 0.00045 0.00045 0.00045
E Nmm−2 1.93E+5 1.10E+5 3.30E+3 3.00E+3 2.70E+3 3.50E+3
P mN 692.0 394.0 11.8 10.8 9.7 12.55
As can be seen from Table 5.2 the material with the greatest generated load is stainless
steel 304 with 692.0 mN. This can be compared to the Acetal copolymer which has the
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lowest generated load of 9.7 mN. The lower generated loads for the plastic materials can be
attributed to their lower Young’s modulus values.
Using beam bending theory the maximum bending stress induced in the arm can be
calculated by the flexure formula [9] and the loads calculated in Table 5.2:
σmax =
Mc
Ix
(5.8)
Where σmax is the maximum normal stress in the beam and will occur at a point furthest
away from the neutral axis, M is the maximum bending moment (comprising of the length
L of the beam multiplied by the load P ), c is the perpendicular distance from the neutral
axis to a point farthest away from the neutral axis and Ix is the moment of inertia of the
cross-sectional area through section x− x.
To determine the stability and durability of the arm under the calculated loading, the
stress and deformation in the components can be calculated using equation (5.8). However
as the materials selected for the beam are non-brittle and the beam will not be fatigue
loaded the stress concentration due to the change in section at the beam support will be
neglected [9]. Table 5.3 shows the maximum calculated stress for all the given materials.
Table 5.3: Induced stress (σmax) in the needle positioning arm
Variables Units Stainless Ti Alloy Nylon 6 PVC Acetal PEEK
Steel 304 6AL 4V Copolymer 450G
Ix mm
4 0.00045 0.00045 0.00045 0.00045 0.00045 0.00045
L mm 4.0 4.0 4.0 4.0 4.0 4.0
P mN 692.0 394.0 11.8 10.8 9.7 12.55
c mm 0.15 0.15 0.15 0.15 0.15 0.15
M Nmm 2.768 1.578 0.047 0.043 0.039 0.050
σmax Nmm
−2 922.78 525.94 15.78 14.34 12.91 16.73
For a structure to be considered stable in operation the maximum stress induced in the
structure must be below the limiting property factor of strength for the material, this limit
is known as the yield point of the material and it is the point where permanent deformation
of the material occurs. The results of the stress analysis for the needle positioning arm
can be seen in Table 5.3 and show that only stainless steel 304 exceeds the material’s
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yield point (which are presented in Table 5.1). Although acetal copolymer has the lowest
generated stress levels of the selected materials it represents 23.5% of its yield point however
PEEK represents only 17.3% of its yield point making it potentially more suitable to this
application.
5.4.1.2 Needle Funnel Arm: FEA Analysis
Selecting PEEK as the preferred material for the needle positioning arm a finite element
analysis (FEA) has been performed using AutoCAD Mechanical 2011 software. The FEA
program calculates the deformation and stress conditions of the part and presents the results
as contours of predicted stress magnitude. Figure 5.10 is a 2D static analysis using the Von
Mises stress to display the results.
Figure 5.10: Von Mises FEA 2D isoareas and displacement analysis of a PEEK needle funnel
arm with a point load of 12.55 mN
The FEA analysis (Figure 5.10) models the needle funnel arm as a cantilever beam
with a fixed support running through the centre of the needle funnel, parallel to the arm.
The results show the maximum Von Mises stress to be 15.47 Nmm−2 from an applied load
of 12.55 mN at the end of the arm. The small variation between the FEA figure and the
calculated figure (Table 5.3) is due to the size of the mesh used on the FEA simulation and
the more accurate modelling of the arm geometry. A stress of 3.86 Nmm−2 can also be seen
running through the beam as a contour of light brown indicated by arrow (A). The analysis
shows that the maximum predicted stress is 6.25 times lower than the 97 Nmm−2 yield point
of PEEK, this gives an acceptable margin for safety to accommodate for any variations in
material and geometry. The displacement analysis, arrow (B), shows the 0.17 mm movement
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of the arm. The resulting stress in the arm is of a magnitude which would allow the arm
to recover back to its original starting position when the applied load is removed. This
will allow the needle funnel to lock into position when it is rotated clockwise. Appendix E
presents a bending trial of a PEEK test piece.
5.4.1.3 Needle Funnel Arm: Shear Stress Analysis
It has been determined that the strength of the PEEK arm is adequate to withstand the
internal bending stress therefore a further analysis can be completed to determine if the
PEEK arm can withstand the shear stress generated from the applied load of 12.55 mN.
To determine if the allowable shear stress for the PEEK material is exceeded the shear
formula [9] can be used:
τ =
V Q
Ixtw
(5.9)
Where V is the internal resultant shear force, Q equals y¯
′
A
′
, where A
′
is the area of
the top portion of the member’s cross-sectional area, above the section plane where tw is
measured and y¯
′
is the distance from the neutral axis to the centroid of A
′
. Ix is the moment
of inertia for the cross-sectional area calculated through section x − x and tw is the width
of the member’s cross-sectional area measured at the point where τ is to be determined.
The results of the shear stress analysis show that a shear stress of 313.7 mNmm−2 is
developed across the beam. Comparing this result with the material’s allowable shear
modulus, 1.31 kNmm−2 confirms it would be an acceptable material choice for the needle
positioning arm.
5.4.1.4 Actuator Stall Torque Analysis
The needle positioning mechanism comprises of a stainless steel needle, a needle funnel, a
needle cam, two ratchets and a micromotor with a four stage gearbox. The micromotor
will be required to rotate these parts from a stationary position up to the maximum RPM
of the micromotor. However the chosen micromotor manufactured by Namiki has a lim-
ited deliverable torque of 1.6 mNm available. It is therefore necessary to determine if the
micromotor is capable of operating the system.
Targeted Drug Delivery: Design, Analysis and Evaluation 167
To determine the torque required to operate the needle funnel system an analysis of the
two separate stages of the system is required.
The first stage of the system is to calculate the torque (T ) required to accelerate the
mass of the needle funnel from rest to its maximum angular velocity. This can be calculated
using the following formula for torque:
T = Ioα (5.10)
Where Io is the moment of inertia and α is the angular acceleration. The needle po-
sitioning mechanism can be modelled as a uniform disc and the moment of inertia for a
uniform disc can be calculated as follows:
Io =
mr2
2
(5.11)
Where m is the total mass of the body and r is the radius of the disc. The mass can be
calculated from the volume of the parts and the specific density of the material they are to
be manufactured from.
The acceleration can be calculated from:
α =
ω2 − ω1
tr
(5.12)
Where ω1 is zero and it is the initial angular velocity at the start, ω2 is the maximum
angular velocity and can be calculated from the motor’s RPM (N = 76) as follows:
ω2 =
2piN
60
(5.13)
tr is 30 ms and it is the rise time. The rise time is the time required to achieve the
micromotor’s maximum RPM [10].
Using equation (5.10) the torque required to rotate the needle funnel mechanism from
zero to the maximum angular acceleration of 265.3 rad/s2 is 0.4µNm. However this figure
does not take into consideration the braking action of the needle funnel arms and the
needle cam legs. Therefore the second stage is to calculate the couple required to maintain
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a constant velocity when the needle funnel arms and needle cam legs come into contact with
the protrusions and ratchet teeth and act like brakes.
The needle funnel arms will be analysed as a static system which is in equilibrium. The
arms will be statically determinate as the unknown couple (M) can be determined from the
static equilibrium equation [11].
The unknown couple can be calculated by generating a free-body diagram of the needle
funnel to obtain a relation between M and the reaction exerted on the needle funnel by the
arms for a state of equilibrium.
Figure 5.11: Free-body diagram of the extended cantilever needle funnel design
Figure 5.11 is a free-body diagram of the needle funnel with the forces exerted by the
arms being represented by the forces R1 and R2. The forces R1 and R2 oppose the counter
clockwise rotation of the needle funnel and the angles θ1 and θ2 are the maximum angle of
deflection of the arms due to the protrusions on the inside face of the body and they have
been calculated at 16.36◦.
Summing moments about point 0 we obtain:
∑
M0 = M − (R1 sin θ1)r − (R2 sin θ2)r = 0 (5.14)
Resolving for the couple M :
M = (R1 sin θ1)r + (R2 sin θ2)r (5.15)
The moment (M) required to maintain a state of equilibrium equates to 33.8µNm. This
is derived from the 12.55 mN force generated by a PEEK arm (Table 5.2) and a maximum
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deflection angle of 16.36 degrees. This process of analysis has also been completed for the
needle cam legs with a result of 33.4µNm required to maintain a state of equilibrium.
The total torque required to operate the needle positioning mechanism would be the
sum of the initial torque required for acceleration and the torques required to overcome the
braking action of the needle funnel arms and needle cam legs, as a worst case scenario could
position the arms and legs at their maximum deflection at the start-up of an operation.
However the combined figures equate to a torque of 67.68µNm which is 23.6 times smaller
than the 1.6 mNm stall torque of the Namiki micromotor, therefore the chosen micromotor
will operate the needle positioning mechanism.
5.4.2 Clockwise Motion: Needle Deployment
Once the desired position of the needle has been established through the anticlockwise
rotation of the needle funnel it is then ready for deployment. Reversing the voltage on
the micromotor reverses the direction of the needle funnel arms, this clockwise rotation
will cause the ends of the needle funnel arms to engage with the protrusions on the inside
face of the microrobot’s body (Figure 5.3, c). This interaction with the arm tips and the
microrobot’s body will prevent any further rotation of the needle funnel and align the needle
with the desired port ready for deployment.
5.4.2.1 Needle Funnel Arm: Buckling Analysis
The micromotor will be applying a constant clockwise torque to the needle funnel to enable it
to maintain its position and deploy the needle, however due to the rotation being prevented
a compressive force will be applied to the ends of the arms. Therefore it is important
that the integrity of the needle funnel arms are maintained under this constant compressive
loading and that they do not fail due to buckling. The compressive load acting on the end
of the arms as a result of the moment generated by the micromotor can be calculated from
the equilibrium equation determined from the static state of the system.
Figure 5.12 is a free-body diagram of a needle funnel arm under a constant load from
the micromotor. It shows the reactions at the end of the arm for a state of equilibrium.
The reaction forceAx opposes the force delivered by the needle funnel arm (F ). The force
generated by the arm is 164.98 mN, this has been calculated from the 0.8 mNm deliverable
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Figure 5.12: Free-body diagram of the forces acting on the needle funnel arm end
torque at the arm radius of 4.85 mm. The angle Θ is a result of the geometry of the
protrusion on the inside face of the body and has been calculated at 30.19◦. The compression
force acting on the arm can be calculated as follows:
Summing forces about the x coordinate we obtain:
∑
Fx = (F cos Θ)−Ax = 0 (5.16)
Resolving for the force Ax:
Ax = F cos Θ (5.17)
Using the derived formula, equation (5.17) the compressive force acting on each arm
equates to 142.6 mN. This axial compressive force will deflect the arm laterally or sideways.
If the extent of this lateral movement is excessive then buckling will occur resulting in
misalignment of the needle with the port in the body or total failure of the mechanism.
Therefore it is essential that the arms can safely support the 142.6 mN compressive force
without buckling.
Assuming the arms behave in a linear-elastic manner when the compressive force is ap-
plied and there is no side load, the calculated compressive force can be checked to determine
the stability of the arm by using Euler’s buckling equation [9]:
Pcr =
pi2EIy
(KeLe)2
(5.18)
Where Pcr is the critical load the column can carry, E is the material’s Young’s modulus,
Le is the effective length of the beam and Ke is the effective-length factor which represents
the unsupported distance between the points of zero moment. As one end of the arm is
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fixed and the other end is restrained as a result of the body’s geometry the effective-length
factor becomes Ke = 0.7. Iy is the moment of inertia for a solid rectangular beam and is
given by:
Iy =
hb3
12
(5.19)
Where h is the height and b is the width of the beam’s cross section.
The critical load required to buckle the needle funnel arm equates to 881 mN using
Euler’s buckling equation (5.18). This can be compared to the calculated compressive force
in the arm of 142.6 mN. As can be seen, the load required to buckle the arm is far in excess
of the load which can be delivered by the micromotor.
5.5 Prototype Manufacture
The following section presents a discussion of the prototyping methods selected to pro-
duce the component parts of the targeting mechanism. One-to-one scale component parts
prototyped through an SLA manufacturing process are presented and also 5:1 scale com-
ponent parts manufactured through conventional CNC milling are presented. The finished
components are evaluated for their dimensional accuracy and for their functionality.
5.5.1 SLA Alpha Prototyping
One-to-one scale parts of the body, needle funnel, needle cam, ratchets, retaining plate
and needle have been produced through an SLA manufacturing process, Figure 5.13 and
Figure 5.14. SLA prototyping was selected as it was a very quick and cost effective method
of realising parts. The purpose of the 1:1 scale prototypes was to test the functionality of
the mechanism and also to determine how easily the parts could be assembled together as
the physical size of the components could make handling potentially very difficult.
Figure 5.13 shows the component parts of the needle positioning mechanism manufac-
tured from Accura 60 which is a resin with similar mechanical properties to polycarbonate
(tensile strength of 58 - 68 Nmm−2 and an elongation at break of 5 - 13%). The spring was
manufactured from stainless steel. The 1:1 scaled parts have been produced on a Viper si2
SLA system at high resolution with a laser beam diameter of 0.075±0.015 mm and a layer
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Figure 5.13: 1:1 scale SLA prototypes. a) shows the needle cam, ratchet, spring and needle
combined with the driving peg b) shows the retaining plate and c) is the needle funnel
thickness of 0.05 mm. The SLA process offers the advantage of producing complex shapes
without the need to invest in expensive tooling, this can clearly be seen with the needle
funnel, Figure 5.13, c). The complex shape of the needle funnel combined with the cross
holes and undercuts would have required complex tooling with movable cores to produce it
through an injection moulding process.
The assembled needle positioning components can be seen in Figure 5.14. Figure 5.14, a)
shows the needle funnel fitted with the needle and spring. Figure 5.14, b) shows the needle
cam mounted in the needle funnel and engaged with the needle’s drive peg. Figure 5.14, c)
shows the needle funnel ratchet and the needle cam ratchet mounted on a drive spindle and
the cavity in the case which will house the targeting mechanism. Figure 5.14, d) shows the
case fitted with the mechanism and the drive spindle at the rear.
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Figure 5.14: Assembled needle positioning mechanism. a) shows the needle funnel, spring
and needle assembled b) shows the needle cam in position c) shows the ratchets and case
cavity and d) shows the case fitted with the mechanism and coupled to a drive spindle
The proof of concept prototypes performed within the allowable design limits for the
material with the arms and legs flexing and returning to their original positions. The
spring allowed the needle to advance 2.0 mm and then return back to rest. However the
performance of the mechanism was severely hindered due to features which were not fully
formed. To drive the mechanism round requires the sharp edges of the ratchet to engage
with the ends of the arms mounted on the needle cam (Figure 5.13, a)). However the arm
tips were not fully formed and the radius of the laser beam resulted in rounded edges on
the ratchet, these combined issues produced an intermittent engagement of the needle cam
arms with the ratchet and therefore resulted in an intermittent operation.
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5.5.2 Needle Positioning Mechanism Prototyping
To validate the efficacy of the needle positioning mechanism a 5:1 scale prototype was
produced using conventional CNC milling techniques. The body and retaining plate were
manufactured in PMMA to allow visualisation of internal component parts. Also a rigid
material was required for the plurality of protrusions in the body which deflect the needle
funnel arms. The needle cam, needle funnel and needle were manufactured from Nylon 6,
which was chosen for its mechanical properties. The material for the spring was stainless
steel. The mechanical properties of the 5:1 scale prototype are related to the materials’
Young’s modulus and the geometry of the component parts therefore the performance of
the 5:1 scale prototype suggests that future prototypes at 1:1 scale will perform as designed.
Figure 5.15 shows the component parts of the needle positioning mechanism.
The stainless steel spring is mounted onto the front section of the needle and butts
up against the drive peg boss. Both the spring and the needle are fed into a captivating
recess in the needle funnel (Figure 5.15). The needle can move linearly in the recess and is
independent of the needle funnel however it will be under constant pressure from the spring
as the end of the spring is retained by the end of the recess. The drive peg on the side of
the needle protrudes outwards from the recess allowing it to engage with the needle cam.
The needle cam sits inside a counter bore in the front of the needle funnel. The counter
bore captivates the needle cam and only allows the cam to rotate. The needle cam sits
with the cam groove engaged with the drive peg on the needle. To prevent the needle
cam from falling out during an operation the retaining plate is placed over the front of
the needle funnel. A boss located towards the outside edge of the needle funnel engages
with a corresponding hole in the retaining plate. The reason for this arrangement is to
provide rotational drive to the holding mechanism for the purpose of positioning the holding
mechanism diametrically opposite the needle.
The assembled needle funnel is loaded into the front of the body where the corresponding
legs engage with the needle funnel ratchet, the needle cam ratchet and the arms engage with
the protrusions. Three equally spaced pins are used to prevent the assembly from separating
from the body when it is being operated. The pins are stepped which allows a press fit with
the body and for them to pass through the body and into a groove which runs around the
outside edge of the retaining plate. To prevent the pins from engaging with the bottom of
the groove and to facilitate easy assembly and removal a larger diameter shoulder has been
incorporated at the end of the pin. The retaining plate would be connected to the holding
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Figure 5.15: 5:1 scale prototypes of the body and ratchets, needle cam, needle and spring,
retaining plate and needle funnel
mechanism via two M3 countersunk head screws which can be clearly seen in Chapter 4,
Figure 4.28.
5.5.3 Needle Deployment
To simplify the operation of the mechanism the needle cam ratchet and the needle funnel
ratchet were joined together to make a drive shaft which was extended such that it could
pass through the body. The end of the drive shaft was threaded allowing a locking nut
arrangement to be secured to it which would prevent the ratchet drive shaft from becoming
unfastened when manually operated. The assembled needle positioning mechanism can be
seen in Figure 5.16 and the mechanism at full extension can be seen in Figure 5.17.
Targeted Drug Delivery: Design, Analysis and Evaluation 176
Figure 5.16: Assembled needle positioning components. Retaining plate has been removed
for clarity
Figure 5.17: Needle positioning mechanism at maximum extension. Retaining plate has
been removed for clarity
5.5.4 Needle Positioning Mechanism Performance
The needle positioning mechanism performs well under manual operation however modifica-
tions to the geometry of key parts were required to allow smooth operation. The dimensional
accuracy of the manufactured parts was the largest problem in the assembly of the needle
positioning mechanism prototype. For example, the needle funnel was designed with ra-
dial clearance between it and the inside bore of the body to allow it to freely rotate when
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positioning the needle and driving the holding mechanism. However the outside diameter
of the needle funnel and the overall thickness had been manufactured outside the expected
tolerance of the part (±0.1 mm). Also, even though a degree of working clearance was de-
signed into the axial alignment of the parts the over-sized geometry caused the mechanism
to lock up. Due to the complex shape of the needle funnel it was a difficult task to manually
remove the excess material however this issue can be overcome in the future by attributing
specific tolerances to the geometric features.
A significant issue contributing to the performance of the mechanism was the straight-
ness of the ratchet drive shaft. As already discussed, the ratchets were joined together
to simplify the operation of the mechanism. However on inspection of the drive shaft it
was clear that the part was outside the limits for straightness. The bent shafts resulted
in a concentricity error with the manual driving nut causing the mechanism to tighten up
intermittently. Also significant radii were left in the base of the ratchets teeth this pre-
vented the needle funnel arms from engaging correctly and driving the mechanism round.
The problems with the drive shaft can be attributed directly to the manufacturing method
selected by the company who produced them. They chose to mill the diameters rather than
turn them and also to mill the ratchet teeth using a bull nose cutter. These manufacturing
choices resulted in the shaft being out of straightness and out of concentricity.
It became evident through manual operation that the needle cam ratchet used to deploy
and retract the needle was potentially redundant in normal use as the drive shaft could be
linked directly to the needle cam. A scenario which utilises the needle cam ratchet would be
if the needle is in the fully forward position and the micromotor was inadvertently driven
anticlockwise the cam ratchet would act as a safety device and allow the micromotor to slip
without causing damage. However it is unlikely this scenario would take place therefore it
would be recommended that the ratchet be removed as this would simplify the design and
ultimately reduce the cost.
5.6 Measurement and Characterisation of the Needle Posi-
tioning Mechanism
This section presents a series of experiments designed to validate the needle positioning
mechanism. The experiments focus on the performance of the needle funnel through quan-
titative assessment of two 5:1 scale model prototypes manufactured from Nylon 6. The
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mechanical properties of the 5:1 scale prototype are related to the materials’ Young’s mod-
ulus and the geometry of the component parts therefore the performance of the 5:1 scale
prototype suggests that future prototypes at 1:1 scale will perform as designed.
5.6.1 Needle Funnel Arm Deflection Protocol
To determine whether the performance of the needle funnel arms correlates with the cal-
culated load at maximum deflection an independent examination of the needle funnel arm
has been performed.
As the calculated forces developed by the needle funnel arms are very low (<2 N) it is
important that the test set-up be stable with limited external influences. Therefore purpose-
built fixtures will be used to perform the protocol on as they offer a stable base and a means
of securely holding the test piece during testing, Figure 5.18.
Figure 5.18: Left: Layout of needle funnel arm deflection fixture; Right: Experimental set-
up comprising: a needle funnel mounted on the test bed of a MultiTest 2.5-i test system
which is fitted with a 2 N loadcell and connected to a computer running EmperorTM (force)
software
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5.6.1.1 Needle Funnel Arm Deflection Procedure
Figure 5.18 shows the test set-up used to determine the load generated by deflecting one
of the needle funnel arms. The needle funnel is securely mounted to a fixture using an M6
caphead screw. The needle funnel arm is positioned such that it is aligned horizontally with
the test bed and the tip of the needle funnel arm aligns with the tip of the 2 mm pointer.
During an operation the needle funnel arm will deflect 0.17 mm this equates to a de-
flection of 0.85 mm for the 5:1 scale prototype. A MultiTest 2.5-i (805-102) test system
manufactured by Mecmesin is fitted with a 2 N loadcell (Intelligent loadcell ILC 879-009,
±0.1% of full scale) to measure the load generated by the deflection of the arm from its
static state through a given distance. A computer running EmperorTM (force) software (v.
1.18-408 (5/10/13)) is connected to the MultiTest system and used to record the deflection
data. The deflection program will be run five times and the data for each run recorded.
The results of the peak deflection load will be combined and the average of these runs will
be used for the comparison with the calculated figure.
5.6.1.2 Results and Discussion
A profile of the load recorded for a needle funnel arm deflection of 0.85 mm is presented in
Figure 5.19. It can be seen in Figure 5.19 that a displacement of 0.85 mm has been reached
and a maximum peak load of 509.9 mN has been recorded at the end of the deflection.
Figure 5.19: Needle funnel arm load deflection profile of a 0.85 mm deflection
Table 5.4 shows the average measured results for a series of deflection experiments on
two prototype needle funnels. To minimise any inaccuracies with the experimental set-up
and with the test procedure a series of results have been recorded from a deflection range
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of 0.75 mm up to 1.05 mm for each of the needle funnel arms, as recording the deflection
data for multiple values will highlight any inconsistencies with the measured results.
Table 5.4: Average recorded loads developed through a deflection range of 0.75 mm to
1.05 mm for each of the needle funnel arms
Deflection Prototype Prototype Average
value No. 1 No. 2 force
(mm) (mN) (mN) (mN)
0.75 474.8 511.25 493.03
0.85 532.8 571.75 552.28
0.95 588.4 631.9 610.15
1.05 634.8 688.4 661.60
As can be seen from Table 5.4 the average load developed by deflecting the needle funnel
arms at the optimum design value of 0.85 mm is 552.28 mN. This figure is approximately
48% lower than the calculated figure and is consistent with the measured figures across the
range of deflections.
The geometry of the arm will influence its performance. The measured figures for the
cross-sectional area of the arms showed that they were marginally undersize and that the
lengths of the arms were an average of 0.1 mm longer than the designed value (with the
material being removed from the back of the slots). These small variations in geometry are
due to inaccuracies in the manufacturing process and will result in a reduced load being
generated by the deflecting arm. The change in geometry only accounts for approximately
3% reduction in performance. However close dimensional inspection of the arms showed
that, in all cases, the arms exhibited a degree of deflection already set into the arm at
rest. The position of the arm tips varied from the designed nominal value by -0.2 mm up
to -0.37 mm.
The movement of the arms can be attributed to stress relieving of the material due
to the chosen manufacturing method and the selected material. The sequence of machin-
ing operations, the speed and cutter selected can all influence the stress developed in the
component material. The net result of the arms positional movement reduces the effective
spring pressure the arms can deliver and therefore could account for the 48% reduction in
the measured results. Changing the material to an engineering material such as PEEK or
annealing the material before machining would reduce the effects of the material’s internal
stress resulting in more dimensionally stable needle funnel arms.
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5.6.2 Durability and Performance of Needle Funnel Arms
The objective of the experiment is to determine the stability of the needle funnel arms when
subjected to multiple operations. During an operation the arms engage with protrusions on
the inside edge of the body causing them to deflect inwards when rotating anticlockwise and
to compress when rotated clockwise (Figure 5.3). Therefore the experiment will manually
simulate a number of operations by subjecting the needle funnel arms to multiple deflections.
5.6.2.1 Needle Funnel Arm Performance Protocol
To determine the stability of the needle funnel arms the 5:1 scale prototype needle funnel,
CNC machined from Nylon 6, is coupled to the retaining plate and mounted inside the
PMMA body. The assembly is subjected to multiple operating cycles with each cycle
combining a 360 degree anticlockwise rotation with a 22.5 degree clockwise rotation. The
needle funnel and assembly can be seen in the top and bottom left of Figure 5.20.
Figure 5.20: Top left: Needle funnel arms, measurements are taken between the arrows;
Bottom left: Needle funnel assembly; Right: TESA Vision 200 measuring system
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A measurement is taken across the protrusions on the inside of the body to confirm they
are within specification (Ø47.75 mm±0.05 mm). The needle funnel arms are measured from
the outside edges of the tips (top left, Figure 5.20). Inspection of the dimension across the
arms and protrusions will be carried out on a digital vision measuring system (TESA Vision
200, TESA Technology UK Ltd.) at 42.4X magnification (right, Figure 5.20). The assembly
is mounted back into the body and manually operated for 10 cycles. On completion of the
10 cycles a further measurement across the needle funnel arms tips is taken. This process
is repeated 10 further times giving a total number of operations of 100 cycles.
5.6.2.2 Results and Discussion
The performance protocol was carried out on two needle funnel assemblies. The results of
the measured dimensions across the tips, series 1 and series 2, can be seen in Figure 5.21.
Figure 5.21: Plot of the measured arm dimension across the tips of two prototype needle
funnels during repeated manual cycling
The results of the performance protocol show both needle funnel arms varying in di-
mension across the tips. The maximum standard deviation was 0.05 mm. The variations on
the measured dimensions can partly be attributed to the inaccuracy of the test method as
the needle funnels were manually aligned on the vision system before measurements were
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taken. Further inaccuracies in measurement can be attributed to the material’s colour as
it proved very difficult to define the edges of the white feature when set against a white
background.
The needle funnel assemblies performed within expected limits, the arms engaged and
disengaged with the protrusions as expected. Series 1 (Figure 5.21) shows an initial starting
dimension across the arm tips of 42.67 mm which is 0.16 mm shorter per side than the nom-
inal design value of 43 mm. However the design of the mechanism would provide 0.73 mm
of engagement with the protrusions. The results show that the needle funnels can maintain
their performance through repeated operations.
5.6.3 Needle Funnel Ratchet Arm Deflection Protocol
For the needle positioning mechanism to function, the needle funnel arms must perform as
designed however the needle funnel ratchet arms, which drive the needle funnel anticlock-
wise, must also perform. The needle funnel ratchet arms can be seen in Figure 5.22.
Figure 5.22: Prototype needle funnels CNC machined from Nylon 6. The ratchet arms can
be seen in the centre of the parts
5.6.3.1 Needle Funnel Ratchet Arm Deflection Procedure
The set-up employed to test the deflection load generated by the needle funnel ratchet arms
is in principle similar to the method used to test the needle funnel arms. However a different
method of fixing the needle funnel ratchet to the needle funnel fixture is required. The test
set-up can be seen in Figure 5.23.
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Figure 5.23: Left: Layout of needle funnel ratchet arm deflection fixture; Right: Experi-
mental set-up comprising: a needle funnel mounted on the test bed of a MultiTest 2.5-i test
system which is fitted with a 5 N loadcell and connected to a computer running EmperorTM
(force) software
The needle funnel is secured to the needle funnel fixture via a 1” G-clamp, making sure
that the G-clamp does not interfere with the load cell adaptor and pointer when it performs
a deflection procedure. The needle funnel ratchet arm is positioned such that it is aligned
horizontally with the test bed and perpendicular to the 2 mm pointer. The side edge of the
2 mm pointer is positioned such that it just touches the tip of the needle ratchet arm.
A MultiTest 2.5-i (805-102) test system manufactured by Mecmesin is fitted with a 5 N
loadcell (Intelligent loadcell ILC 879-010, ±0.1% of full scale) to measure the load generated
by the deflection of the ratchet arm from its static state through a given distance. The
deflection data is captured through a computer running EmperorTM (force) software (V
1.18-408 (5/10/13)) and connected to the MultiTest system. The deflection program will
be run five times and the data for each run recorded. The results of the peak deflection
load will be combined and the average of these runs will be used for the comparison with
the calculated figure.
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5.6.3.2 Results and Discussion
The average measured results for a series of deflection experiments on each ratchet arm on
two needle funnels are presented in Table 5.5. To limit any inconsistencies with the test
procedure a series of results have been recorded from a deflection range of 0.55 mm up to
0.75 mm for each of the needle funnel ratchet arms.
Table 5.5: Average measured loads developed through a deflection range of 0.55 mm to
0.75 mm for each of the needle funnel ratchet arms
Deflection Prototype Prototype Average
value No. 1 No. 2 force
(mm) (N) (N) (N)
0.55 2.04 1.92 1.98
0.65 2.37 2.25 2.31
0.75 2.70 2.55 2.63
Table 5.5 shows the average load developed by deflecting the needle funnel ratchet arms
at the optimum design value of 0.65 mm to be 2.31 N. This figure is approximately 33.6%
lower than the calculated figure.
Although the average deflection force is lower than the calculated force the individual
loads for each arm presents a different result as arm number one on prototype number one
performed within an average of 25.3% of the expected load at deflection, therefore the lower
results recorded for the remaining three arms significantly influenced the overall average
deflection force.
Inspection of the arms under 42.4X magnification showed that the arms were not of
uniform thickness across their length as they ranged from 1.48 mm at the base of the arm
to 1.65 mm at the tip. The manufacturing process has resulted in push-off when machining
the arms, this is evident in the larger thickness at the tips of the arms. However the arms
also exhibited a degree of deflection of an average of 0.295 mm already set into the arm at
rest. These inconsistencies in geometry due to the manufacturing process could account for
the reduction in the spring pressure the arms can deliver.
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5.6.4 Durability and Performance of Needle Funnel Ratchet Arms
The durability of the needle funnel arms has been established, however to complete the
operation of positioning the dispensing needle the needle funnel must engage with the
ratchet, Figure 5.24. The ratchet engages with the tips of the needle funnel ratchet arms
and drives the needle funnel anticlockwise to position the dispensing needle. Reversing the
micromotor’s direction results in the ratchet arms disengaging with the ratchet and riding
over the ratchet teeth, this results in repeated flexing of the arms. Therefore the durability
and stability of the needle funnel ratchet arms must be established through multiple cycling.
Figure 5.24: Needle funnel ratchet arms engaged with the ratchet
5.6.4.1 Needle Funnel Ratchet Arm Performance Protocol
The stability of the needle funnel ratchet arms can be determined through repeated manual
cycling of the needle funnel. The needle funnel is mounted inside the PMMA body and
engages with the ratchet, which is manufactured from Nylon 6. The assembly is subjected
to multiple manual operating cycles with each cycle combining a 720 degree anticlockwise
rotation followed by a 720 degree clockwise rotation. Two rotations clockwise and anti-
clockwise have been selected for the protocol to simulate the possibility that the operator
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may require a number of rotations before selecting the optimum position for delivery.
A measurement is taken across the peaks of the ratchet protrusions on the inside of
the body to confirm they are within specification (Ø9.0 mm±0.05 mm). The needle funnel
ratchet arms are measured from the inside edges of the tips. Inspection of the dimension
between the arm tips will be carried out on a digital vision measuring system (TESA Vision
200, TESA Technology UK Ltd.) at 42.4X magnification. The needle funnel is mounted
back into the body and manually operated for 10 cycles. On completion of the 10 cycles a
further measurement between the needle funnel arm tips is taken. This process is repeated
10 further times giving a total number of operations of 100 cycles.
5.6.4.2 Results and Discussion
After the completion of each 10 cycles the measurements between the needle funnel ratchet
arms was taken and recorded. The results for two sets of prototype needle funnel ratchets
can be seen in Figure 5.25.
Figure 5.25: Plot of the measured arm dimension between the tips of two prototype needle
funnels during repeated manual cycling
Measurement of the ratchet geometry showed that it was at the bottom of the tolerance
limit (Ø9.0 mm±0.05 mm). However the tips of the arms engaged with the ratchet teeth
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and drove the ratchet anticlockwise successfully. The edges of the ratchet teeth retained
a sharp edge from the manufacturing process, this resulted in a positive transition of the
arm tips when riding over the ratchet teeth. However it is recommended for a 1:1 scale
prototype ratchet that it be made from a metal to prevent the edges from being damaged
and to guarantee a positive engagement with the arm tips.
Figure 5.25 series 1 shows that the initial measurement between the arm tips was
7.81 mm which is 0.06 mm greater than the nominal design value of 7.75 mm. The in-
crease in value will have the effect of reducing the amount of engagement the arm tip will
have with the ratchet tooth. However the 5:1 scale prototype offers 0.65 mm of engagement
therefore the small reduction will have a negligible effect on its performance. Series 2 shows
that the initial measurement between the arm tips was 7.65 mm which is 0.1 mm smaller
than the nominal design value. The reduction in value will have the effect of closing the
arms on the ratchet and therefore it would offer a benefit to its performance.
The dimensional stability of the arms was very good as the greatest standard deviation
was found to be 0.008 mm for series 1. The results show that the needle funnel ratchet arms
can maintain their performance through repeated operations. The outcome of the needle
funnel ratchet arm performance protocol confirms the durability and performance of the
needle positioning mechanism.
5.7 Summary
In this chapter a novel concept targeting mechanism has been presented for the purpose of
delivering a targeted dose of medication to a specific site of interest in the small intestinal
tract. It has been shown through analysis, prototyping and testing of a 5:1 scale prototype
that the targeting mechanism is durable and capable of being positioned within a 360 degree
envelope to target a specific location.
The mechanical properties of the 5:1 scale prototype are related to the materials’ Young’s
modulus and the geometry of the component parts, therefore the performance of the 5:1
scale prototype suggests that a scaled down version would perform equally as well. However
in-vivo tests would need to be performed to validate the actual figures.
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Chapter 6
Drug Delivery System: Design,
Analysis and Evaluation
6.1 Introduction
Targeting pathologies of the GI tract such as small intestinal Crohn’s disease or ulcerative
colitis requires the application of medication direct to the specific site [1]. The increased
functionality presented in Chapter 4 and Chapter 5 allows a microrobot to resist peristalsis
and to target a pathology of the GI tract. However the challenge of releasing medication
from the microrobot still remains. This chapter presents the drug delivery system, the
mechanism responsible for the delivery of an onboard supply of medication. This medication
can be in the form of either a suspension or a concentrated volume, however it must be
a liquid. A 1 ml volume of medication has been selected as the optimum dose as it is
representative of the dose published in the prior art [2] and also the quantity being used in
current trials stated in the literature [3]. This chapter focuses on the design and analysis
of solutions to administer a metered dose of medication and the validation of the system
through experimentation.
6.2 Overview
The clinical need to treat pathologies of the GI tract has been discussed in previous chapters.
Chapter 4 and Chapter 5 address the issues of resisting natural peristalsis and targeting a
specific location in the small intestinal tract, however the curative treatment of administer-
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ing a metered dose of medication is required for a successful procedure. Figure 6.1 shows a
concept design of a microrobot with an integrated drug delivery system.
Figure 6.1: Microrobot concept design capable of delivering 1 ml of targeted medication.
Needle shown fully extended and the medication partially deployed
Delivering an onboard supply of medication can be achieved through various means. For
example a number of ideas were explored which utilised a micromotor to drive a leadscrew
which in turn pushed a piston that forced medication out through a port. Another idea was
to utilise a balloon which could be filled with liquid medication. A number of designs which
employed a compression spring were also explored, however all these potential solutions
posed a number of issues such as the requirement for a method to release the spring or
balloon, space constraints or the practicality of swallowing such large devices. Therefore
a solution which utilised a conical spring was chosen as this method offered reduced space
requirement yet retained the potential for high energy release. A selection of delivery
concepts which were explored are presented in Appendix C.
The chosen drug delivery system has the capacity to store a 1 ml volume of medication
onboard the microrobot. The force generated by a compressed conical spring is proposed to
expel the medication. The conical spring engages with a piston and when activated it will
force the medication out of one of sixteen preset holes at the base of the medication chamber.
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The holes have a thin membrane across them to protect the integrity of the medication and
to prevent the medication from leaking into the needle positioning mechanism. Rotating
the needle positioning mechanism will align a port on the back of the needle funnel with one
of the sixteen holes, the remaining holes would automatically be blanked off and therefore
prevent any ingress of the medication. The novel configuration of the conical spring provides
a compact design however a triggering mechanism will also be required to automatically
release the spring.
The following sections discuss the design and analysis of the drug delivery system, the
trigger mechanism and the issue of power distribution through the microrobot. A series of
experiments are presented which validate the drug delivery system.
6.3 Drug Delivery System
Using a compressed spring to drive the delivery of the medication would require allocating
a volume of space within the microrobot for the spring’s solid state volume and for the
spring’s actuation mechanism. A novel way of minimising the spring’s volume is to use a
conical compression spring, Figure 6.2.
Figure 6.2: Conical compression spring configurations, 7.5 coils fully expanded with a vari-
able pitch a) collapsed section view b) and fully coiled position c)
Figure 6.2 shows a variable pitch conical compression spring in its free state a) in the
primed position b) and a plan view in the fully coiled position c). Winding the coils such
as they lie inside each other (Figure 6.2, c) enables the same number of coils to be used as
in a conventional compression spring to generate a force, however it significantly reduces
the space required to hold the spring. For example, a conical compression spring with
six Ø0.5 mm coils would occupy a solid state volume of 40.1 mm3 this can be compared
to a volume of 55.0 mm3 for a conventional compression spring with the same geometry.
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Providing clearance between the coils enables them to be spiralled inside each other. A
variable pitch is required between each coil to allow the spring to collapse at the same rate,
this is due to the larger coils collapsing faster than the tighter coils. This configuration
allows the active coils to bottom simultaneously resulting in a straight line force versus
deflection curve similar to the output of a conventional compression spring. To release the
spring from the compressed position a trigger mechanism will be required. Appendix D
compares the volume of the alternative designs which have been explored.
The conical compression spring will require analysing to determine the optimum medi-
cation delivery force. This will involve analysing a number of spring variables such as the
number of coils, the diameter of the wire and the force required to operate the system.
All these factors will influence each other’s performance and a balance will need to be
determined which will minimise the space required to house the system.
6.3.1 Drug Delivery
To deliver a 1 ml volume of medication to a target site requires the onboard supply of
medication to be pushed through a series of holes allowing it to be expelled through the
needle tip. To achieve this task an evaluation of the force required to expel the medication
must be performed.
The bore of the needle is the most restrictive section of the delivery system for the flow
of medication. The needle has an internal diameter of 0.38 mm and a length of 6.7 mm.
As the needle has a consistent diameter and length Poiseuille’s equation can be used to
model the flow of medication through the needle. The assumptions which will be made
with Poiseuille’s equation are that the medication is incompressible and Newtonian, the
flow is laminar and friction will be ignored [4].
The flow rate of a needle Qf can be calculated as follows:
Qf =
pir4(P2 − P1)
8ηvl
(6.1)
Where r is the radius of the needle’s bore, ηv is the viscosity of the medication and
l is the length of the needle. P1 is the pressure at the end of the needle and P2 is the
pressure required to expel the medication. For the purpose of analysis the viscosity of the
medication will be based on water at 36oC (0.705 x 10−3 Pa s). P1 is the pressure resistance of
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the medication being introduced into the GI tract wall. The interstitial hydrostatic pressure
in subcutaneous tissue can range from -8 mmHg to +6 mmHg for normal tissue however for
tissue with a tumour the pressure can be much greater. Therefore P1 will be taken as the
subcutaneous pressure in a tumour which is approximately +20 mmHg (2.6 kPa) [5].
As the medication must be absorbed by the subcutaneous tissue a delivery time has
been set at 3.5 s (Table 3.1). The flow rate (Qf ) can be calculated by dividing the 1 ml
volume of medication stored onboard the microrobot by the target delivery time (3.5 s).
Rearranging equation (6.1) allows the pressure difference ∆P to be calculated (2.63 kPa).
As the pressure difference ∆P = P2 - P1 the pressure required to deliver the medication in
3.5 s (P2) can be determined, 5.23 kPa. The delivery pressure (P2) multiplied by the area of
the medication chamber’s plunger gives the delivery force required to expel the medication.
The force applied to the medication chamber’s plunger equates to 0.43 N.
The flow of the medication through the needle was assumed to be laminar however to
confirm this the Reynolds number can be used to determine how the medication flow is
acting:
Re =
ρdv
ηv
(6.2)
Where ρ is the density of the medication, d is the diameter of the needle, v is the velocity
of the medication and ηv is the viscosity of the medication.
The Reynolds number for the system equates to approximately 1.9. For Re < 2100
the flow is laminar and for Re > 4000 the flow is turbulent. A Reynolds number between
these two limits results in transition flows which can either be laminar or turbulent. The
low Reynolds number confirms the flow will be laminar and therefore no compensation for
changes in pressure will be required.
There are a number of variables which can affect the delivery time, for example if the
viscosity of the medication were to decrease it would speed up the delivery time while a
decrease in temperature would slow down the delivery time.
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6.3.2 Spring Design Analysis
The geometry of the microrobot places limits on the allowable design parameters which
can be used in the design of a conical spring. However the spring must be designed to fit
within a volume of 40.0 mm3 and deliver a force of 0.43 N over a stroke of 12.05 mm. As
the spring’s deliverable force is known the spring’s deflection f can be calculated by the
following formula for conical compression springs [6]:
f =
16n(r1 + r0)(r
2
1 + r
2
0)Fd
d4G
(6.3)
Where n is the number of active coils, r0 is the mean coil radius of the first coil and
r1 is the mean coil radius of the last coil, Fd is the force, d is the wire diameter and G
is the module of rigidity. A stainless steel wire spring with a module of rigidity value of
69.0 GNm−2 [7] will be used for the spring analysis.
Using an input force of 0.43 N and a combination of 0.254 mm diameter wire, 7.5 active
coils, a mean coil radius of 2.1 mm for the first coil and a mean coil radius of 5.0 mm for
the final coil results in a spring with a free length deflection of 49.73 mm and which only
occupies a volume of 17.89 mm3. However equation (6.3) calculates the deflection (f) based
on a solid length of n x d whereas the compact design of the conical spring requires the
spring wires to be coiled inside each other, this will result in a greater deflection length
and therefore an increase in the initial starting load. As the deflection is known the new
starting load Fc can be calculated as follows:
Fc =
Fd
f
((nd)− d+ f) (6.4)
The increased spring deflection results in a new starting force (Fc) of 0.59 N however
at the end of the 12.05 mm stroke length the conical spring will be delivering 0.43 N. The
deflection force can be used to determine the stress (τ) in the spring and can be calculated
by rearranging the following formula:
Fc =
pid3
16r1
τ (6.5)
The 0.59 N force which is generated by the spring at the start of the stroke results in
915.16 MNm−2 of stress induced in the compressed spring. The requirement for the spring
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is for a single operation therefore the maximum allowable static stresses would be limited to
59% of the material’s ultimate tensile strength (2,200 MNm−2) [8]. The resulting stress in
the spring represents 41.6% of the allowable static stress therefore the variable pitch conical
compression spring design will be acceptable for the application.
6.3.3 Trigger Mechanism
To deliver the 1 ml volume of medication a trigger mechanism is required to release the
compressed conical spring. Releasing the spring remotely at the required moment in time is
a challenging requirement. The system chosen to release the spring is a thermo mechanical
method. This method of triggering the spring relies on the Joule’s effect to heat an igniter
which in turn ignites a pyrogen that melts a Nylon wire. The Nylon wire is employed to
retain the compressed coiled spring. Figure 6.3 shows a layout of the proposed system.
Figure 6.3: Cut-through view of the thermo mechanical trigger mechanism. Heat shield
shown suspended above the igniter and Nylon wire
Figure 6.3 shows a section view through the thermo mechanical trigger mechanism. The
trigger mechanism utilises a Nylon wire to retain the medication chamber piston (Figure 6.1)
which in turn traps the conical spring, preventing it from expanding. The medication
chamber piston has two protrusions which pass through the trigger board. The trigger board
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connects the power supply section to the main body of the microrobot. The protrusions
have been designed with two perpendicular tapered slots. The tapers in the slots retain the
Nylon wire when it is manually wrapped around the protrusions. The Nylon wire passes
over the igniter and propellant. A heat shield is placed over the top of the Nylon wire
and it also encompasses the protrusions. The heat shield is retained by two vertical arms
mounted on the trigger board to prevent it from separating at the point of ignition. Once
the thermo mechanical mechanism has been fired the medication piston will be propelled
towards the front of the microrobot, this action will simultaneously suck the exhaust fumes
and heat from the propellant into the medication chamber, therefore dissipating any heat
generated and preventing heat radiating into the power supply area.
The compressed conical spring will be delivering a load of 0.59 N at maximum com-
pression therefore the Nylon wire must be capable of holding this force without breaking
prematurely or elongating under the strain and partially delivering the medication. A Ny-
lon monofilament wire has been selected which melts at 220 ◦C, has a Young’s modulus
of 3,300 MNm−2 and a diameter of 0.10 mm. The technology chosen to ignite the pro-
pellant, which in turn will melt the Nylon wire, is an electro-pyrotechnic initiator thin
film chip (EPIC) (Vishay Intertechnology, Inc.). The microjoule energy device is a surface
mount device (SMD) (size 0603) comprising a ceramic (alumina) based substrate with a
tantalum nitrogen (Ta2N) deposit as the activating resistor. A deposit of boron potassium
nitrate (BKNO3) (25% boron/75% potassium) propellant is applied to the EPIC igniter.
Boron potassium nitrate ignites at 730 K (456.85 ◦C) [9] and reaches a flame temperature
of 3,000 ◦C [10] therefore it will be capable of melting the Nylon wire.
The resistance (Rtn) of the tantalum nitrogen heating element is dependent on the
resistivity of the material and the geometry of the element. It can be calculated as follows:
Rtn =
rtnl
wt
(6.6)
Where rtn is the resistivity of the tantalum nitrogen material (400µΩ x cm), l is the
length of the heating element, w is the width and t is the material’s thickness.
Using the geometry of 75µm for the length (l), 50µm for the width (w) and 2µm for
the thickness (t) results in a heating element resistance (Rtn) of 3.0 Ω.
The electrical energy (Ei) required to ignite the propellant and melt the Nylon wire can
be calculated by the following formula:
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Ei = lwtρCp∆T (6.7)
Where l is the length of the heating element, w is the width, t is the material’s thickness,
ρ is the density of tantalum nitrogen (11.5 gcm3), Cp is the specific heat of the material
(0.14 J g−1 ◦C−1) and ∆T is the adiabatic temperature required at the heating element.
Using equation (6.7) with the heating element geometry already specified and an ignition
temperature (∆T ) of 456.85 ◦C results in an electrical energy of 5.5µJ required to ignite the
propellant. However a safety factor is required to ensure that the electrical pulse delivered
to the EPIC device is sufficient to ignite the propellant therefore a safety factor of 10 will
be applied. Incorporating the safety factor into equation (6.7) results in 55µJ of electrical
energy required to ignite the boron potassium nitrate propellant.
The firing time (Ft) required to ignite the propellant can be calculated using the following
formula:
Ft =
Ei
RtnI2
(6.8)
Where Ei is the electrical energy required to ignite the propellant, Rtn is the resistance
of the heating element and I2 is the supply current.
Using equation (6.8) with a supply current of 0.5 A results in a firing time of 74µs.
Increasing or decreasing the current will affect the firing time. However the combination
of the heating element geometry and the supply current must be chosen to guarantee the
device does not fire through external influences, such as electro-magnetic interference from
the environment, and can only be fired by the activation energy pulse.
6.4 Measurement and Characterisation of the Drug Delivery
System
This section presents a series of experiments designed to validate the drug delivery system.
The experiments focus on determining the parameters required for the delivery of the med-
ication and on the performance of the conical spring through quantitative assessment of a
1:1 scale model prototype manufactured from stainless steel (BS 2056 Austenitic 302).
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6.4.1 Drug Delivery Performance Protocol
The purpose of the drug delivery experiment is to determine if the chosen delivery speed
of 3.5 s is a suitable delivery speed to expel the 1 ml of onboard medication. The analysis
performed in Section 6.3.1 (equation 6.1) was based on water at body temperature (36oC)
however ex vivo experiments will be performed at room temperature therefore the viscosity
of the water will increase to 1 x 10−3 Pa s to compensate. The implications of this change
will be a reduction in delivery speed to 5 s to maintain the calculated delivery force.
The test set-up used to measure the delivery force required to expel the 1 ml of medica-
tion is presented in Figure 6.4, a). A specially designed plunger has been produced which
can be used with a conventional syringe body. The plunger is independent of the loadcell
adaptor and any sideways movement between the plunger and body has been minimised for
the purpose of reducing friction within the system. The reduction in friction will result in
a consistent force being generated by the plunger assembly.
The mathematical model (equation 6.1) presented for calculating the force required
to deliver the medication assumed a straight through needle orientation and presented no
difference between a vertical and horizontal configuration due to the Reynolds number being
very low, however comparing the flow of a liquid in the vertical configuration (Figure 6.4, b)
with the flow of liquid in the horizontal configuration (Figure 6.4, c) will prove the validity
of this hypothesis.
6.4.1.1 Drug Delivery Procedure
Figure 6.4 shows the test set-up used to determine the force required to deliver a 1 ml volume
of water. The body of a 2.5 ml capacity syringe (300185, BD Plastipak) is securely held in a
fixture. The bore of the syringe (Ø8.60 mm) is used to calculate the linear movement of the
plunger (17.20 mm) required to deliver 1 ml volume of liquid. A MultiTest 2.5-i (805-102)
test system manufactured by Mecmesin is fitted with a 5 N loadcell (Intelligent loadcell ILC
879-010, ±0.1% of full scale) to measure the load required for a delivery. The loadcell has
been programmed to travel at the required delivery speed of 207 mm/min for a distance of
17.20 mm from the tared zero position. A computer running EmperorTM (force) software (v.
1.18-408 (5/10/13)) is connected to the MultiTest system and used to record the delivery
data.
The delivery program will be run multiple times with no liquid being delivered and the
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Figure 6.4: Layout of the medication performance delivery test fixture a), vertical needle
configuration b) and horizontal needle configuration c)
data for each run recorded. The results of the average delivery force will be combined and
the average of these runs will be used to calculate the friction in the system due to the seal
on the plunger. The syringe will be filled with water and a piece of chicken breast flesh
positioned such as the needle tip is embedded into the chicken by approximately 1.5 mm.
Chicken breast flesh has been chosen as it has significant similarities to the tissue of the
GI tract wall [11]. The delivery program will be run multiple times with the data for each
run recorded. The results of the average delivery force will be combined and the average of
these runs will be used to calculate the delivery force required to deliver the 1 ml volume of
water.
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6.4.1.2 Results and Discussion
Measurement of the force required to operate the plunger assembly with the luer lock and
needle fitted were first taken to establish a baseline friction force for the plunger assembly.
Due to the sensitivity of the measuring system and the variability of the results a large
number of deliveries were performed. Over a set of 30 runs the average delivery force for a
dry delivery was 2.32 N.
A series of deliveries were performed which expelled a 1 ml volume of water with the
needle orientated in the vertical configuration and also with the needle orientated in the
horizontal configuration, as this would more closely match the needle orientation in the
microrobot. The needle configurations can be seen in Figure 6.5.
Figure 6.5: Left: Vertical needle configuration; Right: Horizontal needle configuration
The average delivery force for a 1 ml volume of water over 10 runs for the vertical
configuration was 2.755 N, this can be compared to the average delivery force for the same
volume of water over 10 runs for the horizontal configuration which was 2.738 N. The results
show that the average horizontal delivery force is lower than the vertical delivery force. The
small difference in delivery force (17 mN) can be attributed to the sensitivity of the test
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method. However the results confirm that there is very little turbulence in the system and
hence confirms the low Reynolds number and that the flow will be laminar.
A series of deliveries were performed which expelled a 1 ml volume of water into chicken
breast flesh to simulate the intestinal pressure at the end of the needle tip. The needle was
orientated in the vertical configuration as it guaranteed needle penetration and prevented
the chicken breast flesh from being pushed away from the needle due to the pressure of the
delivery force. The set-up used to measure the delivery force can be seen in Figure 6.6.
Figure 6.6: Left: Medication delivery force experimental set-up comprising: a 2.5 ml syringe
body mounted on a block, the Ø0.38 mm bore needle fitted to the syringe and a MultiTest
2.5-i test system fitted with a 5 N loadcell and connected to a computer running EmperorTM
(force) software; Right: Needle delivering liquid into a chicken breast test piece
An overlay of the measured load profiles for three deliveries of a 1 ml volume of water
into chicken breast flesh can be seen in Figure 6.7. The average delivery force required to
expel the volume of water was 2.95 N with a standard deviation from the mean of 40 mN.
However subtracting the baseline friction force for a dry delivery of 2.32 N from the delivery
force results in a delivery force of 0.63 N. This figure is very close to the spring’s calculated
start force of 0.59 N (equation 6.4).
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Figure 6.7: Overlay of three plots of the measured delivery force required to deliver a 1 ml
volume of water into chicken breast flesh
The test result plots highlight the behaviour of the delivery method, for example a spike
of 4.08 N can be seen in sample 3 at the beginning of the delivery (Figure 6.7). The spike
can be attributed to the build-up of liquid due to the chicken breast flesh not absorbing
the water quickly enough and hence causing a back pressure. The measured data suggests
that the delivery speed of 5 s should be increased to allow the medication to penetrate and
be absorbed by the tissue however this is based on the behaviour of chicken breast flesh
at room temperature and in-vivo tests would need to be performed to validate the actual
figures.
6.4.2 Spring Deflection Protocol
To deliver the medication in 5 s the variable pitch conical compression spring must be
capable of delivering the calculated force of 0.59 N at the start of the delivery. Therefore
the design of the spring must be validated to ensure its suitability to perform the task. There
are no British Standards or industry standards for the design of conical compression springs
however the Institute of Spring Technology (IST) provides a software package which is based
on theoretical mathematical models and empirical data to aid in the design and analysis of
conical compression springs and also to determine their suitability for manufacture. The
IST software will be used to verify the calculations derived in Section 6.3.2.
The space available onboard the microrobot to house the spring has changed due to
the requirements imposed by the trigger mechanism therefore the spring parameters will be
modified from those used on the theoretical mathematical model (equation 6.4) to accom-
modate the available space. Using the IST spring calculator professional software (v1.0.18)
a prototype 1:1 scale variable pitch conical compression spring will be designed and eval-
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uated for its suitability to deliver the required starting load and also to perform within
acceptable stress levels (59% of UTS).
A stainless steel wire spring (BS 2056 Austenitic 302S26 G2) with a module of rigidity
value of 70.3 GNm−2 has been selected for the prototype spring. The 0.25 mm diameter
wire has 7.5 active coils, 2 dead coils for the purpose of stabilising the spring during testing,
a mean coil radius of 2.6 mm for the first coil and a mean coil radius of 5.12 mm for the final
coil and a free length of 48.84 mm. The modified spring parameters result in a linear spring
rate of 10.9 mN/mm which equates to a theoretical solid state load of 0.53 N however the
software predicts a solid state load of 0.79 N and a solid state stress of 991 Nmm−2 (45% of
UTS). The discrepancy in load can be attributed to one of the coils prematurely touching
at the final stage of compression, this will result in the coil collapsing which in turn will
increase the spring rate. However it is anticipated that manual modification of the spring
end will eliminate this issue and result in the calculated load (0.53 N).
6.4.2.1 Spring Deflection Procedure
The stainless steel variable pitch conical compression spring will be mounted on a mandrel
and held between two supports which have been designed to hold the end coils in position
while the spring collapses. The test set-up used to measure the force delivered by the
compression of the conical spring is presented in Figure 6.8.
The spring will be tested on a MultiTest 2.5-i manufactured by Mecmesin. A 2 N loadcell
(Intelligent loadcell ILC 879-009, ±0.1% of full scale) will measure the load generated by
the compression of the spring from its free state to its solid state. The test will be run at
a velocity of 145.0 mm/min which matches the calculated delivery speed. The compression
program will be run multiple times with the data for each run recorded. The results of the
average peak force at solid state will be combined and the average of these runs will be
used to calculate the delivery force. A further measurement at 12.05 mm deflection will be
recorded and the average force from the deliveries will be used to determine the spring’s
force at the end of its stroke.
6.4.2.2 Results and Discussion
A total of 10 springs were dimensionally inspected on a digital vision measuring system
(TESA Vision 200, TESA Technology UK Ltd.) with the results showing that the 2.6 mm
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Figure 6.8: Variable pitch conical compression spring deflection load test fixture
mean coil radius for the first coil was outside of the design specification at 2.76 mm and the
springs’ free length was 47.7 mm compared to the design value of 48.84 mm. The reduced
clearance between the coils due to the larger radius of the first coil resulted in the coils
touching during the final stages of compression. The coils could not be manually modified
to reinstate the clearance as initially anticipated therefore the springs were tested through
a stroke length of 46.65 mm to minimise the impact of the coils colliding. Figure 6.9 shows
the conical compression spring in its free state.
The test jig was configured such that the mandrel could pass freely in and out of the load-
cell adaptor without generating a false reading on the loadcell due to friction. A 0.50 mm
by 10.30 mm diameter counter bore was positioned in the loadcell adaptor support to ac-
commodate the large coil and to prevent it from moving during compression. The 0.50 mm
depth of the bore allowed clearance for the coils at the end of the stroke. Figure 6.10 shows
the test set-up used to hold the spring vertically between two supports and via a central
mandrel. The spring is also shown in the fully compressed configuration.
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Figure 6.9: 1:1 scale prototype stainless steel variable pitch conical compression spring
A total of 10 springs were compressed 10 times each from a preloaded compression
of 0.20 mm through a stroke length of 46.45 mm to give a total working compression of
46.65 mm. The stroke length allowed 1.05 mm of clearance at the end of the stroke for
the solid state of the spring. The springs were preloaded to stabilise the coils during the
compression sequence and to accommodate slight variations in the overall length of the
spring. A typical load profile of a spring compression can be seen in Figure 6.11.
Figure 6.11 shows a peak load of 0.94 N at the end of the stroke. As the coils could not
be modified manually to eliminate touching during the compression the measured result can
be compared to the calculated figure of 0.79 N. The higher result can be directly attributed
to the coils contacting each other and increasing the spring rate. Figure 6.11 highlights the
change in spring rate through the compression sequence. Between zero and 30.0 mm the
spring rate is 10.93 mN/mm resulting in a peak load of 0.32 N and between 30.0 mm and
46.45 mm the spring rate significantly increases to 37.6 mN/mm, resulting in the peak load
of 0.94 N. The results for the series of tests show that the springs are consistent with an
average spring rate of 10.97 mN/mm for compression up to 30.0 mm and 32.8 mN/mm up
to 46.45 mm. The abrupt changes in load which are evident at 41.85 mm and 46.1 mm are
due to the coils slipping over each other.
It is a requirement that the spring can deliver a force of 0.43 N at the end of its 12.05 mm
stroke to guarantee delivery of the medication in 5 s. It can be seen in Figure 6.11 that
a load of 0.42 N is developed at 35.65 mm compression which represents the end position
of the piston (12.05 mm). The results of the protocol show that the conical compression
spring will deliver sufficient force to expel the medication in 5 s and that the stress in the
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Figure 6.10: Left: Conical spring held vertically between two supports and further supported
via a mandrel; Right: Spring in the fully compressed configuration
spring will be at a safe level as the overall length of the springs remained the same after
repeated operations. The performance of the spring could benefit from some improvements.
For example, generally increasing the clearance between the coils, reducing the number of
coils and increasing the wire diameter would result in a more stable spring which would
deliver a consistent load and have lower levels of stress. However the deliverable force at
the end of the 12.05 mm stroke would drop off slightly resulting in a longer delivery time.
6.5 Summary
This chapter has presented a novel method for the deployment of a metered dose of medi-
cation which can be stored onboard a WCE. The delivery solution allows manual loading
of medication at the point just prior to administration. This feature gives flexibility in the
choice of medication which can be prescribed to the patient therefore broadening the scope
of its use. The medication will pass through a needle which penetrates the tissue of the GI
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Figure 6.11: Load profile of a typical spring compression
tract wall. During the delivery of the medication any air which is trapped in the needle will
quickly disperse into the subcutaneous tissue causing no adverse effects.
The medication delivery analysis and the delivery force analysis (presented in Section
6.3.1 and Section 6.3.2) have been discussed and validated through experimentation using
1:1 scale prototype parts. It has been shown that a stainless steel variable pitch conical
spring can be wound such that it has a solid state thickness of the wire diameter and
that it can deliver sufficient force to expel 1 ml of medication in approximately 5 s. The
parameters chosen to achieve the delivery speed of the medication can be tailored to suit the
specific viscosity of the medication formula by modifying the spring. However examination
of Poiseuille’s equation (6.1) shows that greater control of the medication flow can be gained
by increasing or decreasing the bore of the needle, this would overcome the limitations
imposed on the design of the conical spring due to the limited available space.
To fully validate the medication delivery mechanism a number of design challenges will
be required to be overcome. For example the trigger mechanism will need to be prototyped
and tested at 1:1 scale and in-vivo experiments will be required to validate the release
mechanism and delivery times. The issue of sealing the medication into the chamber and
preventing the medication from leaking through the front ports requires further work. Also
the impact of the additional friction due to the sealing will need to be taken into consider-
ation when designing and validating the spring.
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Chapter 7
Conclusion
This thesis has presented a novel microrobotic platform concept for targeted drug delivery
in the GI tract, Figure 7.1. To facilitate this aim, three novel micromechanical mechanisms
have been investigated: the first mechanism allowed the microrobot to expand sufficiently
to overcome natural peristalsis; the second mechanism achieved the positional control of a
dispensing needle to allow for targeted drug delivery in the small intestinal tract and the
third mechanism achieved delivery of the onboard medication. The additional functionality
represents the state-of-the-art in mechanism design for WCE. It is hoped that the mecha-
nisms will act as a platform for further research into methods of delivering targeted therapy.
Detailed engineering drawings of the mechanisms can be found in Appendix F.
7.1 Contributions
Chapter 2 reviewed the state-of-the-art in WCE through the evaluation of current and past
literature. A review of the limitations of current practises in colonoscopy was presented
and a review of the clinical benefits of performing endoluminal capsule monitoring was
discussed. An evaluation of the background relating to the main themes of methods for
resisting peristalsis, drug targeting systems and drug delivery systems was presented. A
review of actuators was presented, in the context of WCE, with a view to evaluating their
suitability for adding functionality to current WCEs. The specific problems of available
space when it comes to achieving functionality of actuators was highlighted. Fabrication
methods for manufacturing low-volume high-precision component parts were compared and
their process parameters presented. A discussion of current WCE systems highlighted the
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Figure 7.1: Microrobot concept design capable of resisting peristaltic pressure through an
integrated holding mechanism and delivering 1 ml targeted medication. Holding mechanism
shown partially open and the needle fully extended to give 1.5 mm of needle penetration
relevance of the development status of capsule research as the type of category a capsule is
in highlights the capsule’s technology status.
Chapter 3 set out the aims and objectives for this research project. A methodology was
presented which evaluated three research questions which were chosen for their impact on
the design of the microrobot at the early design concept stage. The questions looked at the
optimal physical geometry of the microrobot, which actuator technology was best suited for
the application and what method of resisting peristaltic contractions could be incorporated
into a WCE. Solutions to the complex issue of delivering power through the microrobot were
presented and methods of controlling the orientation of the needle positioning mechanism
were discussed. A comprehensive technical specification of the microrobotic platform was
presented.
Chapter 4 presented a novel biologically-inspired holding mechanism which could be in-
corporated into the next generation of WCE for the purpose of resisting natural peristalsis
in the GI tract. The expanding holding mechanism was the first reported circumferential
holding mechanism driven by a single micromotor. The presented mechanism utilises a
novel configuration of gearing to allow the compact design to drive the holding mechanism.
The detailed analysis of the gear train and the loading on the gears were presented with
the results confirming the materials the gears are to be manufactured from. An analysis of
the two components of peristaltic force were presented and the circumferential and longitu-
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dinal peristaltic contractions were evaluated for their effect on the micromotor’s ability to
deliver torque. Through analysis it was shown that the proposed mechanism was capable
of withstanding the forces generated by the GI environment. A fully functioning 5:1 scale
prototype of the holding mechanism was evaluated and validated through trials.
Chapter 5 presented a novel targeting mechanism capable of delivering a 1 ml dose of
medication to a target site of interest in the GI tract. The targeting mechanism overcame the
problems of positioning a needle in the GI tract, operating the needle and safely retracting
the needle. The operation of the mechanism has been analytically evaluated which resulted
in the selection of the optimum geometry for the features of the mechanism and also which
materials the mechanism should be manufactured from. The evaluation of a 5:1 scale
prototype of the mechanism was presented and through experimentation the function and
operation of the system was validated.
Chapter 6 presented a novel drug delivery system. The system utilised a stainless steel
variable pitch conical compression spring to expel a 1 ml dose of onboard medication through
a retractable needle which has an internal diameter of 0.38 mm and a length of 6.7 mm. A
thermo mechanical trigger mechanism concept was presented which could potentially release
the compressed conical spring. Through experimentation using 1:1 scale prototype springs
and a specially designed plunger combined with a conventional syringe the method for
delivering the onboard supply of medication was validated.
7.2 Recommendations for Future Work
The microrobot concept mechanisms presented in this thesis have been designed to be man-
ufactured using conventional machining techniques. For example the holding mechanism
could be manufactured using a 9 axis sliding head machining centre (Star SV-20) and the
needle positioning mechanism could be manufactured using injection moulding techniques.
A 1:1 scale prototype is a feasible next step however limited resources prevented a scale
prototype from being manufactured at this stage. It is an important requirement that the
component parts can be manufactured using conventional manufacturing techniques as the
ultimate goal of this research is to produce a low cost microrobot which is disposable.
There are a number of elements of the proposed microrobotic system which were not
analysed and validated as part of this investigation such as the complex electronics required
for the control of the microrobot. However to realise a fully functioning prototype capable
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of delivering targeted therapy these elements will need to be addressed. For example the
method for power distribution described in Chapter 3 requires prototyping and validating
at 1:1 scale, also the concept rotary encoder and the modular power supply unit will also
require prototyping and validating.
A number of experiments designed to validate each of the mechanisms have been per-
formed however further work is required on the mechanisms to allow them to be integrated
into a 1:1 scale WCE and then to validate its ability to perform in-vivo targeted drug deliv-
ery. Specifically the holding mechanism requires testing at 1:1 scale to confirm the efficiency
of the gear train and the successful operation of the holding mechanism in the GI environ-
ment. The micromotor chosen to operate the drug targeting mechanism requires testing at
1:1 scale to confirm it is capable of repeatedly positioning and deploying the needle, also
the needle requires prototyping and testing to confirm it is capable of penetrating the tissue
of the GI tract wall. The drug delivery mechanism has been tested at 1:1 scale however
further work is required on the method of sealing the medication chamber and preventing
premature leaking of the medication through the ports. Also further research is required in
the area of localisation as tracking the progress of the microrobot through the GI tract is
an important requirement.
The proposed mechanisms could be adapted to perform a number of different procedures.
For example, reversing the direction of the drug delivery system would allow the retrieval of a
tissue sample from the intestinal tract rather than the delivery of medication. The following
medical procedures may benefit from future developments in the swallowable microrobotic
platform proposed in this thesis:
7.2.1 Gastrointestinal Biopsy
Examination of histological changes in the GI tract is the gold standard in diagnosing celiac
disease [1]. This method of examination can only be performed through the application of
a biopsy procedure. However the small intestines is a very difficult environment to gain
access to with repeated attempts causing increasing discomfort for the patient. Future
research could focus on modifying the positioning mechanism and adapting it to take a
biopsy sample. The basic principle of reversing the system would enable a sample to be
stored safely onboard.
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7.2.2 Pancreas
There has been much research into methods for replacing the pancreas with a device capable
of releasing the required levels of insulin into the body [2]. A limitation with implantable
devices is that they require the insulin supply to be replaced on a regular basis. The
microrobot would provide a simple system which could be adapted to perform this function.
7.2.3 Electrosurgery
Limitations of conventional endoscopes restrict the treatment of diseases such as angiodys-
plasia as the area of interest can only be treated by bipolar electrocoagulation techniques if
it is within the reach of the endoscope [3]. Adapting the microrobot so that it could perform
electrocoagulation would overcome this issue. Future research could look at adapting the
needle positioning mechanism to carry bipolar probes which would administer an electric
current that would result in localised heat. However a further challenge would be in the
development of batteries which would be required to hold sufficient charge to carry out the
operation and still fit within the package size.
7.2.4 Surgical Tools
The ability to surgically remove pathologies of the GI tract such as polyps would bring
great benefits to patients. This function may be realised by research into a chip-scale
particle accelerator [4]. This new technology may be integrated into a WCE through the
modification of the targeting mechanism. The system could then be utilised to manoeuvre
the laser such that it ablates the target site.
References
[1] W. El-Matary, “Wireless capsule endoscopy: indications, limitations, and future chal-
lenges,” Journal of pediatric gastroenterology and nutrition, vol. 46, pp. 4–12, 2008.
[2] M. Ho, P. Georgiou, S. Singhal, N. Oliver, and C. Toumazou, “A bio-inspired closed-
loop insulin delivery based on the silicon pancreatic beta-cell,” in Circuits and Systems,
2008. ISCAS 2008. IEEE International Symposium on, pp. 1052–1055, IEEE, 2008.
[3] A. C. Steger and J. Spencer, “Obscure gastrointestinal bleeding,” British Medical Jour-
nal, vol. 296, p. 3, 1988.
[4] Y. Shi and A. Lal, “Integrated all-electric high energy ion beam guidance on chip:
Towards miniature particle accelerator,” in Micro Electro Mechanical Systems (MEMS),
2011 IEEE 24th International Conference on, pp. 137–140, 2011.
217
Appendix A
Holding Mechanism Concept
Designs
218
Holding Mechanism Concept Designs 219
A.1 Holding Mechanism Concepts
The microrobot is required to be sufficiently small to pass through the small intestines
without becoming an obstruction, however it is also required to expand in some way to
prevent it from moving when a section of the intestinal wall is being examined or when
medication is being administered. This section presents a selection of concept designs
potentially capable of stopping the microrobot.
Concept design 1 attempts to stop the microrobot by utilising a centrally aligned mi-
cromotor and leadscrew to operate two axially aligned legs, Figure A.1.
Figure A.1: Design concept 1 - two axially aligned legs operated by a centrally aligned
leadscrew and micromotor
A single micromotor is employed to perform multiple operations. Concept design 1 uses
the action of the leadscrew delivering the medication to operate two legs. As the leadscrew
rotates it drives a piston forwards pushing the medication out. Attached to the piston are
pins located in slots at the ends of the legs, hence as the piston moves forwards it pulls the
pins in the slot causing the legs to be deployed.
There are numerous disadvantages with this system. For example, the lever ratio pushing
the legs out is too high and therefore the micromotor cannot generate the required torque
to allow the legs to distend the GI tract wall. In addition, the legs cannot be deployed
before the medication is released and the speed of the micromotor is too high causing the
legs to deploy too quickly.
Concept design 2 (Figure A.2) overcomes the problems of delivering torque, controlling
the operation of the legs and the speed of deployment by aligning the legs circumferentially.
The two-legged design utilises a micromotor which is orientated in a vertical position.
The micromotor is engaged with an annular ring through a small gear which drives the
ring. The annular ring is connected to a gear train which drives the legs in and out. This
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Figure A.2: Design concept 2 - two-legged mechanism
novel configuration reduces the micromotor’s RPM. The reduction in RPM will result in a
multiplication of the micromotor’s torque which will give the legs the strength required to
distend the GI tract wall and hold the microrobot in place.
The advantage of the vertical configuration of the micromotor is that it makes for a very
compact design, resulting in efficient use of space. The two legs, along with the microrobot
itself, will give four points of contact against the GI tract wall. This will distribute the load
from the wall evenly about the microrobot. The rate at which the legs are deployed can be
controlled by the ratio of the gears.
The disadvantage with this configuration is that it can only expand the lumen to a
diameter of 15.14 mm which may not be sufficient to hold the microrobot in position for the
majority of patients.
To try and overcome the limitations of expanding the lumen a third leg has been intro-
duced, Figure A.3.
Design concept 3 uses the same gearing mechanism and micromotor configuration as
design concept 2 however it utilises a third leg to distend the lumen further. The third leg
would simply be driven from the existing gearing (through the addition of a gear) which
would allow the leg to be deployed at the same time as the horizontal legs, Figure A.4.
Figure A.4 shows the basic configuration of the proposed design. The gears driving the
legs are positioned inside the annular ring to reduce the volume of the mechanism however
this configuration has potential problems as the gears will be required to sit one on top
of another making fixation in the centre of the gears difficult. This may be overcome by
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Figure A.3: Design concept 3 - section view through the small intestines (a) three-legged
mechanism (b)
supporting the outside diameter of the gears.
The addition of the third leg results in a circumferential length equivalent to a diam-
eter of 16.56 mm. The 1.42 mm increase in diameter is still below the >53.0 mm target
circumference.
Figure A.4: Three-legged design - legs in the stored position (a) legs in the fully extended
position (b)
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B.1 Targeting Mechanism Concepts
A number of design configurations have been investigated for their potential to achieve the
goals of positioning a needle in the GI tract, operating the needle and delivering medication
from within the confines of geometry based on the Enterion capsule. Each new design
concept is intended to overcome the limitations of the previous versions.
An early concept design which showed potential utilised a micromotor mounted along
the central axis of the microrobot to rotate a needle which would deliver medication to a
specific location within the GI tract, Figure B.1.
(a) CAD layout drawing (b) 3D view
Figure B.1: Design concept 4 - a centrally aligned micromotor and leadscrew for the oper-
ation of the needle and deployment of medication
The principle behind design concept 4 (Figure B.1) was to utilise a single micromotor to
perform the multiple operations required such as deploying the needle, delivering the drug
and retracting the needle. The design consisted of a micromotor connected to a leadscrew.
The leadscrew rotated a cover which was attached to the medication chamber. The pressure
in the medication chamber made it act like a solid mass therefore on initial rotation of the
leadscrew the medication chamber would rotate propelling a pivoting needle out of the side
of the microrobot. The distance the needle protruded was dependent on a pin reaching
the end of a slot in the main body. Once the pin stopped the medication chamber from
rotating, pressure in the medication chamber forced the medication out through the needle.
When delivery was complete the medication cover would automatically lock in the forward
position enabling the reverse action of the micromotor to retract the needle.
After discussion and evaluation of the concept with a medical representative1 it was
agreed that the microrobot should have the ability to position the needle within a 360
degree envelope as this would provide maximum control for the operator to deliver therapy.
1N. Oliver, Clinical Research Fellow, Imperial College London, (Personal communication 18 Feb. 2010).
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Concept design 5 (Figure B.2) utilises a combination of micromotors from Faulhaber
and Maxon Motor, and a Squiggle piezoelectric motor to solve the problem of positioning
a needle within the GI tract.
(a) CAD layout drawing (b) 3D view
Figure B.2: Design concept 5 - micromotor combination for needle advancement and re-
traction
As can be seen from Figure B.2 the Faulhaber motor would be employed to deliver the
medication through the operation of a leadscrew, the Maxon motor would be employed to
rotate the needle 360 degrees while the Squiggle motor would be utilised for the advancement
and retraction of the needle. The linear movement of the Squiggle motor makes it an ideal
choice to operate the needle however attempting to mount the motor inside the dimensions
of a capsule proves difficult as the geometry of the Squiggle motor prevents it from being
mounted perpendicular to the central axis of the capsule.
A further design concept, concept 6 (Figure B.3), overcomes the dimensional constraints
of the Squiggle motor by replacing it with a Ø1.9 mm x 5.5 mm long micromotor mounted on
a platform. The platform can be rotated by the Maxon motor and has access to medication
through ports in the medication chamber wall.
(a) CAD layout drawing (b) 3D view
Figure B.3: Design concept 6 - rotating medication platform driven independently from the
needle operating micromotor
It is clear that using these motors in this type of configuration not only presents technical
challenges, such as supplying power to the motor which would be used to drive the needle
in and out, but also that the overall length of the resulting microrobot (>45 mm) would be
prohibitive due to the constraints imposed by swallowing.
Appendix C
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C.1 Medication Delivery Concepts
Once the target location has been reached and the needle deployed, the final stage of the
procedure is to deliver the medication. This section presents a selection of concept designs
potentially capable of administering medication.
Using a leadscrew as a delivery method substantially increases the length of the micro-
robot. Design concept 7 (Figure C.1) maximises the use of space by employing a spring to
activate the medication delivery mechanism. The spring would be employed to push a disc
which in turn would force the medication out through small apertures in the capsule body.
The apertures are inline with a medication delivery mechanism. The medication delivery
mechanism is shaped such that it funnels the medication out through a needle. The needle
is mounted on the medication delivery mechanism and can be driven in and out by a second
micromotor which is also mounted on the medication delivery mechanism.
(a) CAD layout drawing (b) 3D view
Figure C.1: Design concept 7 - spring activated medication delivery mechanism and au-
tonomous needle operation
Using the spring as the medication delivery method releases the micromotor in the
centre of the capsule. The micromotor can now be re-orientated so that it can be employed
to rotate the medication delivery mechanism. This configuration drastically reduces the
volume of the microrobot.
Design concept 8 (Figure C.2) overcomes the requirement for a second motor to drive
the needle in and out by employing a novel mechanism to position and operate the needle.
The design of the needle positioning mechanism consists of a Ø1.5 mm x 10.5 mm long
geared micromotor manufactured by Namiki, two opposing ratchets, a needle funnel, a
needle cam and a movable needle. In addition, features integral to the microrobot’s body
are required.
The novel aspect to this mechanism is that it uses a micromotor to perform two separate
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(a) CAD layout drawing (b) 3D view
Figure C.2: Design concept 8 - novel single micromotor configuration performing two sep-
arate operations
operations. The first operation is the angular control of the position of the needle and the
second is the advancement and retraction of the needle. The medication will be stored in a
compartment of the body and delivered through the needle by means of pressure generated
by a piston. The piston action will be similar to the operation of a syringe and will be
activated by a spring.
It is a requirement that the needle can be positioned at selected points within a 360
degree envelope. For the purpose of prototyping, 16 equally-spaced fixed positions have been
chosen. The angular positioning of the needle is achieved by the anticlockwise rotation of
the micromotor while the advancement and retraction of the needle is achieved by the
clockwise rotation of the micromotor.
An overall reduction in length for the microrobot can be achieved by reconfiguring the
component parts. By placing the power supply inside the area of the compressed spring
(Figure C.2, a) the length of the microrobot reduces from 32.2 mm to 26.95 mm, it also has
the added advantage of allowing easy connection to the micromotor’s terminals.
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D.1 Volume Comparison
The continued improvements from the design iterations presented in Appendix B and Ap-
pendix C can be seen through an analysis of the total volume of the concept designs com-
pared to the target volume of the Enterion capsule (Table D.1). The higher the resulting
merit index the more easily the design can be swallowed.
Table D.1: Concept design volume merit index
Enterion Design 4 Design 5 Design 6 Design 7 Design 8
Design volume cm3 2.86 3.62 4.10 4.26 2.88 2.38
Enterion volume cm3 2.86 2.86 2.86 2.86 2.86 2.86
Merit Index 1 0.79 0.70 0.67 0.99 1.2
Concept designs 1, 2 and 3 have been omitted as they are only partial designs
As can be seen from Table D.1, the results from the volume merit index show that
design concept 7 closely matches the target volume of the Enterion capsule. However design
concept 8 has a volume merit index of 1.2 which is a 16.8% reduction in volume compared
to the target Enterion capsule. This highlights the improvement which has been gained by
employing the novel needle positioning system and power configuration.
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E.1 PEEK Beam Bending Trial
Before prototyping a scaled model of the needle funnel (Chapter 5, Figure 5.3, a)) it was
necessary to gain an idea of how the chosen PEEK material would perform in reality rather
than relying on simulated results. For this purpose a PEEK test piece was devised and
subjected to a range of bending loads, Figure E.1, b).
(a) Von Mises FEA analysis (b) PEEK test piece
Figure E.1: Von Mises FEA 2D isoareas analysis (a) and plan view of PEEK test piece at
42.4X magnification (b)
Figure E.1 represents a Von Mises FEA analysis (a) and a magnified view of the actual
PEEK test piece (b). The dimensions of the arm are 2.15 mm long by 0.3 mm high and
0.4 mm wide. The test piece is shorter than the required 4.0 mm long needle positioning
arm as a result of the restrictions imposed by the available manufacturing method. However
the results will be valid as a longer lever arm will result in a lower applied load and hence
a lower induced stress in the beam.
An FEA analysis has been carried out on the test piece before prototyping the piece
to ensure the geometry is within reasonable operating parameters. Using a calculated
maximum load of 0.19 N from the predicted deflection of 200µm it was found that the
maximum Von Mises stress of 68.26 Nmm−2 was restricted to the surface of the corners of
the test piece with only a contour band of dark blue penetrating through the arm between
17.06 Nmm−2 and 22.75 Nmm−2. The predicted results show that there would be no areas
of the arm which would exceed the 97 Nmm−2 yield point of PEEK.
The deflection experiment was performed on a profile projector type PJ-300 manufac-
tured by Mitutoyo at 10X magnification. The edge of the test piece was aligned with the
profile projector’s cross hairs to ensure the test piece was in a horizontal alignment at the
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start. The cross hairs were then advanced 50µm away from this edge. The arm tip was
gently pushed until it reached the cross hairs whereupon it was released allowing the arm
to return to its original position. This process was repeated for 100µm, 150µm and 200µm
positions with the arm successfully returning to its origin after each new position. This
method of testing ensures the accuracy of the deflection measurement.
The successful movement of the arm through to the 200µm position gives added con-
fidence that the prototype needle positioning arm will perform as required, as the 200µm
distance exceeds the design requirement of 170µm.
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Figure F.1: Final assembly drawing
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Figure F.2: CAD layout drawing of the needle CAM
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Figure F.3: CAD layout drawing of the leg cover
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Figure F.4: CAD layout drawing of the gearbox - legs
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Figure F.5: CAD layout drawing of the needle carrier
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Figure F.6: CAD layout drawing of the main body
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Figure F.7: CAD layout drawing of the 16 teeth needle funnel ratchet
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Figure F.8: CAD layout drawing of the 0.1 mod spur gears
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Figure F.9: CAD layout drawing of the 0.2 mod bevel gear set
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Figure F.10: CAD layout drawing of the bevel gear cover
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Figure F.11: CAD layout drawing of the expanding leg (right)
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Figure F.12: CAD layout drawing of the expanding leg (left)
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Figure F.13: CAD layout drawing of the centre support
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Figure F.14: CAD layout drawing of the leg tie
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Figure F.15: CAD layout drawing of the needle funnel
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Figure F.16: CAD layout drawing of the 16 teeth cam ratchet
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Figure F.17: CAD layout drawing of the flexible contact PCB
Detailed Engineering Drawings 251
Figure F.18: CAD layout drawing of the leg pivot pin
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Figure F.19: CAD layout drawing of the domed top
Detailed Engineering Drawings 253
Figure F.20: CAD layout drawing of the case pin
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Figure F.21: CAD layout drawing of the contact pin
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Figure F.22: CAD layout drawing of the flexible needle funnel PCB
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Figure F.23: CAD layout drawing of the case pin (large)
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Figure F.24: CAD layout drawing of the needle grinding details
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Figure F.25: CAD layout drawing of the variable pitch conical compression spring
